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 The emergence and spread of antibiotic resistance in bacteria 
constitutes one of the major challenges to global public health and is 
predicted to further escalate during the 21st century. One of the most 
frequent multi-drug resistant pathogens is methicillin-resistant 
Staphylococcus aureus (MRSA), a gram-positive coccoid bacterium that 
causes difficult to treat infections with severe morbidity and 
mortality rates. Many of the commonly used antibiotics target steps 
in the biosynthesis of peptidoglycan (PG), a robust but flexible mesh-
like macromolecule that withstands the intense internal turgor in the 
cell, among other functions. The integrity of the PG layer is of the 
utmost importance to bacteria, which must ensure that incorporation 
of new PG strands and remodelling of the existing ones is timely 
coordinated with the progression of the cell cycle. Despite its clinical 
relevance, many fundamental biological processes in S. aureus remain 
to be elucidated.  
In this thesis we have used Super-Resolution Structured 
Illumination Microscopy (SIM) to show that S. aureus cells grow 
continuously during the entire cell cycle and undergo slight 
elongation. Cell growth is accompanied by PG synthesis, which 
occurs all around the periphery of the cells before the initiation of 
septum synthesis and strikingly shifts almost exclusively to mid-cell 
in preparation for division. Intrigued by the timely shift of peripheral 
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to septal PG incorporation, we decided to investigate the molecular 
mechanism mediating this transition. We studied the localisation of 
most proteins known to be involved in PG synthesis in S. aureus and 
determined that the putative PG precursor flippase MurJ localised to 
the septum in a manner dependent on the presence of divisome 
components DivIB, DivIC and FtsL, and that MurJ recruitment was 
required for septal PG incorporation. Inhibiting MurJ activity 
prevented PG incorporation both at the periphery and at mid-cell and 
affected the initiation of septum synthesis. Our data indicates that 
timely recruitment of MurJ to the divisome constitutes a novel 
mechanism which prokaryotes use to incorporate PG at two locations 
in the cell in the absence of an elongation machinery  
We concluded our characterisation of the S. aureus cell cycle 
by investigating the dynamics of the process of reshaping the flat 
division septum into a curved surface (popping), following daughter 
cell splitting. We determined that this process occurs in less than 2 
miliseconds and is dependent of both autolysin activity and internal 
turgor pressure. After splitting, the flat septum generated a curved 
surface which occupied approximately 40% of the cell surface and 
this proportion did not change with the progression of the cell cycle. 
This indicates that the new wall material coming from the septum of 
the mother cell is not selectively remodelled during the cell cycle. 
In an effort to identify new targets which could be useful for 
pathogen specific drug design, we studied the Fem family of 
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transferases, which build the characteristic pentaglycine crossbridges 
present in the PG of S. aureus. Depletion of femAB expression in the 
background of community-associated MRSA (CA-MRSA) strain 
MW2 was lethal and caused cells to appear as pseudomulticellular 
forms that lysed due to extensive membrane damage, indicating that 
pentaglycine crossbridges are required to withstand internal turgor. 
Mutation of residues K180 and R181 of FemA, located in the α6 helix, 
predicted to be involved in binding of tRNA, led to a severe decrease 
in FemA activity, indicating that the α6 helix of FemA is important 
for protein activity and could be a good target for drug design. 
A second approach to contribute to antibiotic development 
consisted on investigating the modes of action (MOA) of novel small 
molecules PC190732 and DNAC-1 using cell biology tools. We found 
that PC190732 caused delocalisation of S. aureus FtsZ away from the 
mid-cell, which in turn led to the concomitant delocalisation of PBP2, 
indicating that PC190732 caused cell death by interfering with 
divisome assembly and septal PG synthesis. In contrast, DNAC-1 led 
to rapid permeabilisation of the cell membrane, loss of membrane 
potential and consequent delocalisation of membrane-associated 
proteins FtsZ, PBP2 and PBP4. 
This dissertation aimed to understand how PG synthesis is 
coordinated with the progression of the cell cycle in a clinically 
relevant pathogen, and to use this knowledge to contribute towards 










 A resistência a antibióticos em bactérias constitui um dos 
maiores desafios à saúde pública mundial na actualidade, e prevê-se 
que a situação vá piorar significativamente durante o Séc. XXI. Um 
dos grandes factores de risco são estirpes da bactéria Gram-positiva 
Staphylococcus aureus resistentes à meticilina (MRSA), que causam 
infecções hospitalares de difícil tratamento e com elevadas taxas de 
mortalidade. Muitos dos antibióticos de uso comum têm como alvo 
passos da síntese do peptidoglicano (PG), uma macromolécula 
robusta e flexível que suporta a elevada pressão interna na célula, 
entre outras funções. A integridade da camada de PG é de extrema 
importância para a bactéria, pelo que os processos de incorporação de 
novas cadeias de PG e de remodelação das cadeias existentes têm de 
ser coordenados de modo preciso com o ciclo celular. Apesar da 
relevância clínica de S. aureus, muitos dos processos biológicos 
fundamentais ainda não foram elucidados nesta bactéria.  
 Nesta dissertação utilizámos microscopia de superresolução 
(SIM) para mostrar que as células de S. aureus aumentam de volume 
durante todo o ciclo celular e alongam ligeiramente. Este crescimento 
celular é acompanhado de síntese de PG, que ocorre 
homogeneamente em toda a superfície da célula antes do início da 
síntese do septo, mas que surpreendentemente transita quase 
exclusivamente para o meio da célula, em preparação para a divisão 
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celular. Para investigar o mecanismo molecular subjacente a esta 
transição, estudámos a localização da maioria das proteínas 
envolvidas na síntese de PG em S. aureus. Verificámos que a 
localização no septo da proteína MurJ, a possível translocase dos 
percursores do PG, depende da presença dos componentes do 
divisoma DivIB, DivIC, FtsL, e que o seu recrutamento é necessário 
para a incorporação de PG no septo. Para confirmar esta hipótese 
usámos um inibidor de MurJ e verificámos que a incorporação de PG 
tanto na periferia da célula como no centro foi drasticamente 
reduzida, e que tal preveniu o início da síntese do septo. Os nossos 
estudos indicam que o recrutamento da MurJ para o divisoma 
constitui um novo mecanismo pelo qual procariotas inserem novo PG 
em duas localizações distintas da célula, quando não possuem uma 
maquinaria de elongação.  
 Concluímos a nossa caracterização do ciclo celular de S. aureus 
ao investigar a dinâmica do processo de remodelação do septo plano 
para uma superfície curva, que ocorre imediatamente após a 
separação das células-filhas. Este é um processo extremamente 
rápido, que ocorre em menos de 2 milisegundos, e que depende tanto 
de actividade enzimática de hidrólases do PG como de pressão 
osmótica interna na célula. Após a separação das células-filhas, a 
remodelação do septo gera uma superfície curva que ocupa 
aproximadamente 40% da superfície total da célula. 
Surpreendemente, esta proporção não sofre alterações durante o ciclo 
celular, indicando que, ao contrário do que se pensava até à data, o 
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septo da célula-mãe não é selectivamente remodelado durante o ciclo 
celular.  
 De modo a identificar novos alvos moleculares que possam 
ser explorados no desenvolvimento de antibióticos específicos contra 
S. aureus, decidimos estudar as proteínas Fem, transferases que 
sintetizam as pontes de pentaglicinas características do PG de S. 
aureus. A redução da expressão de femAB na estirpe MW2, uma 
estirpe MRSA isolada na comunidade (CA-MRSA), resultou em 
células pseudo-multicelulares e na consequente lise celular devido a 
ruptura da membrana, o que indica que as pontes de pentaglicinas 
são necessárias para o PG suportar a pressão osmótica interna da 
célula. A mutação dos aminoácidos K180 e R181, contidos na hélice 
α6 da FemA, levaram a uma diminuição acentuada da actividade da 
proteína, o que sugere que esta região é importante para actividade e 
que pode constituir um bom alvo para o desenvolvimento de 
antibióticos contra S. aureus. 
 De modo a contribuir para o desenvolvimento de antibióticos, 
investigámos o mecanismo de acção (MOA) em S. aureus de duas 
novas moléculas – o PC190732 e o DNAC-1 – através de técnicas de 
biologia celular. Observámos que o PC190732 causou a deslocalização 
de FtsZ para fora do septo, com concomitante deslocalização de 
PBP2, o que indica que o PC190732 leva à morte celular por interferir 
com a síntese de PG no septo. Em contraste, o DNAC-1 levou à 
rápida permeabilização da membrana celular, dissipação do potencial 
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de membrana e consequente deslocalização da FtsZ, PBP2 e PBP4, 
proteínas associadas à membrana.  
 Esta dissertação teve como objectivo determinar como é que a 
síntese de PG é coordenada com o ciclo celular de uma bactéria de 
importância clínica e usar esse conhecimento para contribuir para a 




















Bacteria and us: an evolving relationship 
 To study bacteria is to study Life itself. It is the journey of how 
life appeared in our planet and how it thrives under the most extreme 
of circumstances. It is to realize that Nature will always find a way to 
improvise, to adapt and to overcome any challenge. It is to witness 
the constant struggle of organisms, competing and cooperating with 
each other, screaming for their right to exist. 
 Modern bacteria descend directly from unicellular 
microorganisms that were the first lifeforms to appear on Earth and 
were the dominant species for about 3 billion years thereafter1,2. 
Bacteria have spent this time evolving diverse metabolic pathways 
that allow the use of a wide range of energy sources. Hence bacteria 
can survive in virtually every ecological niche, from the deepest 
ocean bed3 to the highest mountain peaks4, from ice-cold marine 
environments5 to volcanic springs and hydrothermal vents6. Some 
bacteria produce spores that are resistant to cosmic rays and UV 
radiation7, leading scientists to speculate that spores could withstand 
interstellar travel and, in turn, that life on Earth has been seeded by 
meteorites carrying microorganisms (Panspermia). Others form vast 
photosynthetic blankets over the oceans and have single-handedly 
caused the oxygenation of the Earth’s atmosphere and the 
consequential mass extinction of most anaerobic species at the time. 
Some bacteria live inside other bacteria, which themselves colonise an 
animal host, the three organisms thriving in a symbiotic circle8. 
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The Microbiome  
All higher order multicellular organisms studied to date, from 
plants to animals including humans are complex ecological 
environments inhabited by thousands of prokaryotic species, along 
with other microorganisms, the so called microbiome9. 
Microorganisms that establish commensal or mutualistic 
relationships with the host are collectively described as microflora 
and often constitute an important part of the host’s metabolism. The 
gut flora in particular is known to provide protection against 
pathogenic species10, to indirectly stimulate the development of the 
immune system11 and to break down complex metabolites using 
enzymes the host lacks12. Accordingly, sudden changes in microbiota 
composition have been implicated with numerous health afflictions, 
from cardiovascular disease13 to type 2 diabetes14. Exciting new 
avenues of microbial research have been exploring the notion that the 
composition of intestinal microbiota might influence cerebral 
development and social behaviour15,16. Although the long-standing 
myth that there are ten times more microbial cells than human cells in 
our bodies has been recently debunked, current estimates still predict 
that microbes outnumber our own cells17. This has prompted many 
scholars and lay media outlets to enthusiastically propose that we are 
more bacterial than human, or that bacteria are in control of our 
brains, a hyperbolic argument that undermines the complexities of 
interspecies relationships. Instead, perhaps the definition of what is 
self and what is foreign needs to be revised, taking into consideration 
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that in reality the human body functions as an association of 
eukaryotic and prokaryotic cells. 
The Eternal War 
The concept of “good bacteria”, the usage of bacterial 
supplements for direct consumption (probiotics), or medical 
therapies based on using bacteria are ideas that only started to gain 
significant traction in public knowledge towards the tail end of the 
20th century. Bacterial infections are traditionally regarded as some of 
the worst public health challenges Mankind has faced. Some 
infectious diseases such as the plague, caused by Yersinia pestis, have 
historically appeared in waves of epidemics, with the 14th century 
wave (Black Plague) claiming two thirds of the European population 
at the time. Other infectious diseases such as tuberculosis or cholera, 
caused by Mycobacterium spp. and Vibrio cholera, respectively, have 
constantly existed since antiquity18 and are far from being eradicated 
from the modern world. 
Serious bacterial infections were typically a death sentence 
until Alexander Fleming’s discovery of penicillin in a mouldy Petri 
dish in 192819. Penicillin was one of the first discovered antibiotics 
and considered a miracle drug at the time, effective against a wide 
range of bacterial infections and easily tolerated by patients. 
Penicillin is part of a family of molecules called β-lactams, which 
target the aptly named penicillin-binding proteins (PBPs), enzymes 
involved in bacterial wall synthesis. Following a large push to 
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overcome the limitations associated with mass producing the drug, it 
was readily deployed to the Allied frontlines during World War II to 
treat infections in wounded soldiers20. Penicillin usage became 
widespread in clinical practices and soon thereafter, bacterial strains 
resistant to penicillin started to appear. What follows can be 
described as an arms race between humans and bacteria: new drugs 
have sequentially been developed to deal with resistant strains and as 
soon as they are introduced, bacteria develop resistance against them, 
prompting the need for new drugs. This cycle propagated throughout 
the 20th century and the situation has escalated to a point in which the 
so called “superbugs”, bacteria resistant to several classes of 
antibiotics, have emerged21-24. Superbugs are poised to become the 
most serious public health challenge that Humanity will face in the 
21st century, threatening to take us back to a pre-penicillin dark age of 
medicine25.  
Staphylococcus aureus in the Age of Antibiotic Resistance 
 One of the higher risk superbugs is the Gram-positive human 
pathogen Staphylococcus aureus, which is the focus of this dissertation. 
S. aureus are small (~1 µm) non-motile coccoid Firmicutes which form 
golden (Latin aureus) colonies when cultivated in blood plates and 
appear as grape-like clusters when observed under the microscope. 
These bacteria are usually part of the human microbiota, colonising 
the skin and the nasopharynx asymptomatically in about as much as 
a third of the human population26,27. When the skin or mucosal 
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protective layers are breached, S. aureus is capable of causing a wide 
range of infections, from skin and soft tissue infections to pneumonia, 
septicaemia, infective endocarditis and osteomyelitis28. Transmission 
is usually through skin-to-skin contact between carriers or through 
contact with contaminated objects or surfaces29-32. S. aureus is 
primarily a threat in healthcare settings, where it affects 
immunocompromised individuals or debilitated patients recovering 
from surgery32.  
 Antibiotic resistance in S. aureus has been eloquently 
described as a process that occurs in waves21. The first wave of 
resistant strains in the 1940s expressed a plasmid-encoded β-
lactamase, capable of degrading the β-lactam penicillin, thus 
rendering it inactive33,34. To counter this, methicillin, a semisynthetic 
derivative of penicillin that binds PBPs but is insensitive to β-
lactamase, was developed in 195935. The emergence of methicillin 
resistant S. aureus strains (MRSA) marked the second wave of 
resistance21. MRSA strains acquired the resistance determinant mecA, 
contained in an exogenous DNA mobile element designated SCCmec 
(staphylococcal cassette chromosome mec), which was inserted in the 
genome36-39. mecA is proposed to have originated from Staphylococcus 
sciuri through horizontal gene transfer, due to the presence of a mecA 
evolutionary ancestor in all isolates of this species40. It encodes for 
PBP2A, an enzyme that has low affinity for β-lactams and thus is still 
active in the presence of these antibiotics41,42. This mechanism of 
resistance then confers high level resistance to all classes of β-lactams 
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(penicillins, cephalosporins, carbapenems). Adjacent to mecA in the 
SCCmec are mecR1, encoding a membrane signal transduction protein 
and mecI, a transcriptional regulator. These genetic elements ensure 
that mecA expression is usually repressed43. However, heavy 
methicillin (mis)usage in the 1970s has created selective pressure that 
resulted in isolates that have mutations in the mecA or mecI promoter 
regions, which loosened the control over mecA expression44. These 
strains with permissive PBP2A expression thus constitute the 
ongoing third wave of MRSA21.  
 In spite of the development of several generations of new 
antibiotics, infections by MRSA have reached global epidemic 
proportions. MRSA now represents >60% of nosocomial isolates of S. 
aureus in a variety of countries45 and carriage of hospital-acquired 
MRSA (HA-MRSA) is endemic among hospitalized patients22,46. The 
2016 surveillance atlas from the European Centre for Disease Control 
(ECDC) reports that the proportion of isolates resistant to methicillin 
in staphylococcal infections sits above 20% in 10 out of 30 European 
countries analysed. MRSA prevalence is particularly high in Southern 
and Eastern European countries, for example in Portugal 





Figure 1. MRSA prevalence in Europe in 2016. Surveillance Atlas for 
infectious diseases of the European Centre for Disease Control, showing the 
proportion of methicillin resistant S. aureus (MRSA) isolates found in 
bloodstream infections reported in Europe in 2016. The prevalence of MRSA 
is particularly high in Southern and Eastern Europe. Adapted from 
http://atlas.ecdc.europa.eu.  
 
 Usually confined to healthcare settings, MRSA infections have 
started to emerge in communities during the late 90s. These 
community-acquired MRSA strains (CA-MRSA) constitute the 4th 
wave of S. aureus resistance and have been reported in the US, 
Canada, Asia, South America and Europe47-50. Contrasting with HA-
MRSA, CA-MRSA strains can infect otherwise healthy individuals 
without predisposing risk factors. CA-MRSA strains constitute a 
major public health concern in the US in particular, where the vast 
majority of infections are caused by a clone known as pulse-field type 
USA30051. USA300 is an extremely virulent strain, infamous for 
causing life-threatening infections that progress unusually rapidly 
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and spread from host-to-host with ease, even when compared to 
other MRSA strains49,52,53. 
Traditionally, MRSA strains are reliably susceptible to the 
glycopeptide vancomycin54. Vancomycin is an inhibitor of cell wall 
synthesis which is extracted from soil prokaryote Amycolaptosis 
orientalis and that started being commercialized ca. 195455. 
Vancomycin therapy was typically a last resort measure against 
difficult to treat MRSA infections, mainly because vancomycin is 
significantly nephrotoxic, but also due to increased awareness of how 
bacteria acquire resistance54. Nevertheless, the increasing spread of 
MRSA demanded an over-reliance on vancomycin use and 
unsurprisingly, the turn of the century witnessed the emergence of 
vancomycin intermediate (VISA) and vancomycin resistant (VRSA) S. 
aureus strains56,57. As of today, S. aureus has managed to evolve 
resistance to virtually every sophisticated antibiotic that has been 
developed against it, including protein synthesis inhibitors such as 
minocycline58 and linezolid59 or the potent membrane depolarization 
effect of daptomycin60. Resistance mechanisms are often quite 
inventive too, for example in order to avoid exposure to daptomycin, 
resistant S. aureus strains have evolved to release phospholipids that 
sequester this antibiotic, preventing it from reaching the bacterial 
membrane, where it is active61. The extraordinary ability of this 
species to overcome every challenge it has been presented with is 
truly a testament to Nature’s adaptability. 
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An exciting recent report by Ling and colleagues62 describes a 
new natural antibiotic, teixobactin, an inhibitor of cell wall synthesis 
with exceptional activity against several Gram-positive pathogens. 
Importantly, serial passages of both S. aureus and M. tuberculosis 
strains in the presence of low dosage teixobactin, a method 
commonly used to simulate acquisition of resistance through 
selective pressure, failed to produce resistant mutants62. It is possible 
that teixobactin is part of a family of undiscovered natural products 
which have evolved to minimize resistance development by target 
microorganisms and their introduction into the clinic could be an 
important, even definitive, step in the struggle against superbugs. Yet 
the lessons learned from the 20th century antibiotic 
development/resistance acquisition cycles mandate a cautious 
optimism, as bacteria have proven time and time again that they will 
have a say. 
The State of Antibiotic Development 
 Most antibiotics in current clinical use were discovered in the 
50s, known as the Golden Age of antibiotic discovery, and have since 
lost patent protection which equates to now being sold as low-cost 
generics. Thus, large pharmaceutical companies now channel their 
resources towards the development of cancer and chronic disease 
therapies, which provide tremendous financial returns63,64. 
Development of new drugs used to treat infections is mostly handled 
by start-up small biotechnology companies nowadays and following 
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the drug development cycle and introduction to the market, sales of 
new molecules often severely underperform64. Examples of recent 
drugs in the market are fidaxomycin, a highly potent antibiotic 
specific for the treatment of Clostridium difficile infections65, or 
glycopeptides oritavancin/telavancin, which were specifically 
developed to treat serious MRSA infections66. Yet despite the 
advantages in patient treatment provided by these new drugs, the 
reality is that in the market they compete directly with generic 
vancomycin and daptomycin, which are much more affordable, and 
so remain the preferential treatment64. Moreover, new drugs have to 
be used only as a last resort, in order to ensure that they will still be 
efficient when the common therapies fail, as was the case when 
vancomycin was introduced. These restrictions, while logical and 
necessary, severely harm sales of new antibiotics which in turn 
decrease the push to invest in new solutions.  
An avenue of drug development that is considerably more 
marketable is towards synergistic therapy, where a new molecule is 
commercialized as an adjuvant in combination with an existing 
antibiotic. A prime example of those is the β-lactam/β-lactamase 
inhibitor combination therapies, of which the amoxacillin/clavulanic 
acid combination (Clavamox, Augmentin) remains the golden 
standard. The recent emergence of Klebsiella pneumoniae strains 
resistant to these treatments (carbapenem-resistant 
Enterobacteriaceae or CRE) has spurred on efforts to find new 
treatment combinations. A promising solution for the coming CRE 
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scourge is a combination of new β-lactam, relebactam, with the old 
imipenem plus β-lactamase inhibitor cilastatin, which is being 
developed by Merck, Inc. and is currently in Phase 3 clinical trials67. 
Other antibiotic classes which have been used for many decades but 
have seen a significant push in development recently are i) 
macrolides, protein synthesis inhibitors, most which are derivatives 
of “old” drug erythromycin that achieve high tissue penetration and 
thus are effective at treating intracellular infections68; ii) 
fluoroquinolones, that inhibit DNA gyrase and topoisomerase IV, of 
which Zabofloxacin (Dong Wha Pharmaceutical Co. Lda.) is currently 
in Phase 3 and showing high activity against upper respiratory tract 
infections (S. aureus, Streptococcus pneumoniae, Moraxella catarrhalis)69; 
iii) oxazolidinones, protein synthesis inhibitors, such as MRX-1 
(MicuRx Pharmaceuticals, Phase 2) which is being developed 
primarily as a response to the emergence of vancomycin-resistant 
enterococci (VRE) but also works well against MRSA70. Another class 
of antibiotics that has only recently started being considered for 
therapy are the defensin mimetics. Defensins are small antibacterial 
peptides that form part of the innate immunity in animals and plants. 
Because defensins are small molecules, synthesing them in vitro is a 
fairly simple process; unfortunately the first attempts to produce 
defensin mimetics led to molecules with low potency and stability64. 
The hopes for defensins as viable treatment options now rest with 
brilacidin (Polymedix), a defensin-mimetic designed to mimic the 
amphiphilic properties of antimicrobial peptides71. Brilacidin is 
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currently in Phase 2 trials and showing high activity against MRSA, 
while analogs with enhanced specificity towards Gram-negative 
superbugs are in concurrent development71.  
Besides the aforementioned teixobactin breakthrough, no 
other new classes of antibiotics have been discovered in the past 50 
years, and antibiotic resistance is evolving faster than the arrival of 
new drugs into clinical practice62. There is a clear urgent need for 




The Bacterial Armour 
Survival of most bacteria depends on their ability to build a 
robust cell wall that can interface with the external milieu. Therefore it 
comes as no surprise that the vast majority of natural or synthesized 
antibiotic classes target the bacterial wall. The cell wall composes the 
thick outermost layer of the cell in Gram-positive bacteria (excluding 
encapsulated species) or sits underneath the outer membrane in 
Gram-negatives72,73. In both types of prokaryotes, the scaffold of the 
cell wall is the cross-linked polymer peptidoglycan (PG), also known 
as murein. PG is a mesh-like structure that can be up to 20-40 nm in 
thickness in Gram-positives74. The cell is under constant osmotic 
stress due to high internal pressure, which is sustained by the long 
glycan strands of peptidoglycan, crosslinked to each other through 
flexible peptide bridges. This generates a robust but elastic structure 
that prevents the protoplast from lysing75. In most Gram-positive 
bacteria, the cell wall envelope is also composed of polysaccharides, 
teichoic acids and proteins that are covalently linked or immobilized 
to PG76.  
Peptidoglycan Structure 
The basic architecture of PG is remarkably well conserved in 
Eubacteria. Glycan strands are composed of alternating 1,4-linked N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) 
disaccharides. Glycan length can range from 6 disaccharide units in S. 
aureus77 to 20-50 units in Escherichia coli or Bacillus subtilis75,78. Attached 
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to the carboxyl group of the MurNAc residue is a chain of amino 
acids commonly known as stem peptide, whose length and 
composition varies considerably between bacterial species79. Stem 
peptides are typically composed of L- and D- amino acids and one 
dibasic amino acid in the third position of the chain. This amino acid 
is either L-lysine, which is found in most Gram-positive species 
including S. aureus (Fig. 2A); or meso-diaminopimelic acid, found in 
most Gram-negative bacteria and some Gram-positives, such as B. 
subtilis79,80. One dissacharide unit containing a stem peptide is 
commonly known as a muropeptide (Fig. 2A).  
Another structural feature of PG is the presence of crosslinks, 
which are peptidic connections between glycan strands. Crosslinks 
can be done directly from the D-alanine moiety in the fourth position 
of the stem peptide to the meso-diaminopimelic acid of another 
muropeptide, as is observed in E.coli and B.subtilis PG72,79. 
Alternatively muropeptides can be cross-linked via peptide bridges 
(crossbridges) that show significant interspecies variation. For 
instance, Gram-positive bacteria Weissella viridescens and Enterococcus 
faecalis build crossbridges composed of D-alanine81 or D-alanine-D-
alanine82, respectively, while S. pneumoniae can alternate between L-
alanine-L-alanine and L-alanine-L-serine crossbridges or do direct 
crosslinking of glycans83. In contrast, S. aureus crosslinks its PG using 
pentaglycine bridges between the D-alanine in the fourth position of a 
muropeptide and the L-lysine in the third position of another (Fig. 
2B). This unique feature likely confers high structural flexibility to the 
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whole PG macromolecule, which possibly allows for the high degree 
of crosslinking (up to 90%) that has been observed in S. aureus 
strains84,85.  
 
Figure 2. Structure of Staphylococcus aureus peptidoglycan. (A), A 
muropeptide of S. aureus PG consists of a GlcNAc-MurNAc disaccharide 
with a five amino acid stem peptide linked to MurNAc and a pentaglycine 
crossbridge connected to L-lysine. (B), Crosslinking of glycan strands in PG, 
using pentaglycine bridges, is done between the D-ala in the fourth position 
of the stem peptide of the first muropeptide and the L-lysine in the second 
muropeptide. 
 One of the most complex unsolved challenges in biochemistry 
pertains to the spatial structure of peptidoglycan, which likely varies 
from bacteria to bacteria, even among ones that possess identical PG 
chemical compositions86. The two main models proposed for the 
organization of PG are the layered87,88 and the scaffold89,90 (hedgehog) 
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models, which differ on the orientation of PG growth in respect to the 
membrane. The former depicts layers of PG growing parallel to the 
membrane, while the latter states that glycan strands grow outward 
from the membrane and orthogonal to it. In Gram-negative species 
the scaffold model does not seem compatible with the architecture of 
PG, because vertical alignment of the long glycan chains (average 30 
disaccharide units) would far exceed the maximum sacculus 
thickness measured to date (7 nm)89,91. Accordingly, cryo-electron 
tomography (CET) observations in Caulobacter crescentus revealed 
loosely packed and disordered PG sheets running in parallel to the 
bacterial membrane, favouring the layered model92. More recently, 
Turner and colleagues93 used atomic force microscopy (AFM) to 
probe a variety of Gram-negative species and found large pore 
structures distributed randomly in the sacculus, also consistent with a 
loose configuration. As mentioned above, glycan chain length is quite 
small in S. aureus (average 6 disaccharide units). Therefore it has been 
suggested that the vertical alignment of highly crosslinked PG would 
be more resistant to mechanical stress than short layers aligned along 
the membrane, favouring the scaffold model89. However, a recent 
approach to this problem by Kim et al.94, using solid-state NMR, 
revealed a surprisingly ordered and densely packed structure with 
parallel orientation to the membrane, as predicted in the layered 
model. Interestingly, the authors also characterized PG from E. 
faecalis, which has a (L-Ala)3 crossbridge structure, as well as S. aureus 
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mutants with shortened crossbridges and could conclude that bridge 
length is likely a key determinant in the spatial organization of PG94,95.  
Building the Wall - Overview 
 Peptidoglycan biosynthesis is a multi-enzymatic pathway that 
spans three compartments of the bacterial cell: the cytoplasm, the 
inner and the outer leaflets of the bacterial membrane, as depicted in 
Fig. 3. A detailed description of this pathway will be given in the 
following sections. As mentioned above, most of the known 
antibiotics target specific steps in this pathway; brief descriptions of 
their molecular targets will be given, when applicable. 
 
Figure 3. PG biosynthesis in Staphylococcus aureus. Synthesis of PG can be 
divided in three stages, each taking place in a different bacterial 
compartment. (1) the first stage takes place in the cytoplasm, with the 
synthesis of the soluble precursor UDP-MurNAc-pentapeptide, which is 
then transferred to lipid carrier undecaprenyl-pyrophosphate, giving Lipid I 
(2) During the second stage, at the inner side of the membrane, a GlcNAc 
moiety is transferred to lipid I, giving lipid II, which is further modified by 
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the addition of a pentaglycine bridge, before being flipped across the 
membrane. (3) In the last stage, at the outer leaflet of the membrane, lipid II 
is incorporated into the growing PG network by transglycosylation and 
transpeptidation reactions. Adapted from 96. 
 
Building the Wall – The cytoplasmic steps 
PG synthesis in S. aureus starts with the reversible conversion 
of Fructose-6-P to the nucleotide sugar-linked precursor uridine 
diphosphate-GlcNAc (UDP-GlcNAc) by GlmSMU proteins97. The first 
committed step in PG synthesis is the conversion of UDP-GlcNAc 
and phosphoenolpyruvate into uridine diphosphate-MurNAc (UDP-
MurNAc) and inorganic phosphate. This reaction is catalysed by 
MurA and MurB enzymes98-100. This is followed by synthesis of the 
stem peptide, beginning at the carboxyl group of UDP-MurNAc, with 
amino acids L-ala, D-glu, L-lys being sequentially added by the MurC, 
MurD and MurE enzymes, using adenosine triphosphate (ATP) as a 
source of energy 101-104. In the last cytosolic steps, alanine racemase 
(Alr) converts L-alanine to D-alanine and D-alanine:D-alanine ligase 
(Ddl)105 forms a dipeptide bond between two D-ala moieties, which 
are subsequently ligated to the stem peptide through MurF activity106. 
This originates the basic cytoplasmic PG precursor UDP-MurNAc-
pentapeptide. Fosfomycin and D-cycloserine are two naturally 
occurring antibiotics produced by species of Streptomyces which shut 
down PG synthesis at the cytoplasmic stage. The former inactivates 
MurA by alkylating an active site cysteine residue107, while the latter 
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is a cyclic analogue of D-alanine that can compete for the active site of 
both Alr and Ddl, thus inhibiting the activities of these enzymes108,109.  
Building the Wall - The inner membrane steps  
 During the second stage of PG biosynthesis, the UDP-
MurNAc-pentapeptide is transferred to the membrane acceptor 
undecaprenyl pyrophosphate, also known as bactoprenol, through 
the activity of the MraY translocase, giving the PG intermediate lipid 
I110. Bactoprenol is a lipophilic molecule which allows the transport of 
hydrophilic molecules across the cell’s hydrophobic membrane. Lipid 
I is then converted into Lipid II by the activity of MurG, an enzyme 
that adds an UDP-GlcNAc moiety to lipid I via β-1,4-linkage111. At 
this point, the FemXAB family of transferases add directly and 
sequentially five glycines to the L-lys residue of the stem peptide in 
lipid II112. This pentaglycine bridge, which is a unique feature of S. 
aureus among prokaryotes, is used at a later stage to crosslink several 
layers of PG. First identified as factors required for the full expression 
of methicillin resistance, termed fem or aux factors113,114, each Fem 
protein uses glycyl-charged tRNA molecules as substrate112. 
Furthermore, each Fem protein has strict substrate specificity, with 
FemX being responsible for adding the first glycine, FemA the second 
and the third, and FemB the fourth and fifth glycines, and no Fem 
protein can substitute for another115-117.  
 Following the synthesis of the pentaglycine bridge, lipid II is 
further modified by amidation at the D-Glu residue of the stem 
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peptide by the glutamine amidotransferase GatD and the MurT 
ligase, possibly working in a bi-enzyme complex118,119. The amidated 
Lipid II-pentaglycine precursor is then finally translocated (flipped) 
across the membrane. The identity of the lipid II flippase has been a 
subject of heated debate. Two possible candidates based on 
experimental evidence are MurJ, a member of the MOP (multidrug/ 
oligosaccharidyl-lipid/polysaccharide) exporter superfamily120-122, or 
FtsW, a member of the SEDS (sporulation, elongation, division and 
synthesis) protein family123,124. Although in vitro flippase activity has 
been demonstrated for E. coli FtsW123, recent work by Meeske and 
colleagues125 proposed that SEDS proteins are peptidoglycan 
transglycosylases that likely function together with a cognate PBP 
during PG polymerization. Moreover, flipping of lipid II in B. subtilis 
was shown to require MurJ ortholog YtgP (also a MOP) or in its 
absence, backup flippase Amj which shows homology to MurJ121. This 
makes MurJ the most likely flippase, at least in Gram-positives. 
. Several antibiotics are known to inhibit steps of the inner 
membrane stage of PG biosynthesis. For example, transfer of the 
soluble UDP-MurNAc-pentapeptide to bactoprenol can be blocked 
either directly, using tunicamycin, a nucleoside which binds to 
MraY126,127, or indirectly using bacitracin, a molecule that prevents the 
turnover of bactoprenol128. Others include murgocil129 or cyslabdan130 
which target MurG or FemA, respectively. Recently developed 
molecules 3-{1-[(2,3-Dimethylphenyl)methyl]piperidin-4-yl}-1-




both from Merck, are likely MurJ inhibitors131. While the antibiotics 
mentioned above directly inhibit enzymes, the so called 
nonribosomal peptide synthetase (NRPS)-derived natural products 
such as ramoplanin and the more recently described teixobactin and 
lysobactin132, recognize the reducing end of lipid-linked cell wall 
precursors, namely lipid I and lipid II, and bind to it, halting PG 
synthesis at that point132.  
Building the Wall - The outer membrane steps 
 At the third and final stage of PG biosynthesis, lipid II is 
released from bactoprenol (which is recycled) and is incorporated 
into the growing PG network via transglycosylation (TG) and 
transpeptidation (TP) reactions82. The new subunit of PG is attached 
to the growing glycan chain through transglycosylation between the 
reducing end of the MurNAc in the nascent glycan chain and the C-4 
carbon of the glucosamine residue in the lipid-linked precursor, using 
the phosphodiester-muramic acid bond as a source of energy 133. This 
reaction can be catalysed by the transglycosylase (TGase) domain of 
bifunctional PBP2134 or monofunctional TGases MGT and SgtA135 in S. 
aureus. The moenomycin family of phosphoglycolipid antibiotics 
reversibly bind the TGase domain of these proteins. SEDS protein 
RodA has also been shown to have TGase activity125.  
 TP and crosslinking, in turn, are done by first cleaving the D-
ala-D-ala bond at the terminus of the stem peptide in one glycan 
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subunit. This breakage then drives energetically the reaction between 
the resulting peptidyl end (D-ala) and an acceptor group present in 
another glycan. In S. aureus the acceptor group is the last glycine of 
the synthesised pentaglycine crossbridge, whereas in bacteria with 
direct crosslinking the acceptor is the dibasic amino acid in the stem 
peptide97. The TP reaction is done by the transpeptidase (TPase) 
domain of the PBPs. Molecules containing β-lactam rings, such as 
penicillin, methicillin, cephalosporins and carbapenems are 
collectively known as β-lactam antibiotics. β-lactam rings bind and 
irreversibly acylate the catalytic serine in the PBPs TPase active site, 
acting as suicide substrate homologues136,137. This causes the enzyme 
to lose activity which in turn prevents the transpeptidation of PG 
strands. The inhibition of TP can also be achieved with glycopeptide 
vancomycin, although the mechanism is quite different. Vancomycin 
is a very large hydrophilic molecule that can form hydrogen bonds 
with the D-ala-D-ala termini of the PG stem peptides, and thus, 
through steric hindrance, prevents access of the PBPs to their 
crosslinking substrates138.  
Building the Wall – The PBPs 
In contrast to bacteria such as E.coli and B.subtilis, which 
contain genomic sequences encoding for 12 and 16 PBPs, respectively, 
in methicillin-susceptible S. aureus (MSSA) strains there are only four 
PBPs – three high-molecular weight  PBPs 1-3 and one low molecular 
weight PBP4139,140. PBP1 is essential for cell viability141. Inactivation of 
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the TPase domain of PBP1 was shown to cause a decreased degree of 
PG crosslinking but not loss of viability, suggesting that this protein 
fulfils a second, unknown essential function to the cell142. PBP2 is a 
Class A PBP that is the only bifunctional PBP in the cell, possessing 
both N-terminal TGase and C-terminal TPase domains, which are 
highly conserved. The TPase domain of PBP2 is essential in MSSA 
strains and it seems to be sufficient to ensure cell survival in the 
absence of other PBPs143. It has been postulated that the main function 
of the TPase domain of PBP2 is the very initial crosslinking of 
muropeptides up to pentameric molecules, gradually losing affinity 
to the substrate as its degree of polymerization increases144-146. This 
protein localizes at mid-cell and this localisation was shown to be 
dependent on interactions with its transpeptidation substrates, as 
treatment with cell wall targeting antibiotics affects its localisation 
pattern147. The function of PBP3 remains elusive, as this protein was 
shown to be non-essential for viability and its deletion did not lead to 
any observable phenotypes148. PBP4 is also dispensable for cell 
viability, however it has been shown to be important during PG 
polimerization146,149. Deletion of PBP4 causes a severe decrease in 
higher-order crosslinking during PG synthesis, which in turn results 
in decreased stiffness of the whole cell envelope, as measured by 
atomic force microscopy (AFM)150. Also interestingly, PBP4 activity 
has been linked to methicillin resistance in CA-MRSA strains, but not 
in HA-MRSA strains151. PBP4 is recruited to mid-cell through 
interactions with wall teichoic acids (WTA), components of the cell 
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wall envelope important for cell morphogenesis and virulence. It has 
been postulated that this mode of regulation constitutes a temporal 
cue that ensures that extensive cross-linking of PG layers is stalled 
until the remaining components of the envelope are assembled152. 
MRSA strains contain an additional PBP – PBP2A, acquired from 
another species. Unlike PBP2, PBP2A lacks a TGase domain but its TP 
domain is virtually insensitive to β-lactam acylation. When MRSA 
strains are challenged with β-lactam treatment, PBP2’s TGase domain 
and PBP2A’s TPase domain cooperate in the assembly of PG, possibly 
in a protein complex153,154. As PBP2 localisation requires substrate 
recognition, PBP2A could recognize its substrate and recruit acylated 
PBP2 to the mid-cell, where both proteins ensure PG incorporation.  
Peptidoglycan Remodelling 
Growth and division of the bacterial cell requires not only 
synthesis of new PG but also its breakage, remodelling and recycling. 
This is done by enzymes collectively known as PG hydrolases or 
autolysins. There is seemingly a specific PG hydrolase for every 
glycosidic and amide bond present in peptidoglycan, although not all 
bacterial species possess the full set of hydrolases155. Hydrolases can 
be generally classified as muramidases, glucosaminidases, amidases, 
endopeptidases and carboxypeptidases. These enzymes fulfil 
numerous functions in the cell, from regulating cell growth to lysing 
the mother cell during sporulation or generating holes in the cell wall 
for the deposition of structures such as flagella. Peptidoglycan can be 
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regarded as a large mesh sustaining the cell, defining its shape74. In 
order for the cell to grow, new material must be inserted in the PG 
network, causing the mesh to expand. This expansion must require 
the rupture of covalent PG bonds by hydrolases156,157. Evidence for 
this theory comes from observations that both Gram-positive158 and 
Gram-negative159 bacteria shed peptidoglycan fragments during 
growth, a process termed peptidoglycan turnover. These fragments 
can constitute up to 40% of the existing PG in one generation, as seen 
during E.coli growth159. Because PG hydrolytic activity needs to be 
regulated, it has been proposed by Höltje that PG synthases and 
hydrolases form multi-enzymatic complexes that are coordinated in 
space and time during the bacterial cell cycle160. This would ensure 
that hydrolases are only active in sites of new synthesis. For Gram-
positive bacteria, that have multiple layers of PG, an inside-to-outside 
growth model has been proposed161,162. This model supports the 
notion that new material is inserted underneath the existing layers, 
cleaved by autolysins in order to stretch and bear the mechanical 
stress. Gradually, the outermost layers are degraded and released as 
turnover material to the surrounding medium.  
Hydrolytic activity is also required for daughter cell 
separation. At the end of the bacterial life cycle, the division septum 
must be cleaved, allowing the mother cell to split into two equal 
daughter cells. In S. aureus, this process seems dependent on the 
major hydrolase Atl, a bifunctional enzyme with both amidase and 
endo-β-N-acetylglucosaminidase domains163,164. Null mutants of atl 
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show a variety of phenotypic alterations, including a disordered 
division pattern, formation of large cell clusters due to defective cell 
separation and impairment of biofilm formation163,165. In accordance 
to its role in daughter cell separation, Atl products bind to precise 
locations of the equatorial rings of the staphylococcal cell, both at the 
septum but also at the next division plane166,167. Interestingly this 
mechanism of localisation seems to be dependent on an exclusion 
strategy mediated by wall teichoic acids, as reported by Schlag and 
colleagues168. Evidence for hydrolase activity being involved in cell 
separation also comes from an S. pneumoniae mutant lacking 
glucosaminidase LytB169, and E. coli170 and Neisseria gonorrhoeae171 
mutants lacking amidases AmiA-C. In each case, cell populations 
were composed of long chains of unseparated cells, indicating that 
following septation, the daughter cells failed to split properly. A 
recent report by Klöckner et. al.172 showed that Chlamydia pneumoniae, 
an intracellular pathogen that lacks a typical peptidoglycan layer, 
expresses an essential hydrolase AmiA that surprisingly contains a 
penicillin-binding domain. Chlamidyal AmiA was effective at 
separating daughter cells in an E.coli amidase mutant, suggesting 
functional conservation of this enzyme172. Because chlamydiae lack 
true PG, it is likely that AmiA fulfils a second essential role not 
related to hydrolytic activity, which highlights the fact that many 




The Division Machinery 
The cell cycle of prokaryotes is in essence a straightforward 
and regular process. Most bacterial cells double their internal content, 
replicate their genetic material, synthesise a septum at mid-cell and 
divide into two identical daughter cells by binary fission. At the core 
of the cell cycle is a macromolecular protein machinery responsible 
for cell division called the divisome, which is coordinated by the 
conserved tubulin homologue FtsZ173. Many genes involved in the 
divisome, including ftsZ, are contained in the universal division and 
cell wall (dcw) cluster, which is conserved in many bacterial 
species174. FtsZ undergoes GTP-dependent polymerization into 
filaments, with a repeating arrangement of subunits, which form a 
ring around the longitudinal midpoint (the septum) of the cell. This 
structure is commonly referred to as the Z-ring175. Up until the turn of 
the millennium, it was believed that all bacteria and archaea used an 
universal cytokinetic machinery based on the Z-ring176. This turned 
out not to be true, as whole genome sequencing revealed that species 
of Chlamydia177 and the Planctomycetes178 phylum, along with the entire 
archaeal kingdom of Crenarchaea179 manage as well without FtsZ. 
Nevertheless, these are exceptions to the rule: the Z-ring instructs and 
directs division in prokaryotes. 
The assembly of the divisome follows a sequential order of 
events that have been extensively studied in model organisms B. 
subtilis and E.coli180. This process can be generally divided into two 
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stages, which will be described in depth in the following sections. 
During the first stage the division site is selected and FtsZ assembles 
into a ring which is tethered to the membrane, resulting in a structure 
called the proto-ring. In the second stage the proto-ring recruits 
additional proteins including cell wall synthases, forming the mature 
divisome, which then constricts the membrane leading to cytokinesis 
and cell separation.  
Division Site Selection  
 Correct positioning of the Z-ring at the future site of cell 
division (mid-cell) is dependent on protein systems acting as space 
regulators. This systems can be either negative, in the sense that they 
inhibit FtsZ polymerization at inappropriate sites or positive, by 
localizing at mid-cell and promoting Z-ring assembly there. Two well 
studied examples of negative space regulation are the Min system 
and nucleoid occlusion181,182, depicted in Fig. 4A. In the Min system, a 
MinCD protein complex that inhibits FtsZ polymerization either 
oscillates from one end of the cell to the other, creating a gradient 
where the concentration is highest at the cell pole (as seen in E.coli 
and Neisseria sp.), or is directly recruited to the cell poles by DivIVA, 
which has affinity for negative membrane curvature (in B.subtilis). In 
both cases, the middle of the cell becomes the preferential zone for 
the Z-ring to form183 (Fig. 4A). The nucleoid occlusion system, in turn, 
prevents premature septation until replication of the chromosome is 
complete184. Nucleoid occlusion effectors Noc in S. aureus185 and B. 
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subtilis186 or E.coli homologue SlmA187 bind specific DNA sequences 
that are heterogeneously distributed inside the cell, being more 
abundant near the origin of replication, which is positioned at mid-
cell during initial stages of the cell cycle. As DNA replication 
progresses, the origin of replication and the nucleoid effectors are 
gradually moved towards the cell poles, which allows for 
polymerization of FtsZ at the middle188,189 (Fig. 4A). Examples of 
positive space regulators that promote Z ring assembly include S. 
pneumoniae mid-cell anchored protein MapZ190 or the SsgAB191 protein 
complex in actinomycetes, which directly recruit FtsZ to mid-cell.  
Division site selection in S. aureus is a more complex affair. 
Cells divide sequentially in three specific orthogonal planes, a trait 
that is rather uncommon in prokaryotes192. This results in cell clusters 
that resemble a bunch of grapes, giving the genus its namesake (from 
greek staphylē). Remarkably, in order to divide precisely in the correct 
plane, each generation of cells must ‘remember’ the previous two 





Figure 4. Division site selection in bacteria. (A), Bacterial division begins 
with polymerization of FtsZ as a ring structure at mid-cell (Z-ring), which in 
B. subtilis is spatially regulated by the Min and nucleoid occlusion systems. 
The MinCD system, which inhibits FtsZ polymerization, is recruited to the 
negatively curved cell poles, creating a Min zone that prevents Z-ring 
assembly. Nucleoid occlusion effector Noc binds specific DNA sequences 
that are more abundant near the origin of replication (yellow circles) and 
prevents FtsZ polymerization through steric hindrance (Noc zone), avoiding 
the bisection of the nucleoid. (B), Schematic of an S. aureus cell that has 
formed an equatorial division septum (in red). Prior to the next cell division, 
each daughter cell will replicate and segregate the DNA along its long axis, 
positioning the origin of replication (yellow spheres) at the edge of the 
nucleoid. The next plane of division can be any of the infinite number of 
planes (meridians) shown, however only one (in green) will not bisect the 
nucleoid. (C), Schematic of a cell showing the current division plane (in 
green, n), the previous division plane (n-1, in red) and the division plane 
from two generations prior (n-2, in red). Each division plane is placed 
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orthogonally to the previous generation plane. In each cycle, the origins of 
replication (yellow spheres) segregate towards the cross-junctions (red discs) 
of the two previous planes used, by an unknown mechanism. This 
epigenetic information automatically defines the next division plane (in 
green). Panels (B) and (C) were adapted from 185. 
 
 While S. aureus seems to lack any apparent Min system or 
homologues193, it does use nucleoid occlusion to avoid guillotining of 
the DNA by the divisome. As reported by Veiga et. al.185, mutants 
lacking Noc were shown to form multiple Z-rings that were no longer 
placed in perpendicular planes to each other. Furthermore, inhibiting 
DNA replication or promoting condensation with chloramphenicol, 
in the presence of Noc, led to abnormal non-orthogonal FtsZ 
structures. These data suggested that division site selection in S. 
aureus is determined by the axis of chromosome segregation185. DNA 
segregation in bacteria invariably occurs along the longer axis of the 
cell, presumably due to conformational entropy of the replicating 
nucleoid in a confined space194. However, spherical cells possess an 
infinite number of cell axes with the same length which are 
theoretically valid for chromosome segregation, resulting in an 
infinite number of possible division planes (Fig. 4B). Yet S. aureus 
always chooses the one division plane that is precisely orthogonal to 
both planes from the two previous generations. The authors 
proposed a model where the chromosome origins of replication 
would always segregate towards the intersection points of the last 
two planes of division (cross-junctions). In this scenario there is only 
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one plane that does not bisect the nucleoid. That plane is 
perpendicular to the previous plane and will automatically become 
the next division plane (Fig. 4B and C)185. This model is consistent 
with previous observations by Electron Microscopy (EM), showing 
that the surface of S. aureus contains “scars” from the two previous 
division cycles195 and by AFM analysis on purified cell wall 
preparations, which revealed a large belt of PG in the division plane 
with a ‘piecrust’ structure, which remains after division as an 
orthogonal rib 196. These cross-junctions, scars or orthogonal ribs may 
then constitute epigenetic information that specifies the division 
planes in cocci. Nevertheless, this model presumes the existence of a 
yet unknown factor that pulls the origins of DNA replication towards 
the cross-junctions. 
Assembly of the Proto-ring 
Once the division site is selected, FtsZ polymers have to be 
tethered to the cytoplasmic membrane, as FtsZ lacks membrane 
interacting domains. This is achieved through interactions with FtsA 
and either SepF (in Gram-positives) or ZipA (in γ-proteobacteria)175 
(Fig. 5). FtsA is an ATP-binding actin homologue that associates with 
the membrane through its C-terminal amphipathic helix and 
constitutes the second most conserved protein in bacteria, after 
FtsZ197. Purified FtsA was shown to assemble into actin-like 
protofilaments in artificial lipid monolayers and mutations that 
disrupt these filaments were found to lead to defects in cell 
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division198,199. Moreover, FtsA was shown to be required for FtsZ 
treadmilling200. Treadmilling is the molecular mechanism wherein 
subunits are added to one end of a polymer while other subunits are 
removed from the opposing end. Importantly, the rate that subunits 
are added to one end is higher than the rate of subunit removal in the 
other end, which generates apparent movement of the whole 
filament. Using high resolution total internal reflection fluorescence 
(TIRF) to image FtsZ in an artificial membrane bilayer, Loose and 
colleagues200 found that ATP-bound oligomers of FtsA promote the 
treadmilling of FtsZ filaments. Interestingly, ftsA mutants of B. subtilis 
can still divide, albeit slowly, and this deficiency can be compensated 
by overexpression of the other membrane tether, SepF, suggesting 
that these two proteins perform similar functions in this organism201. 
FtsZ polymerization must not only be tightly regulated in space and 
time but also in extent. Inactivation of EzrA, an inhibitor of FtsZ 
polymerization that is conserved in the Firmicutes phylum, leads to 
the presence of extra Z rings away from mid-cell in B. subtilis, which 
results in asymmetric division202. EzrA was also shown to be involved 
in cell size homeostasis in S. aureus, with ezrA mutants showing 
abnormally large phenotypes and misplacement of the Z ring203,204. Its 
counterpart, ZapA, is a Z-ring associated protein which seems to 
promote FtsZ polymerization, as it was shown to stimulate the 
formation of higher order FtsZ assemblies in vitro and to be essential 
in cells producing lower amounts of FtsZ205. Together these proteins 





Figure 5 – Divisome assembly in B. subtilis. The assembly of the divisome 
begins with polymerization of FtsZ, the extent of which is controlled by 
ZapA and EzrA, which act as positive and negative regulators, respectively. 
The Z-ring is tethered to the membrane through protein interactions with 
FtsA and SepF. Together these proteins constitute the proto-ring. During the 
second stage of divisome assembly, the proto-ring recruits a large group of 
proteins to mid-cell, including FtsW, enzymes involved in PG synthesis 
(PBP1, PBP2B), PG hydrolases, DNA translocases (FtsK/SpoIIIE family) and 
the FtsL/DivIB/DivIC trimeric protein complex, of unknown function. The 
resulting megacomplex constitutes the mature divisome. The dashed line 
represents the time delay between the two stages of divisome assembly. 
Divisome Maturation 
 Following the assembly of the proto-ring, this structure 
recruits a second group of divisome proteins including FtsW, PG 
synthases, PG hydrolases, DNA-binding proteins (FtsK/SpoIIIE), and 
proteins that presumably promote interactions between the Z ring 
and the PG synthesis machinery180,206. The time delay between the two 
stages of divisome assembly has been reported to be at least 20% of 
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the cell cycle in B. subtilis207. Despite decades of research into the 
divisome, the biochemical functions of many of the second stage 
proteins remains unknown. A group of membrane spanning proteins 
DivIB, DivIC and FtsL in Gram-positives and their orthologues FtsQ, 
FtsB and FtsL in Gram-negatives are conserved in all species for 
which divisome assembly has been investigated208,209. DivIC and FtsL 
are unstable proteins by themselves, but when together with DivIB 
can form a strong heterocomplex that is recruited to the divisome and 
that is required for mid-cell localisation of PBP2B in B. subtilis208,210. 
DivIB, DivIC and FtsL appear to be structural proteins due to lack of 
enzymatic domains and are fairly similar in structure, each 
possessing a short N-terminal cytoplasmic domain, a single 
transmembrane domain and a larger periplasmic domain. Studies 
using conditional mutants have shown that the expression of DivIB is 
essential for S. aureus growth and that depletion of divIB causes a 
blockage in the completion, but not the initiation of septum 
formation211. 
Another group of proteins that are recruited during the 
second stage of divisome assembly are the members of the conserved 
FtsK/SpoIIIE family of DNA translocases212,213. All members possess a 
C-terminal ATPase domain which forms homo-hexameric DNA 
motors responsible for the translocation of DNA away from the 
division site, avoiding bisection of the nucleoid by the septum213,214. 
These proteins bridge two essential steps of the bacterial life cycle: 
septum synthesis and DNA replication and segregation, and the 
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timing of their recruitment likely constitutes a major molecular 
checkpoint for cell cycle progression. Also of particular note is FtsN, a 
PG-binding protein found in E.coli with homologues in Caulobacter 
crescentus but otherwise poorly conserved in bacteria215. The exact 
function of FtsN is still unknown, however it is the last essential 
division protein to arrive at mid-cell and it was shown to be required 
for the recruitment of the E.coli Tol-Pal complex216, which mediates 
outer membrane invagination, the PG hydrolase AmiC217 and to 
stimulate the activity of PG synthase PBP1b in vitro218. In light of these 
data, it has been proposed that the arrival of FtsN functions as a 
signal indicating that divisome assembly is complete, triggering 
septation in E.coli219. No homologues of FtsN have been found in 
Gram-positive bacteria, suggesting a different mechanism to initiate 
PG synthesis at mid-cell exists in these organisms.  
 Following divisome maturation and septal peptidoglycan 
synthesis and remodelling, the division macromolecular machinery 
constricts along the axis of the cell, causing cytokinesis to complete 
and the mother cell divides. The origin of the force that leads to cell 
envelope constriction has gathered substantial interest during these 
past years. The “iterative pinching model”, proposed by Li and 
colleagues220 states that bending of the FtsZ polymers could generate 
the force necessary to constrict the membrane. A cycle of GTP-
dependent FtsZ polymerization, membrane attachment and 
depolymerisation would lead to constriction, a mechanism 
functionally similar to the eukaryotic cell actomyosin ring, wherein 
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myosin motors pull actin bundles together, generating a contractile 
force221. However, this model has been challenged recently by 
observations that permanent cell wall deforming requires several 
minutes of applied bending force222. The fast dynamics of FtsZ 
subunit turnover223 and treadmilling224,225, which occur on the 
seconds-scale, make it unlikely that the Z-ring exerts a direct 
sustained mechanical force on the membrane226. Additionally, 
computational models predict that the Z-ring can generate pulling 
forces of up to 100 pN227, a value which sits well below the opposing 
force exerted by the cell’s internal turgor, which in B. subtilis is 
estimated to be close to 106 pN/nm228. Alternatively, PG synthesis and 
turnover at the septum could provide the required force for 
cytokinesis, and the function of FtsZ treadmilling would be to 
dynamically organize the synthesis machinery226. In support of this 
notion, the speed of PBP3 movement in E.coli was shown to be 
linearly correlated with the speed of FtsZ treadmilling225 and the ~100 
seconds time-scale dynamics of FtsZ clusters also matched well with 
the ~40 seconds incorporation time for newly synthesised PG strands 




Coordinating cell growth and peptidoglycan synthesis 
 The morphological diversity that exists in bacteria is truly 
staggering. Traditionally, bacteriology research has focused mostly 
on pathogenic species, which tend to maintain a cylindrical or 
spherical regular shape but others are bent, flat sided, triangular, 
helical and even square-shaped, among a myriad of other 
possibilities. There are bacteria that create bulbous extensions of their 
cells, bacteria that live in colonies where each individual cell is 
partially differentiated, behaving as a primitive multicellular 
organism; bacteria that grow as branched filaments, not unlike a tree, 
and bacteria that shapeshift during their cell cycle230,231. In truth every 
prokaryote adopts the shape that allows it to better thrive in the 
particular ecological niche that it inhabits, with that particular shape 
gradually perfected through evolution. Cell morphology influences 
most of everything in the bacterial lifestyle from nutrient 
accessibility, to colonization of surfaces, to motility and survival 
against other species230. The morphology of most bacteria is dictated 
by their cell wall, functioning as an exoskeleton. This became 
apparent in the late 50s when isolated cell wall sacculi were shown to 
retain the particular shape of the original cell232. Moreover, mutations 
that affected cell shape were almost always mapped to genes 
involved in cell wall synthesis233-235. Interestingly, it seems that there is 
a trend that correlates increased complexity of PG synthesis to 
deviations from the basic shape, the sphere236 (summarized in Fig. 6).  
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Truly spherical cocci, such as Staphylococcus and Neisseria, 
synthesise peptidoglycan mainly at the division septum237,238, a 
process that is coordinated by FtsZ and the divisome, as described 
above. Adapting a more complex shape than the sphere requires an 
additional level of spatio-temporal regulation of PG synthesis, which 
can translate to having independent macromolecular protein 
machineries acting on different locations of the cell. Elongated 
ellipsoids (also called ovococci) such as streptococci, lactococci and 
enterococci possess specific PBPs solely dedicated to peripheral 
growth, acting independently from the PBPs associated to the 
divisome236. In S. pneumoniae peripheral PG synthesis, catalysed by 
dedicated PBP2b, is localised in equatorial rings close to mid-cell, 
which mark sites of the previous division239,240 (see Fig. 6). This PG 
insertion occurs in tandem and in close proximity to septal synthesis, 
which is done by PBP1a and PBP2x240,241, and leads to the slight 
elongation observed in these bacteria. The mechanism that 
coordinates this extraseptal PG synthesis is unknown, although it has 
been postulated that FtsZ could control both modes of synthesis242.  
Elongation in rod-shaped bacteria is mechanically more 
complex243. Rods such as B.subtilis possess a machinery dedicated to 
elongation, the so called elongasome, that is coordinated by the 
cytoskeletal actin homologue MreB244. MreB assembles in short 
patches that move circumferentially along the cell and presumably 
direct the enzymes required for lateral PG synthesis, including the 
SEDS transglycosylase RodA, the transpeptidase PBP2 and the 
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putative signalling protein RodZ244,245. Similarly to the mechanisms 
proposed for divisome constriction, it has been suggested that 
peripheral PG synthesis provides the force that drives processive 
movement of the MreB patches along the cell244,246. Interestingly, 
MreB-dependent elongation is not ubiquitous in rods. Rods that lack 
MreB seem to rely on signal transduction by eukaryotic-type 
serine/threonine kinases (ESTKs) for maintaining correct shape236. For 
example, either overexpression or depletion of ESTKs locus pknAB in 
Mycobacterium tuberculosis led to narrow and overly elongated cells247. 
ESTKs fulfil a plethora of regulating functions in prokaryotic cells 
including stress response248, antibiotic resistance249 and cross-talk 
between the divisome and autolysins250. It has been proposed that 
elongation in the absence of MreB can be triggered by ESTKs which 
cause a molecular shift from septal to peripheral PG synthesis251. If 
proven correct, such a mechanism constitutes an interesting 
alternative for peripheral PG synthesis in the absence of a MreB 
cytoskeleton. Compelling evidence towards this model was obtained 
by depleting StkP, the sole ESTK present in S. pneumoniae, which 
caused a shift from ovoid to rod cell shape, suggesting that peripheral 
cell wall synthesis was exceeding septal synthesis251.  
Another well studied case pertains to how Caulobacter 
crescentus requires a single protein to acquire its characteristic curved, 
crescent shape. Caulobacter crescentin is a cytoskeletal protein that 
forms mechanically rigid coiled-coil filaments252; knockout of the creS 
locus causes cells to lose the crescent shape and become regular 
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rods253. This is because crescentin filaments localise near the 
membrane, asymmetrically, on only one side of the cell (Fig. 6), and 
either mechanically induce concave curvature directly, or more likely, 
interfere locally with the directional motions of the MreB 
elongasome252,254. 
 
Figure 6. Cell shape maintenance in prokaryotes requires spatial 
coordination of PG synthesis. Deviation from the simplest cell shape – the 
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sphere (S. aureus) - to elongated ellipsoids (S. pneumoniae), cylindrical (B. 
subtilis) or crescent cell shape (C. crescentus) requires additional levels of 
regulation of PG synthesis. Left panels – structural elements known to be 
involved in directing PG incorporation in the cell: the divisome (present in 
most bacteria), the elongasome (in rods), equatorial rings marking previous 
division sites (in ovococci), and filaments of crescentin (in Caulobacter). Right 
Panels – cocci possess only one mode of PG incorporation, which takes place 
at the septum during division, and one PG synthesis machinery. Besides 
septal PG synthesis, ovococci and rods also incorporate PG at the side wall, 
leading to peripheral growth. While rods possess a machinery dedicated to 
lateral PG synthesis, coordinated by MreB patches moving circumferentially 
around the cell, ovococci may switch between the two modes via ESTK 
signalling. Similarly to rods, C. crescentus also possesses two machineries for 
PG incorporation, but the presence of bundles of crescentin on one side of 
the cell interferes locally with the elongasome, generating asymmetry. Some 
examples of PG synthases known or presumed to be part of each machinery 
are shown140,236,255,256.  
 
S. aureus possesses 4 native PBPs, S. pneumoniae has 6 PBPs 
and the E.coli genome encodes for as much as 12 PBPs236. This could 
be interpreted as a trend where going from spheres to rods translates 
to an increased number of PBPs that are required to define shape. 
One could then speculate that rods have evolved from cocci, 
developing additional modes of PG synthesis to increase the 
complexity of their cell wall. While the Last Common Ancestor (LCA) 
from which all bacteria descend from was likely spherical, all 
evidence suggests that modern cocci such as S. aureus descend from 
rods. The deepest branches of the prokaryotic tree are composed 
exclusively of rods230,257, and coccus-to-rod transitions have never 
been observed, either phylogenetically or experimentally. 
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Conversely, rod-to-sphere differentiation events seem prevalent in 
bacteria and fundamentally tied to nutrient availability. E. coli cells 
become smaller and more spheroidal through expression of late stage 
BolA and the RpoS sigma factor258,259, while Arthrobacter and 
Acinetobacter spp. transition from rod to cocci when entering 
stationary phase260. S. aureus possesses at least two homologs of 
proteins that are part of the rod elongasome, MreC and MreD, which 
are essential for viability in B. subtilis261, E.coli262 and C. crescentus263. 
Knockout mutation of either of the corresponding genes led to no 
observable phenotypes or loss of viability in S. aureus COL264, while in 
another study deletion of either mreD or mreCD in S. aureus SH1000 
caused modest alterations in cell volume and shape265. Deletion of 
divIVA, which is required for division site selection in rods266, 
similarly did not impair normal cell division267. These data suggest 
that such elements may constitute vestigial DNA of a rod-shaped 





 In order to produce this dissertation I focused on investigating 
the interplay between PG synthesis and cell morphology in S. aureus. 
Specifically, I wanted to explore the possibility that these bacteria 
require peptidoglycan incorporation all around the cell surface 
during certain stages of the cell cycle in order to maintain their 
correct shape. I also aimed to determine how the PG synthesis 
machinery of S. aureus is recruited specifically to the divisome, when 
it is time for the cells to divide. Furthermore, in order to identify 
possible targets for pathogen-specific drug design, I wanted to 
examine the importance of crossbridge formation towards the 
structural stability of the S. aureus wall. Finally, throughout my 
studies I also focused on understanding the mechanisms of activity of 
new molecules with potential to become useful alternatives for 
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Abstract 
Staphylococcus aureus is an aggressive pathogen and a model 
organism to study cell division in sequential orthogonal planes in 
spherical bacteria. However, the small size of staphylococcal cells has 
impaired analysis of changes in morphology during the cell cycle. 
Here we use super-resolution microscopy and determine that S. 
aureus cells are not spherical throughout the cell cycle, but elongate 
during specific time windows, through peptidoglycan synthesis and 
remodelling. Both peptidoglycan hydrolysis and turgor pressure are 
required during division for reshaping the flat division septum into a 
curved surface. In this process, the septum generates less than one 
hemisphere of each daughter cell, a trait we show is common to other 
cocci. Therefore, cell surface scars of previous divisions do not divide 
the cells in quadrants, generating asymmetry in the daughter cells. 
Our results introduce a need to reassess the models for division plane 





Staphylococci are spherical organisms that divide sequentially 
in three orthogonal planes over three consecutive division cycles1,2. 
This mode of division is less common in bacterial cells than 
equatorial division, observed in many genera. Division in three 
planes implies that cells retain information about the positioning of 
the two preceding divisions in order to divide with precision. Given 
that this spatial information varies with each division, it cannot be 
encoded by DNA3. Peptidoglycan, the major component of the 
bacterial cell wall, has been proposed to encode epigenetic 
information in the form of protuberant, ring-like structures that mark 
previous division planes and are used by Staphylococcus aureus to 
divide accurately in sequential perpendicular planes3. 
Orientation of division planes is merely one of the distinctive 
features of the staphylococcal cell cycle. S. aureus has been proposed 
to have only one cell wall synthesis machine, which incorporates 
peptidoglycan mostly at the division septum4,5, while rod-shaped 
bacteria such as Escherichia coli or Bacillus subtilis have two major cell 
wall synthesis machines, one for incorporation of new peptidoglycan 
at the division septum and another for elongation of the lateral wall4. 
Accordingly, S. aureus has only four native Penicillin-Binding 
Proteins (PBPs 1-4), described to localize at the septum, while E. coli 
and B. subtilis have 12 and 16 PBPs, respectively, which localize at the 
septum or at the lateral wall4. PBPs are enzymes involved in the last 
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steps of peptidoglycan biosynthesis, which catalyse the 
polymerization of the glycan strands, as well as their crosslinking via 
peptide stems. Given that an elongation-specific machinery seems to 
be absent in S. aureus, increase of the cell surface area required for 
growth has been attributed to a process of reshaping the flat septum 
into curved hemispheres of the two daughter cells, which occurs 
immediately after splitting of the mother cell during division2. 
Reshaping of the flat septum, resulting in doubling of the external 
surface area of peptidoglycan, could theoretically occur in the 
absence of synthesis, if accompanied by changes in the angle of the 
glycan chains with respect to the peptide chains6. Alternatively, 
increase of the surface area could be driven by hydrolysis of 
peptidoglycan bonds catalysed by specific autolysins. At least 13 
genes of the S. aureus genome encode known or putative 
peptidoglycan hydrolases, although the products of only three of 
these genes (atl, sle1 and lytM) have been characterized. Of these 
genes, atl encodes the major autolysin in S. aureus, which is involved 
in the separation of the daughter cells after division7,8. Interestingly, 
orthogonal rings of Atl can be observed by immunoelectron 
microscopy at the surface of S. aureus cells, similar to scars of 
previous divisions9, confirming that information regarding the 
localisation of previous, orthogonal, division planes can be present at 
the cell surface. 
S. aureus is an aggressive pathogen and one of the most 
important nosocomial bacteria causing antibiotic-resistant infections. 
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Despite its clinical relevance, the small size of staphylococcal cells 
(with a ~1 m diameter, only four times larger than the diffraction 
limit of resolution of conventional light microscopy) has impaired a 
detailed analysis of its cell cycle and of the morphological changes 
that occur as S. aureus grows and divides. This lack of knowledge 
extends to the cell cycle of other cocci as well. Therefore detailed 
characterization of the mode of growth and division of S. aureus has 
implications for the global understanding of the cell cycle of cocci. 
Here, we have used super-resolution microscopy to analyse the 
dynamics of cell shape and size during the cell cycle of S. aureus. We 
found that, contrary to current thinking, S. aureus cells elongate 
before dividing. Furthermore, we show that the division septum 
generates less than one hemisphere of each daughter cell and 
therefore scars of previous divisions do not mark quadrants of the 
cell. Our results suggest that the models for division plane selection 
in cocci should be re-examined. 
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Experimental Procedures 
Bacterial growth conditions 
Strains and plasmids used in this study are listed in Table 1. S. 
aureus strains were grown in tryptic soy broth (TSB, Difco) with 
aeration at 37 °C or on tryptic soy agar (TSA, Difco) at 30 °C or 37 °C. 
For microscopy experiments, overnight cultures of S. aureus strains 
were diluted 1:200 in fresh TSB medium and allowed to grow at 37 °C 
until an OD600nm of approximately 0.5. Cells were then harvested and 
resuspended in the same medium. Escherichia coli and Sporosarcina 
ureae strains were grown in Luria-Bertani broth (LB, Difco) with 
aeration, or LB agar (LA, Difco) at 37 °C or 30 °C, respectively. 
Antibiotics ampicillin (Amp) and erythromycin (Ery) were added to 
the media at a final concentration of 100 µg ml-1 and 10 µg ml-1, 
respectively, when necessary. 5-Bromo-4-chloro-3-indolyl β-D-
galactopyranoside (X-gal) was used at 100 µg ml-1. Expression of 
PBP4 from plasmid pBCBPM115 was induced with cadmium chloride 
(1 µM). Expression of Sle1 from plasmid pSle1 was induced with 








Escherichia  coli    
DC10B Δdcm in the DH10B background; Dam 
methylation only 
10 







RN4220 Restriction-deficient derivative of NCTC8325-4 R. Novick 
COLΔpbpD pbp4 in-frame deletion mutant of parental strain 
COL 
12 
COLpPBP4-YFP COL encoding a C-terminal YFP fusion to PBP4 
at the native locus 
13 
COLΔatl Δatl in-frame deletion mutant of parental strain 
COL 
This study 
COLΔsle1 Δsle1 in-frame deletion mutant of parental strain 
COL 
This study 
COLΔsle1pBCBover COLΔsle1 with pBCBover This study 
COLΔsle1pSle1 COLΔsle1 complemented with pSle1 This study 
COLwalKRi COL strain with WalKR operon under the control 
of the IPTG inducible Pspac promoter; Eryr 
This study 
NCTCΔlytM ΔlytM in-frame deletion mutant of parental 
strain NCTC8325-4 
This study 





NCTC strain with the pbpD gene substituted by 
the pbpD-PAmCherry photoactivable derivative 
This study 
BCBPM120 COLΔpbpD with pCNX This study 
BCBPM138 COLΔpbpD with pBCBPM115, encoding PBP4 
under the control of PCad 
This study 
Sporosarcina ureae SL6708  Derivative of S. ureae ATCC 1388  14 
 
Cell shape dynamics during the staphylococcal cell cycle 
85 




pMAD E. coli-S. aureus shuttle vector with a thermosensitive 
origin of replication for Gram-positive bacteria; 
AmprEryr lacZ 
15 
pMUTIN4 Integrative vector for S. aureus encoding IPTG inducible 
Pspac promoter; Ampr, Eryr 
16 
pCN34 Vector containing the aphA-3 kanamycin resistance 
cassette 
17 
pCN51 Shuttle vector containing a cadmium inducible Pcad 
promoter; AmpR EryR 
17 
pCNX Shuttle vector containing a cadmium inducible Pcad 
promoter; AmpR KanR 
This study 
pGC2 E. coli/S. aureus shuttle vector, Ampr Cmr 18 
pDH88 B. subtilis with Pspac promoter and lacI 19 
pBAD/HisB-
PAmCherry1 
Plasmid encoding the sequence of the photoactivable 
PAmCherry1 protein 
20 
pΔatl pMAD derivative with the up- and downstream regions 
of atl 
21 
pΔlytM pMAD derivative with the up- and downstream regions 
of lytM 
This study 
pΔsle1 pMAD derivative with the up- and downstream regions 
of sle1 
This study 
pBCBover pGC2 derivative containg Pspac promoter and lacI This study 
pSle1 pBCBover encoding Sle1 under the control of Pspac 
promoter 
This study 
pwalKR pMUTIN4 derivative containing the ribosome binding 
site and 5’ end of walKR 
This study 
pBCBRP007 pCNX derivative containing Pcad-RBS-pbpD-7aaLinker-








pBCBRP008 pMAD derivative containing truncated pbpD-7aa-
PAmCherry-Downstream region; AmpR EryR 
This study 
pBCBPM115 pCNX encoding PBP4 under the control of Pcad This study 
 
Construction of S. aureus mutants  
The full sequences of each primer used to construct mutants 
are in Table 2.  
Table 2. Oligonucleotides used in this study 
 












P4_lytM TGGAGATCT GGAGCGTAACTGATGATAG 
yycF fw EcoRI GCGCGCGAATTCTATTAATGATTTAAGAAAAGAGG 
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Table 2. Oligonucleotides used in this study 
 










Underlined sequences correspond to restriction sites 
The COL∆atl, COL∆sle1 and NCTCΔlytM null mutants were 
constructed using the pMAD vector15 containing the upstream and 
downstream regions of each gene of interest, to allow recombination 
and integration of the plasmids into the chromosome, followed by 
their excision with the genes to be deleted. Briefly, upstream and 
downstream regions of sle1 and lytM were amplified by PCR, using 
primers P1_sle1/P2_sle1 and P3_sle1/P4_sle1, P1_lytM/P2_lytM and 
P3_lytM/P4_lytM, respectively. The PCR fragments encoding the 
upstream and downstream regions of each gene were joined by 
overlap PCR using the pairs of primers P1_Sle1/P4_Sle1 and P1_lytM 
and P4_lytM. The resulting fragments were digested with NcoI and 
BglII (Fermentas) and cloned into the pMAD vector, giving plasmids 
p∆sle1 and pΔlytM, which were propagated in E. coli DC10B and the 
inserts were sequenced. The plasmids, as well as p∆atl21, were then 
electroporated into S. aureus RN4220 strain at 30 °C, using Ery and X-
gal selection, and transduced into COL or NCTC8325-4 using phage 
80α. The integration of the plasmids into the chromosome and their 
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excision was done as previously described22. Gene deletions were 
confirmed by PCR and sequencing of the amplified fragment.  
For complementation of COL∆sle1, plasmid pBCBover was 
constructed by introducing a DNA fragment containing the Pspac 
promoter, a multiple cloning site and the lacI gene into the S. aureus 
replicative vector pGC218. For that, two DNA fragments, one 
containing the Pspac coding sequence and HindIII, SmaI, and XbaI 
restriction sites and a second one encompassing a BglII restriction site 
upstream of the lacI gene, were amplified from pDH88 plasmid19 by 
using respectively the pair of primers Pspac_pDH88_P9_XhoI_SalI / 
Pspac_pDH88_SpeI_P10 and Pspac_pDH88_SpeI_P11 / Pspac-
pDH88-P12-XhoI-EcoRI. These two PCR products were then joined in 
a second PCR, using primers Pspac-pDH88_P9_XhoI_SalI and Pspac-
pDH88-P12-XhoI-EcoRI, to originate a 1743bp fragment in which a 
SpeI restriction site was introduced between XbaI and BglII 
restriction sites. The resulting fragment was restricted with SalI and 
EcoRI, cloned into the pGC2 vector and sequenced. The pSle1 
plasmid was constructed by cloning the entire sle1 coding sequence 
downstream of Pspac promoter in pBCBover. For that, a 1024bp DNA 
fragment containing sle1 gene and its upstream RBS site was 
amplified from NCTC8325-4 genome using primers Sle1_FW_XmaI 
and Sle1_RV_XbaI, digested with SmaI and XbaI and cloned into 
pBCBover. The insert was then sequenced. Both pBCBover and pSle1 
plasmids were electroporated into RN4220 (selection with 10 µg ml-1 
chloramphenicol) and subsequently transduced, using phage 80α, to 
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strain COLΔsle1, generating strains COLΔsle1pBCBover and 
COLΔsle1pSle1 respectively.  
Construction of an S. aureus COL mutant with yycFG (also 
known as walKR) under the control of the IPTG-inducible Pspac 
promoter was done using the pMUTIN4 plasmid16. A 518-bp 
fragment containing the ribosome binding site and 5’ end of yycF 
(walR) was amplified using primers yycF_fw_EcoRI and 
yycF_stop_rv_BamHI. The DNA fragment was then digested with 
EcoRI and BamHI, cloned into pMUTIN4 giving plasmid pwalKR, 
which was propagated in E. coli DC10B and the insert was 
sequenced. Plasmid pwalKR was then electroporated into S. aureus 
RN4220 at 37 °C, using erythromycin selection, and transduced into 
COL using phage 80α. Integration of the plasmid occurred through a 
single crossover event, placing the walKR operon under the control of 
the Pspac promoter. 
To study PBP4 localisation in S. aureus NCTC8325-4 by 
PALM, we replaced the pbpD gene, encoding PBP4, for a gene 
encoding a photoactivatable derivative (pbpD-PAmCherry). For that 
purpose, pbpD was cloned fused to PAmCherry120 in the backbone of 
pCNX. The pCNX plasmid was constructed by substituting the erm 
erythromycin resistance cassette of the pCN51 plasmid17 by the aphA-
3 kanamycin cassette from pCN3417, using ApaI and XhoI restriction 
sites. To clone pbpD-PAmCherry into pCNX, a fragment encompassing 
a ribosomal binding site, the pbpD gene lacking the stop codon and 
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seven codons encoding an amino acid linker was amplified using 
NCTC8325-4 genomic DNA as template and primers P1pbp4pCNX 
and P2pbp4pCNX. A fragment encompassing PAmCherry1 was 
amplified from the pBAD/HisB-PAmCherry1 plasmid20 using 
P3pbp4pCNX and P4pbp4pCNX primers. The two fragments were 
joined by overlap PCR, digested with BamHI and EcoRI, ligated into 
the pCNX plasmid generating plasmid pBCBRP007, and the insert 
was sequenced. We then replaced the pbpD gene from its native locus 
in the S. aureus genome by the pbpD-PAmCherry fusion. For this 
purpose two DNA fragments were amplified, one encompassing a 
truncated pbpD (last 999 bp), a sequence encoding a 7 amino acid 
linker and PAmCherry1 amplified from the pBCBRP007 plasmid using 
primers P1pMADpbp4PAmCherry and P2pMADpbp4PAmCherry 
and a second DNA fragment of 1,000 bp corresponding to the region 
downstream of pbpD amplified from the NCTC8325-4 genome, using 
primers P3pMADpbp4PAmCherry and P4pMADpbp4PAmCherry. 
The two fragments were joined by overlap PCR using primers 
P1pMADpbp4PAmCherry and P4pMADpbp4PAmCherry, digested 
with BamHI and XmaI restriction enzymes and cloned into pMAD, 
generating pBCBRP008. Correct sequence of the insert was confirmed 
and the pBCBRP008 plasmid was electroporated into RN4220 and 
subsequently transduced to NCTC8325-4 strain using phage 80α. 
Integration and excision of pBCBRP008 from the genome was 
performed as previously described22; colonies in which pbpD had 
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been replaced by the pbpD-PAmCherry were identified by PCR and 
the strain was named NCTCΔpbpD::pbpD-PAmCherry. 
To complement COL∆pbpD with a plasmid encoding PBP4, 
the 1.3 Kb pbp4 gene was PCR amplified from NCTC8325-4 genomic 
DNA using primers PBP4pCadP1BamFW and 
pCADPBP4wt_EcoREV and cloned into the pCNX replicative 
plasmid, under the control of a cadmium inducible promoter, using 
BamHI and EcoRI sites, generating plasmid pBCBPM115. Plasmids 
pCNX and pBCBPM115 were electroporated into RN4220 and then 
transduced into COL∆pbpD, giving rise to strains BCBPM120 
(COL∆pbpDpCNX) and BCBPM138 (COL∆pbpDpPBP4).  
Scanning electron microscopy 
Exponentially growing S. aureus COL cells11 were harvested 
by centrifugation, resuspended in fixative solution (2.5% 
glutaraldehyde in 0.2 M sodium cacodylate buffer, pH 7.4), deposited 
on glass discs (Marienfeld) and kept for 1 week at 4 °C. The fixative 
solution was subsequently removed and the cells were washed three 
times with sodium cacodylate. The sample was progressively 
dehydrated by immersion in a graded series of ethanol (50% - 100%) 
and then mounted on aluminum stubs with carbon adhesive discs 
(Agarscientific). The sample was critical-point dried under CO2 and 
sputter coated with gold-palladium (Polaron SC7640) for 200 s at 10 
mA. SEM observations were performed using secondary electron 
images (2 kV) with a Hitachi S4500 instrument at the Microscopy and 
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Imaging Platform (Micalis, B2HM, Massy, France) of the INRA 
research center of Jouy-en-Josas (France).  
Super-resolution Structured Illumination Microscopy (SIM) 
SIM imaging was performed using a Plan-Apochromat 63x/1.4 
oil DIC M27 objective, in an Elyra PS.1 microscope (Zeiss). Images 
were acquired using either 3 or 5 grid rotations, with 34 µm grating 
period for the 561 nm laser (100 mW), 28 µm period for 488 nm laser 
(100 mW) and 23 µm period for 405 nm laser (50 mW). Images were 
acquired using a Pco.edge 5.5  camera and reconstructed using ZEN 
software (black edition, 2012, version 8.1.0.484) based on a structured 
illumination algorithm23, using synthetic, channel specific Optical 
Transfer Functions (OTFs) and noise filter settings ranging from -6 to 
-8. 
Fast time-lapse imaging of S. aureus 
A 2 µl aliquot of an exponentially growing culture of S. aureus 
was placed on an agarose pad in TSB. Cells were imaged at 2 ms 
intervals for a total time of 10 seconds, using a Pco.edge 5.5 camera 
and a Plan-Apochromat 100x /1.46 NA Oil DIC ELYRA objective in 
an Elyra PS.1 microscope (Zeiss). 
Labelling and imaging of S. aureus 
For time-lapse experiments S. aureus cells were incubated with 
the membrane dye Nile Red (Invitrogen) at a final concentration of 10 
µg ml-1, for 5 minutes at 37 °C, with agitation (550 rpm). 
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Subsequently, the cells were placed on an agarose pad containing 
50% TSB in Phosphate Buffer Saline (PBS) and imaged during growth 
by SIM. Image sets were acquired every 3 minutes, for a total period 
of 1 hour, using 2% of 561 nm laser power and 50 ms exposure times. 
Measurements were performed on reconstructed super-resolution 
images using ZEN software. 
To determine the fraction of old/new cell wall in S. aureus, 
cells were stained with either a wheat germ agglutinin Alexa Fluor 
488 conjugate (WGA-488, Invitrogen) or fluorescent D-amino acid 
HADA 24,25 at a final concentration of 2 µg ml-1 and 250 µM, 
respectively. The cells were incubated at 37°C with agitation for 5 
minutes or 30 minutes for WGA-488 or HADA, respectively. 
Unbound dye was removed from the media by washing cells with 
TSB and cells were then incubated with Nile Red (10 µg ml-1) for 5 
minutes at room temperature and placed on an agarose pad 
containing 50% TSB in PBS. Cells showing uniform WGA-488 or 
HADA staining were imaged by SIM at 0, 3, 6, 30 and 60 minutes, 
using 2% 561 nm laser with 50 ms exposure for Nile Red, 3% 488 nm 
laser with 50 ms exposure for WGA-488 and 20% 405 nm laser with 
100 ms exposure for HADA. 
To evaluate localisation of peptidoglycan synthesis activity, S. 
aureus cells grown to an OD600nm of approximately 0.5 were labelled 
with fluorescent D-amino acid NADA (250 µM) for 20 minutes at 37 
°C, 550 rpm. Cells were then washed with PBS, placed on an agarose 
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pad and visualized by SIM, using 10% 488 nm laser, 100 ms exposure. 
For pulse labeling experiments, S. aureus cells were incubated with 
either HADA or its L-enantiomer HALA 24 for 5 min at 37°C, 550 rpm 
and then imaged as described above. 
S. aureus cell wall labelling with vancomycin was performed 
by incubating the cells for 2 minutes at room temperature with a 
mixture containing equal amounts of vancomycin (Sigma) and a 
BODIPY FL conjugate of vancomycin (Van-FL, Molecular Probes) to a 
final concentration of 0.8 µg ml-1. Cells were visualized by SIM, using 
2% 488 nm laser, 100 ms exposure. 
Labelling and imaging of Sporosarcina ureae 
To determine the fraction of old/new cell wall in S. ureae by 
time lapse microscopy, cells from cultures at OD600~0.5 were stained 
with WGA-488 at a final concentration of 6 µg.ml-1. The cells were 
incubated at 30°C with agitation for 10 minutes. Unbound dye was 
removed from the medium by washing cells with LB. Cells were then 
incubated with Nile Red (10 µg ml-1) for 5 minutes at room 
temperature and placed on an agarose pad containing 50% LB in PBS. 
Cells showing uniform WGA-488 labeling were imaged by SIM at 0, 
15, 30, 45 and 60 minutes, using 2% 561 nm laser with 50 ms exposure 
for Nile Red, 3% 488 nm laser with 50 ms exposure for WGA-488.  
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Photoactivated Localisation Microscopy (PALM) 
To observe PBP4-PAmCherry single molecules by PALM, an 
overnight culture of NCTCΔpbpD::pbpD-mCherryPA was diluted 
1/200 in TSB and incubated at 37 °C. At mid-exponential phase 
(OD600nm 0.6), 1 ml of culture was harvested by centrifugation and 
washed with 1 ml of PBS. Cells were re-suspended in 20 µl of PBS 
and 1 µl was placed on a thin layer of 1.2% agarose in PBS mounted 
on a gene frame. Image sequences for PALM analysis were obtained 
using a Zeiss Elyra PS.1 microscope with a 100x 1.46NA objective, 
additional magnification of 1.6X, equipped with an EMCCD camera 
(Andor - iXon DU897) using Zeiss ZEN software. For an initial bleach 
of auto-fluorescent molecules and unwanted pre-activated 
fluorophores, the sample was first imaged with a 561 nm laser at 
~0.76 kW cm-2 and 33 ms exposure for 2,000 frames. After bleaching, 
the continuous activation and imaging of PAmCherry molecules was 
performed for 8,000 frames by simultaneously irradiating the sample 
with a 405 nm laser at ~1.9 W cm-2 and a 561 nm laser at ~ 0.76 kW cm-
2, using 33 ms of exposure time. To maintain a stable density of 
fluorophores photo activating in each frame and compensate the 
depletion of PAmCherry molecules during the course of the 
experiment, the intensity of the 405 nm laser was increased until ~ 38 
W cm-2. Post-processing of the last 8,000 frames was performed using 
the ZEN software where an xy 2D-Gaussian fit was applied to the 
individually resolvable sub-diffraction molecules present in each 
frame (mask of 9 pixels with a minimum signal to noise ratio of 6). 
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Hyperosmotic shock  
Cells were grown in TSB until an OD600nm of approximately 0.5 
and then incubated for 30 minutes at 37 °C with agitation (700 rpm) 
in the presence of NADA (250 µM). The cells were harvested, washed 
once with 50 mM Tris-HCl buffer pH=7.5 containing a saturating 
concentration of NaCl (4.96 M) and incubated for 15 minutes at 37 °C. 
Cells were pelleted and placed on an agarose pad containing the 
same medium used to perform the hyperosmotic shock and imaged 
by SIM. 
Calculation of cell dimensions  
To calculate the volume of each cell, an ellipse was fitted to 
the border limits of the cellular membrane of Nile Red labelled cells, 
overlaying the membrane dye signal. Subsequently, the shorter and 
longer axes were measured, coinciding with the septum and the axis 
perpendicular to it, respectively. The volume of the cell was obtained 
by an approximation to the volume of a prolate spheroid (equation 1) 






Cell surface area was calculated using the Knud Thomsen 
approximation26 (equation 2) to calculate the surface area of 
ellipsoids, where 𝑎 corresponds to the longer semi-axis and b and c 
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correspond to shorter semi-axes, which are identical in the case of S. 
aureus cells.  
(2) 𝑆 ≈ 4π [
1
3
 × (𝑎𝑏1.6𝑎𝑐1.6𝑏𝑐1.6)]1/1.6 
To evaluate cellular symmetry and identify “D” shaped cells, cells in 
Phase 1 of the cell cycle were selected and an ellipse was fit to the cell 
borders corresponding to the old cell wall. The ellipse centre was 
defined as the middle point of the longer axis and the distances from 
this point (along a perpendicular axis) to new peripheral cell wall and 
old peripheral cell wall were calculated (see Fig. 8d). Symmetry was 
assessed by the ratio between the distance from the centre to the old 
cell wall and the distance from the centre to the new cell wall. A cell 
was considered as asymmetric when this ratio was more than 1.33, i.e. 
when the distance from the cell centre to the new cell wall was less 
than 75% of the distance to the old cell wall. 
Calculation of fluorescence ratio in NADA labelled cells 
NADA labelled S. aureus cells were observed using a Zeiss 
Axio Observer microscope equipped with a Photometrics CoolSNAP 
HQ2 camera (Roper Scientific) and Metamorph 7.5 software 
(Molecular Devices). To quantitatively assess D-amino acid 
incorporation, the fluorescence signal at the septum and at the 
peripheral cell wall was determined for 50 cells with fully formed 
septa. A fluorescence ratio (FR) for septal versus peripheral cell wall 
signals was determined as previously described27. 
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Statistical analysis  
Statistical analyses were done using GraphPad Prism 6 
(GraphPad Software). Unpaired student’s t-tests were used to 
evaluate the differences in cellular volume and shape between cell 
cycle stages and between the initial and final stages of each phase, as 
well as to compare fluorescence ratios between peripheral and septal 
wall signal intensity.  One-way ANOVA was used to compare 
old/new cell wall fraction at different time points. P-values ≤ 0.05 
were considered as significant for all analysis performed and were 
indicated with asterisks: *P ≤ 0.05, **P ≤ 0.01 and ***P ≤ 0.001. 
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Results 
S. aureus cells elongate during the cell cycle 
To follow morphology dynamics during the cell cycle of S. 
aureus, cells of wild-type strain COL were labelled with the 
membrane dye Nile Red, placed on an agarose pad containing 
growth medium and imaged during growth at room temperature by 
Super-Resolution Structured Illumination Microscopy (SIM) (Fig. 1a). 
During the initial phase of the cell cycle (here referred to as Phase 1), 
prior to initiation of division septum formation, cells were 
approximately spherical in shape, as determined by calculating the 
ratio between the longer axis of the cell (perpendicular to the division 
septum) and the shorter axis (coincident with the septum) and then 
became slightly elongated (Fig. 1c, Fig. 2 and Table 3). In a second 
stage (Phase 2), cells initiated and completed the synthesis of the 
division septum and did not significantly elongate. Finally, during 
the last stage of the cell cycle (Phase 3), cells with a complete septum 
elongated further, before splitting into two daughter cells. Splitting 
was accompanied by fast reshaping of the flat septum to become 





Figure 1. Morphological changes during the cell cycle of Staphylococcus 
aureus. (a) S. aureus COL cells were stained with membrane dye Nile Red 
and imaged by SIM for 60 min, at 3 min intervals. Phase 1 (P1) cells have 
recently divided and have not initiated synthesis of the septum. Phase 2 (P2) 
cells are undergoing septum synthesis. Phase 3 (P3) cells have a complete 
septum and are going to split into two daughter cells. Coloured arrows 
indicate periods of cell elongation. The time interval between panels was 
6 min. Scale bar, 1 μm. (b) Duration of each phase of the cell cycle 
(represented as a fraction of the duplication time) was measured in 
individual cells imaged by SIM while growing at room temperature on 
agarose slides containing growth medium (inner circumference); or after 
growing in liquid culture, at 37 °C, and placed on the microscopy slide just 
before imaging (outer circumference). (c) Elongation of S. aureus cells during 
the cell cycle was evaluated by calculating the ratio of the longer to the 
shorter axis of each cell. n=40 cells for each phase. (d) Cell volume was 
measured at the beginning and at the end of each phase of the cell cycle. 
Cells increased their volume continuously throughout the cell cycle. n=40 for 
each phase. Data in (c,d) were collected from two independent experiments 
and are represented as box-and-whisker plots where boxes correspond to 
the first to third quartiles, lines inside the boxes indicate the median and 
ends of whiskers represent the minimum and maximum of all data. 
Statistical analysis was performed using the unpaired t test (***P<0.001; ns, 
not significant). 
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Figure 2. Size measurements of S. aureus cells imaged by SIM during the 
cell cycle. (a) The shape of S. aureus cells was approximated to a prolate 
spheroid and superimposition of an elipse was used to measure the longer 
and shorter cellular axes during the different phases of growth. Scale bar = 1 
µm (b) Scatter plot of the measurements of the longer (a) and shorter (b) 
axes of S. aureus cells when starting (Initial) and finishing (Final) each of the 
three growth phases defined in Fig. 1. 
 
Table 3: Average ratio of longer/shorter axes of S. aureus cells upon 
initiation and completion of the three phases of the cell cycle. 
Strain P1 P2 P3 
 Initial Final Initial Final Initial Final 
COL 1.11±0.04 1.17±0.06 1.19±0.05 1.21±0.04 1.22±0.06 1.27±0.05 
COLΔpbpD 1.13±0.09 1.17±0.07 1.20±0.06 1.23±0.05 1.22±0.04 1.28±0.06 












1.20±0.08 1.19±0.06 1.19±0.06 1.20±0.07 1.23±0.10 





Although we were able to observe cells undergoing complete 
cell cycles by SIM imaging, we noticed a delay in growth, when 
compared to cells on the same slide that were not exposed to laser 
light. Photodamage is cumulative and therefore could cause an 
increasing bias towards longer duration of growth phases over the 
course of the experiment. In order to overcome this limitation, all 
quantitative analyses were only performed on the first complete 
growth phase of each cell (i.e., in cells observed finishing the previous 
phase and starting the next phase), and not on the entire cell cycle. 
Using this approach we measured the duration of each growth phase 
of the S. aureus cell cycle (Fig. 1b). Cells spent approximately half of 
the cell cycle in Phase 1 (479%), with the other half being spent in 
septum synthesis (Phase 2, 247%) and the final elongation step 
(Phase 3, 296%), with a cell cycle duration of 66  9 minutes. Because 
the cells analysed by this method were growing at room temperature 
on growth medium containing agarose pads, on the microscope 
stage, we independently confirmed the length of each phase by 
growing S. aureus cells in liquid culture with aeration at 37C, 
labelling cell membranes and immediately observing them by SIM. 
The percentage of cells observed in each phase should be 
proportional to the fraction of the cell cycle spent in that stage. Fig. 1b 
shows that similar results for the duration of Phases 1-3 were 
obtained by both methods. 
Interestingly, at the timescale of this experiment, we never 
observed intermediate stages in the process of cell splitting and 
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reshaping of the flat septum into a curved surface, implying that 
these events are likely to be extremely fast. In order to verify this 
assumption, we imaged cells growing on an agarose pad, at 2 ms 
intervals (Fig. 3a). S. aureus cells divided into two daughter cells in 
the interval between two acquisitions, indicating that splitting takes 
less than 2 ms (n=10). The spatial and temporal resolution of these 
images does not allow us to determine if (i) splitting and septum 
reshaping occur simultaneously, as one could expect if remodelling of 
the flat septum did not require any enzymatic activity and resulted 
solely from the increased turgor pressure imposed upon the septum 
as it splits and becomes exposed to the external milieu, or (ii) splitting 
and septum reshaping are two consecutive processes. We reasoned 
that if the latter hypothesis was correct, we should be able to capture 
intermediates in the division process in which the septum had 
already split but remained flat. For this purpose we fixed cells during 
exponential growth and imaged them using Scanning Electron 
Microscopy (SEM) (Fig. 3b). In agreement with previous data9, we 
observed recently divided cells in which the previous septum was 
seen as a smooth flat surface, indicating that septum splitting and 




Figure 3. Splitting of S. aureus cells occurs on the millisecond timescale. 
(a) Dividing S. aureus cells were imaged on an agarose pad, acquiring frames 
every 2 ms, showing that splitting of the mother cell occurs in <2 ms 
(between the 2 ms and the 4 ms frame). Time is indicated in milliseconds. 
Scale bar, 1 μm. (b) To capture intermediate stages in the splitting process, S. 
aureus cells were fixed with glutaraldehyde during growth and imaged by 
SEM. The cell on the left has just divided in two daughter cells. The previous 
division septum is seen as a smooth flat surface indicating that septum 
splitting and reshaping into a curved hemisphere are likely to be sequential 
events. Note that cells with flat septa were not as rare as could be expected 
given the speed of the splitting process. It is therefore possible that the cell 
treatment required for SEM stabilizes this stage. Scale bar, 750 nm. 
 
The septum gives less than one hemisphere of each daughter cell 
Previous descriptions of the S. aureus cell cycle suggested that 
cell wall synthesis occurred mainly, if not only, at the division 
septum5. Furthermore, it was assumed that the “new” cell wall 
material from the septum of the mother cell formed one complete 
hemisphere of each of the daughter cells, while the other hemisphere 
was made of “old” cell wall material originating from the peripheral 
wall of the mother cell. However, we observed that just prior to 
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splitting, at the end of Phase 3, the mother cell has an ellipsoid shape, 
with a semi-major axis of 0.700.04 m (perpendicular to the septum) 
and two semi-minor axes of 0.550.03 m (equivalent to the radius of 
the septum), resulting in a septal surface area of 0.95 m2. After 
splitting, at the beginning of Phase 1, each daughter cell has semi-
major and semi-minor axes of 0.520.03 m and 0.460.03 m, 
respectively. Therefore, the total surface area of each daughter cell is 
~2.89 m2 (see Experimental Procedures for Knud Thomsen 
approximation used for calculations), of which 0.95 m2, or ~33%, 
should be composed of new cell wall material, originating from the 
septum of the mother cell. The remaining ~67% of the cell surface 
should be composed of “old” cell wall material, originating from one 
hemisphere of the mother cell, i.e., the distribution of old and new 
cell wall material should not be 50% of each, as previously 
assumed3,5,6 (Fig. 4a). To determine whether the mode of S. aureus 
growth was consistent with these assumptions, cells were labelled 
with a green fluorescent derivative of wheat germ agglutinin (WGA-
488), a lectin which labels N-acetylglucosamine residues present in 
peptidoglycan and in wall teichoic acids. Importantly, WGA labels 
the cell wall present at the cell surface (peripheral wall) but does not 
diffuse into (and therefore does not label) the division septum. Cells 
were next washed to remove unbound WGA-488, and stained with 
the membrane dye Nile Red, which diffuses through the septum and 
therefore labels the entire membrane of the cell. Finally, cells were 
placed on an agarose pad containing growth medium and imaged by 
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SIM during growth (Fig. 4b). Cells whose surface was completely 
labelled by WGA-488 were selected for analysis and both the 
perimeter of each cell, as well as the fraction of the cell surface made 
of old cell wall (WGA-488 labelled), were measured. In agreement 
with our model, we found that after splitting of the mother cell, each 
daughter cell had 61.33.3% (n=30) of its surface labelled by WGA-
488, i.e., made of old cell wall, clearly showing that the flat septum, 
even after reshaping, does not contribute to half of the cell surface 
(Fig. 4c).  
These results were confirmed in a second experiment, similar 
to the one described above, in which cells were labelled with HADA 
instead of WGA-488. HADA is a blue fluorescent derivative of 3-
amino-D-alanine that can be incorporated in the pentapeptide chain 
of peptidoglycan24. Selected cells whose entire surface was labelled 
with HADA at time zero were followed during growth for 60 minutes 
(Fig. 4d). Similar to the results obtained with WGA-488 labelling, 
upon splitting of the mother cell, 62.53.4% of the surface of each 
daughter cell was labelled with HADA.  
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Figure 4. Asymmetrical inheritance of cell wall material during S. aureus 
cell division. (a) Schematic representation of the possible modes of division 
and growth of S. aureus. Peripheral cell wall of the mother cell is represented 
in green and cell membrane is represented in red. Upon division of the 
mother cell, the new cell wall material, derived from the previous septum, 
may constitute 50% of the surface of each daughter cell, if the surface area of 
the flat septum increases as it becomes curved (I), or 33%, if there is no 
increase in the surface area of septum material (II). In the latter case, the cell 
can then grow by peptidoglycan synthesis and/or autolysis either at the site 
of the new cell wall material only (III) or throughout the entire cell surface 
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(IV). (b) S. aureus COL cells were labelled for 5 min with peripheral cell wall 
dye WGA-488 (green), washed and stained with membrane dye Nile Red. 
Cells were placed on an agarose pad and resumed growth at room 
temperature. Upon division, the old cell wall preserved the green WGA-488 
signal. Cells were imaged by SIM at 3, 30 and 60 min after splitting. The cell 
indicated by the arrow underwent a second round of division. (c) The 
fraction of WGA-488-labelled cell wall (green) relative to cell perimeter (red) 
remained above 0.60 during the cell cycle, n=30. No statistically significant 
variation was found (P>0.05). (d) An experiment equivalent to that described 
in panel (b) was done using cell wall dye HADA instead of WGA-488. (e) 
The fraction of cell wall labelled with HADA (blue) relative to the cell 
perimeter (red), decreased slightly during the first 30 min but remained 
above 0.60 during the cell cycle, n=30. (P=0.03). (f) The cell wall of 
Sporosarcina ureae was labelled with WGA-488, washed, labelled with Nile 
Red and imaged by SIM. Panels show the same cell before and after division, 
indicating that old cell wall material (green) constitutes more than half of the 
daughter cells surface. Contrast of individual channels was adjusted on 
merged images. Scale bars, 0.5 μm. Data in (c,e) are represented as box-and-
whisker plots where boxes correspond to the first to third quartiles, lines 
inside the boxes indicate the median and ends of whiskers represent the 
minimum and maximum of all data. Statistical analysis was performed 
using one-way analysis of variance. 
 
Careful inspection of SEM images of S. aureus cells confirms 
that the “old” cell wall constitutes more than 50% of the surface of 
each daughter cell (Fig. 5). Cell wall material which is at least one 
generation old has been described as having an irregular, rough 
appearance, while newly synthesized cell wall, resulting directly 
from the septum of the mother cell, has a smoother appearance with 
concentric rings 3,28, with a clear border separating the two types of 
cell surface 29. These borders, seen in Fig. 5 and denoted in blue in the 
Cell shape dynamics during the staphylococcal cell cycle 
109 
schematic representation of the cells, are clearly not placed at mid 
cell, reinforcing the idea that more than half of the surface of S. aureus 
cells is at least one generation old.  
 
Figure 5. Scars of previous divisions do not mark cell quadrants. SEM 
images of S. aureus COL cells showing an asymmetric scar (blue line in 
scheme) corresponding to the previous division site and a fissure located in 
the middle of the cell (red line), presumably corresponding to the next 
division site. The new cell wall (light brown), resulting from septal material 
from the mother cell, which has a smooth surface immediately after division 
(first panel), occupies less than half of the total surface. Scale bars, 600 nm. 
 
We then asked if this mode of division of spherical cells, in 
which the division septum of the mother cell generates less than one 
hemisphere of each daughter cells was restricted to S. aureus or 
common to other cocci. Labelling of peripheral cell walls in 
Sporosarcina ureae with WGA-488 showed that division of spherical 
cells from this organism also results in daughter cells with a fraction 
of approximately 60% of the surface made of “old” cell wall (Fig. 4f).  
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S. aureus grows by remodelling the entire cell surface 
The fact that cell wall synthesis in staphylococci occurred 
mainly, if not exclusively, at the division septum5, led to the 
suggestion that S. aureus does not enlarge during the cell cycle and 
that the conversion of the flat division septum into one hemisphere of 
each daughter cell accounted for the doubling in volume required for 
cell division to take place3,5,6. Importantly, the diffraction limit of 
resolution of conventional light microscopy (~250 nm) 30,31 impaired, 
until now, detection of size variations in the range of those required 
for the doubling of S. aureus cell volume (see discussion). These 
variations can, however, be observed by SIM, which improves the 
lateral xy resolution to approximately 110 nm32. Using this technique, 
we observed that staphylococcal cells increased in volume during the 
entire cell cycle, from a volume of 0.47±0.07 µm3 at the beginning of 
Phase 1 to a volume of 0.91±0.12 µm3 at the end of Phase 3 (Fig. 1d 
and Table 4). If enlargement of S. aureus cells was due mainly to the 
remodelling of the flat septum into a hemisphere, the volume 
increase should be essentially restricted to the process of splitting and 
reshaping of the septum. On the contrary, we have observed that 
there is no significant increase in volume when staphylococcal cells 
divide, i.e., that each of the two daughter cells has approximately half 
of the volume of the Phase 3 mother cell (Fig. 1d). Furthermore, the 
largest and fastest increase in volume occurs during Phase 3 
(Δvolume = 0.16±0.07 μm3 at a rate of 0.009±0.003 µm3 min-1, Table 4), 
during which there is no reshaping of the flat septum, clearly 
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indicating that other mechanisms must be involved with the 
enlargement of S. aureus cells. 
Table 4. Average volume (µm3) of S. aureus cells upon initiation and 
completion of the three phases of the cell cycle. 
 
Strain 
P1 P2 P3 
Initial Final Initial Final Initial Final 




0.59±0.10 0.61±0.08 0.69±0.09 0.70±0.07 0.86±0.11 















* P ≤ 0.05,  ** P ≤ 0.01, *** P ≤ 0.001 mutants vs. parental strain COL (n=40 cells for 
each strain) 
Next we wondered if enlargement of cells occurred via 
remodelling only of the material derived from the previous septum 
or via remodelling of the entire cell surface (Fig. 4a). In the former 
case, the percentage of “new” cell wall should increase during the 
course of the cell cycle, eventually reaching half of the total cell 
surface, while in the latter case the ratio of new to old cell wall 
observed immediately after splitting of the mother cell (~39% to 
~61%, respectively, Fig. 4b) should be maintained over the cell cycle. 
Therefore, following the growth of cells in which the “old” cell wall 
was labelled with WGA-488 should allow us to determine how S. 
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aureus cells enlarge. The perimeter of WGA-488 labelled cells 
increased from 3.080.17 m to 3.400.21 m after 60 minutes on the 
slide, confirming that cells were growing. Under these conditions, the 
fraction of cell wall labelled by WGA-488 remained at 60.63.2%, 
even in cells that were already initiating the next round of division 
(Fig. 4b and c). Similar results were obtained with HADA labelled 
cells, in which the fraction of labelled cell wall remained at 60.53.8% 
after 60 minutes (Fig. 4d and e), indicating that cell enlargement was 
due to remodelling of the entire cell surface and not exclusively of the 
septal material. 
S. aureus enlarges via peptidoglycan synthesis and autolysis 
Enlargement of bacterial cells can occur via synthesis of new 
peptidoglycan, autolysis of old peptidoglycan, or a combination of 
both processes. We have previously observed that peptidoglycan 
synthesis occurred mostly at the division septum5. Given that we 
have now shown that growth of staphylococcal cells occurs via 
remodelling of the entire cell surface, we considered the possibility 
that enlargement was mainly due to autolytic activity. However, 
autolysis without synthesis would lead to a thinning and/or increase 
in the porosity of the old peptidoglycan mesh over consecutive 
generations. Since approximately 60% of old cell wall is transmitted 
to daughter cells in each cell division, staphylococcal cells would 
have regions of the surface a few generations old, which were 
necessarily submitted to the enlargement process multiple times. 
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Thinning of these regions due to peptidoglycan autolysis without 
synthesis could therefore endanger the integrity of the bacterial cell. 
Making use of newly available tools to study peptidoglycan synthesis 
and to image protein localisation, we revisited the question regarding 
the localisation of peptidoglycan synthesis in S. aureus. S. aureus cells 
were labelled with HADA, which can be incorporated by PBPs in the 
pentapeptide chain of peptidoglycan24. Cells in growth phases 2 and 
3, i.e., cells with partial or complete septa, showed labelling mostly at 
the septum, in agreement with previous reports showing that the 
majority of PBP activity takes place at the septum4,5,33. However, 
peripheral signal was also observable (Fig. 6a). Labelling around the 
entire cell surface was even more noticeable in Phase 1 cells, lacking a 
division septum (Fig. 6a, arrows). 
 
Figure 6. Fluorescent D-amino acid HADA is incorporated at the 
peripheral wall of S. aureus cells. S. aureus COL cells were labelled for 5 
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minutes with HADA, a fluorescent derivative of 3-amino-D-alanine that can 
be incorporated in the pentapeptide chain of peptidoglycan (a) or its L-
enantiomer HALA that should not be incorporated into the peptidoglycan 
(b), used as a control for non-specific binding. Cells were then imaged by 
SIM, showing that the peripheral walls of cells in phase 1 (examples 
indicated by white arrows) were labelled by HADA but not by HALA. Scale 
bars = 10 m 
 
We then asked which of the four native S. aureus PBPs had 
peripheral activity. Given that PBP1 and PBP2 are essential proteins 
in MSSA strains and therefore cannot be depleted34,35, S. aureus 
mutants lacking PBP3 and PBP4 were initially tested. For this 
purpose, we used a green fluorescent variant of HADA, NADA. 
COLpbpD cells, lacking PBP4, were virtually devoid of NADA 
labelling away from the septum (Fig. 7b), when compared to COL 
(Fig. 7a), showing that this protein is the main enzyme responsible for 
the peripheral signal. Complementation of COLpbpD with a 
plasmid-encoded PBP4 resulted in recovery of the peripheral signal 
(Fig. 7c and d). A comparison of the ratio of the septal versus 
peripheral fluorescence signal in the COL parental strain (7.91±0.42) 
and COLΔpbpD (18.7±0.76) confirmed that incorporation of D-alanine 
labelled analogues was essentially absent from the peripheral wall of 
the mutant lacking PBP4 (Fig. 7e). In agreement, localisation of a 
fluorescent derivative of PBP4 showed that although this protein is 
mainly localized at the septum, as we have previously reported 36, 
peripheral fluorescent signal could also be observed (Fig. 7f). 
Quantification by PhotoActivated Localisation Microscopy (PALM) 
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showed that 2611% of the total PBP4 molecules (fused to 
photoactivatable mCherry) in phase 3 cells are present at the 
peripheral membrane (Fig. 7g). 
 
Figure 7. PBP4 is active at the division septum and at the peripheral wall. 
(a) S. aureus COL cells were incubated for 20 minutes with NADA and 
imaged by wide-field fluorescence microscopy. Cells with partial (Phase 2) 
or complete (Phase 3) septa (arrows) showed labelling mostly at the septum, 
although some fluorescent signal could also be observed at the peripheral 
cell surface. Cells without septa (Phase 1, asterisks) showed NADA 
incorporation at the peripheral cell wall. Scale bar = 5 µm. (b) COLΔpbpD 
cells, lacking PBP4 were imaged as described above. NADA incorporation at 
the peripheral cell surface was virtually absent both in cells undergoing 
septation (arrows) and in newly split cells (asterisk), indicating that PBP4 is 
responsible for the majority of peripheral NADA incorporation. Scale bar = 5 
µm. (c,d) Strain COLΔpbpD was complemented with empty pCNX vector 
(c) and pCNX encoding PBP4 under the control of Pcad (d), in the presence 
of cadmium chloride (1µM), and imaged as above. NADA incorporation at 
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the peripheral cell surface was only observed in the strain complemented 
with PBP4. Scale bar = 5 µm. (e) The intensity of the NADA fluorescence 
signal was measured at the septum and peripheral wall, in cells (n=50) with 
complete division septa, and the ratio between septal and peripheral signal 
was calculated for each cell. This ratio was significantly higher for 
COLΔpbpD than for COL cells (18.7±5.4 vs 7.9±3.0, P<0.001) showing that 
the mutant lacking PBP4 is deficient in peripheral NADA incorporation. 
This ratio was also higher in COLΔpbpD containing the empty vector pCNX 
than in the same strain complemented with plasmid-encoded PBP4 (18.2±5.7 
vs 10.2±5.4, P<0.001).(f) Localisation of a YFP-tagged derivative of PBP4 
inCOL cells by wide-field fluorescence microscopy showing that a small 
fraction of PBP4 localizes at the cell periphery. Scale bar = 5 µm. (g) PALM 
image showing PBP4-PAmCherry localisation in S. aureus NCTC8325-4 
background. Cells (n=50) showing PBP4-PAmCherry in complete septa 
(white arrow) were used to quantify the number of PBP4 molecules 
(n=27533) present either at the peripheral membrane (26±11%) or at the septa 
(74±11%). Images are false coloured showing red to white increasing 
intensity range. Scale bar, 1µm. 
 
Furthermore, the duration of Phase 1 is longer in COLpbpD 
than in the parental strain COL (Fig. 8a) and the cell volume is 
smaller (Table 4), reinforcing the hypothesis that PBP4 is one of the 
proteins that have a role in peripheral peptidoglycan synthesis 
during this growth phase. In contrast, cell elongation is unaffected in 
COLpbpD cells (Table 3), suggesting that additional proteins play a 
role in cell growth. We therefore evaluated the role of two major 
autolysins, Atl7 and Sle137 in cell enlargement and elongation, as well 
as in septum remodelling, by deleting chromosomal atl or sle1 genes 
of strain COL. The lack of Atl amidase and glucosaminidase activities 
led to larger cells which are less elongated when compared to the 
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parental strain COL (Tables 3 and 4), indicating that Atl autolytic 
activity is involved not only in cell separation, as previously shown8,9, 
but also in cell size homeostasis and shape maintenance. COLsle1 
cells remain elongated throughout the entire cell cycle, which could 
result from increased stiffness of peptidoglycan in the absence of Sle1 
amidase activity, possibly impairing correct reshaping of the cell 
following division. Furthermore, these cells have a longer Phase 3 
than the parental strain COL (Fig. 8a), suggesting that cell splitting is 
impaired in this mutant.  
Interestingly, we have observed the appearance, albeit at low 
frequency, of cells with the shape of the letter “D” in cultures of 
COLsle1 (Fig. 8b, arrows). These cells seem to be impaired in the 
process of reshaping of the flat septum, generated immediately after 
the splitting of the mother cell, into a curved hemisphere. D-shaped 
cells were never observed in the parental strain COL by SIM. This 
phenotype seems to be a consequence of defects in specific autolytic 
enzymes whose activity is required for the reshaping of the flat 
septum, since asymmetric cells were also identified at higher 
frequencies than in the parental strains in (i) an sle1 deletion mutant 
in the background of a different S. aureus strain, namely NCTC8325-4 
(Fig. 9b); (ii) an NCTC8325-4 mutant lacking LytM, an autolysin with 
glycylglycine endopeptidase activity38 (Fig. 9c); (iii) a COL mutant 
depleted for the two-component system WalK/WalR (also known as 
YycG/YycF), which positively controls autolytic activity39 (Fig. 9e). 
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Interestingly, although WalKR is essential in RN422039, strain COL 
grows in its absence. 
 
Figure 8. Effect of impaired peptidoglycan synthesis or autolysis on the 
cell cycle and morphology of S. aureus. (a) Duration of phases of the cell 
cycle of S. aureus mutants lacking peptidoglycan synthesis enzyme PBP4 
(COLΔpbpD, total duration of cell cycle 73±10 min) or autolysins Atl 
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(COLΔatl, 82±8 min) and Sle1 (COLΔsle1, 86±15 min), compared with the 
parental strain COL (66±9 min). Cells (n=40 for each phase) were growing in 
solid medium and only cells that completed at least one growth phase 
during the time of the experiment were included in the analysis. 
Approximately 50% of COLΔpbpD cells that initiated Phase 1 did not 
complete it (versus 20% of COL cells) and were not included in the analysis. 
(b) The cell wall of COL and COLΔsle1 was stained with Van-FL and imaged 
by SIM. Asymmetric cells with a shape close to a ‘D’ (white arrows) were 
observed, indicating that reshaping of the flat septum into a curved 
hemisphere following division was impaired in this mutant. (c) 
Exponentially growing COL and COLΔsle1 cells were stained with NADA, 
incubated for 15 min in saturating concentration of NaCl, placed on an 
agarose pad containing the same salt concentration and imaged by SIM. 
Cells with a shape close to a ‘D’ (examples indicated by white arrows) were 
observed at higher frequency in the mutant lacking Sle1 (right) than in the 
parental strain COL (left). Scale bars, 2 μm. (d) Symmetry of cells depicted in 
panels b and c was assessed by fitting an ellipse to the cells (n=50 for each 
class) and defining its centre (X) as the middle point of the shorter axis (A). 
The distances from X to new peripheral cell wall (B) and old peripheral cell 
wall (C) were calculated. Cells were considered as asymmetric (black bars) if 
the ratio C/B was more than 1.33 and symmetric (grey bars) when this ratio 





Figure 9. Effect of impaired peptidoglycan autolysis on the morphology of 
S. aureus. Cells of MSSA strain NCTC8325-4 (a), its mutant lacking autolysin 
Sle1 (NCTCΔsle1, (b)), or lacking autolysin LytM (NCTCΔlytM, (c)) were 
labelled with cell wall dye Van-FL and imaged by SIM, confirming the 
presence of D-shaped cells in the mutants. (d) Symmetry of cells depicted in 
panels “a” to “c” was assessed as described in Fig. 8d, showing an increase 
in the frequency of asymmetric cells in the two autolysin mutants. (e) Cells 
of MRSA strain COL with the two-component system walKR (positive 
regulator of autolysins) placed under the control of the IPTG-inducible 
promoter Pspac (COLwalKRi), were grown in the presence or in the absence 
of inducer, labelled with Van-FL and imaged by SIM, showing the presence 
of D-shaped cells. (f) Symmetry of cells depicted in panel “e” was assessed 
as described in Fig. 8d, showing an increase in the frequency of asymmetric 
cells upon depletion of the WalKR two-component system. Scale bars = 2 m 
In order to determine if turgor pressure also had a role in 
driving the reshaping of the flat septum, we incubated COL and 
COLsle1 in buffer containing saturating NaCl concentration. The 
decreased turgor pressure led to higher frequency of “D” shaped or 
asymmetric cells both in COLsle1 and in parental strain COL, albeit 
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to lower levels in the parental strain (Fig. 8d). Strain COLsle1 
complemented with a plasmid-encoded Sle1 behaved as the parental 
strain COL (Fig. 10). These results suggest that the division septum 
requires the action of both autolytic enzymes and turgor pressure to 
change from a flat to a curved surface, although we cannot exclude 
the possibility that the effect of NaCl is due to an impact on the 
activity of autolysins. 
 
Figure 10. Complementation of COLΔsle1 with plasmid-encoded sle1. (a) 
Cells of COLΔsle1 strain were transformed with empty vector pBCBover 
(left) or the same vector encoding sle1 under the control of IPTG inducible 
Pspac promoter (right) were labelled with NADA, incubated for 15 minutes in 
saturating concentration of NaCl, placed on an agarose pad containing the 
same salt concentration and imaged by SIM. Asymmetric cells with a shape 
close to a “D” (white arrows) were observed in higher frequency in the 
strain containing the empty vector. Scale bars = 2 m. (b) Symmetry of cells 
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depicted in panel “a” was assessed as described in Fig 8d, showing that the 
phenotype of strain COLΔsle1 is complemented by the expression of Sle1 
from a plasmid. 
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Discussion 
Despite its importance as a clinical pathogen, the small size of 
S. aureus cells has impaired a detailed analysis of the morphological 
changes occurring during its cell cycle, given that size variations 
required to double the cell volume are close to the limit of resolution 
of conventional optical microscopy: S. aureus cells are approximately 
1 m in diameter (or 0.52 m3 in volume). Approximating the cell 
shape to a sphere, an increase of the diameter to 1.26 m is sufficient 
to double cell volume. However, this 260 nm increase is close to the 
diffraction limit of resolution of conventional optical microscopy, 
which is ~250 m for most biocompatible fluorophores30,31. 
  The current model for S. aureus cell division postulates that 
cells do not significantly enlarge during the cell cycle and that the 
major variation in cell volume occurs upon splitting of the mother 
cell, when the flat septum is reshaped into a curved surface to 
generate one hemisphere of each daughter cell. This model was based 
on the fact that both incorporation of new peptidoglycan material and 
localisation of the major peptidoglycan synthesis enzymes, the PBPs, 
occurred mostly at the septum5,22,33,34,36, two observations that still 
hold true. However, here, by fast imaging of dividing S. aureus cells, 
we show that reshaping of the division septum is an extremely rapid 
process, on the timescale of less than two milliseconds, and therefore 
not compatible with a duplication of cellular volume and the 
consequent abrupt changes in concentrations of cellular contents. It is 
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therefore more likely that, similar to other bacteria, the volume of S. 
aureus cells gradually increases over the cell cycle, but these size 
variations are too small to be observable by conventional light 
microscopy. 
Recent advances in fluorescence microscopy, specifically the 
introduction of super-resolution techniques, now allow an 
unprecedented level of detail in the analysis of bacterial cell 
morphology. Making use of SIM, with a lateral resolution of 
approximately 110 nm32, we measured variations of the volume of S. 
aureus cells and concluded that (i) cell volume increases gradually 
over the entire cell cycle and (ii) there is no substantial increase in cell 
volume due to reshaping of the flat septum, given that upon splitting 
of a mother cell, each newly generated daughter cell has 
approximately half of the mother cell´s volume. Furthermore, and 
contrary to previous assumptions, the cell wall material resulting 
from the division septum of the mother cell (new cell wall) does not 
constitute half of the cell surface of each daughter cell, but 
approximately 33% (Fig. 11). Taken together, these observations 
suggest that other mechanisms besides septum reshaping are 
responsible for cell growth in S. aureus. 
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Figure 11. Comparison of two models for S. aureus growth and division. 
(a) Previous model which assumed that S. aureus cells remained 
approximately spherical over the cell cycle and that, on division, the cell 
wall material from the septum of the mother cell increased in cell surface 
area to constitute half (one hemisphere made of new cell wall) of the cell 
surface of each daughter cell. As a consequence, scars of previous divisions 
divided the cell in quadrants and formed T-junctions at the cell poles, which 
could be used as topological cues to direct cellular processes such as 
chromosome segregation. These scars were proposed to encode epigenetic 
information that could be used by S. aureus to determine orthogonal 
placement of division septum. (b) In the model proposed based on this 
work, S. aureus cells are approximately spherical at the beginning of the cell 
cycle and elongate as the cell cycle progresses. On division, there is no 
increase in the surface area of the previous septum, which becomes ∼33% of 
the surface area of each daughter cell. This asymmetry in the regions 
composed of new and old cell wall results in scars of previous divisions that 
do not divide cells in quadrants. Consequently, T-junctions of scars of two 
previous divisions are not located at the cell poles. Two consecutive 
divisions in orthogonal planes are depicted in panels (a,b). 
Upon division of the mother cell, S. aureus cells could grow by 
(i) remodelling and enlarging only the new cell wall material or (ii) 
remodelling the entire cell surface. In the first case, the surface area 
corresponding to new cell wall material would be expected to expand 
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from 33% and eventually constitute half of the cell surface, while in 
the second case the 33/67 ratio of new/old cell wall would be 
maintained during the entire cell cycle. We have labelled peripheral 
cell wall with a lectin (WGA-488) as well as a fluorescent derivative 
of D-alanine (HADA) and confirmed that the latter hypothesis is 
correct.  
Cell enlargement can occur by synthesis of new peptidoglycan 
material, autolysis of old peptidoglycan or a combination of both 
processes. The fact that the entire cell surface is enlarged during 
growth, but different sections of the surface vary in age, seems 
incompatible with the notion that peptidoglycan synthesis or 
autolysis alone are responsible for the increase in cell surface. If that 
were the case, then regions with different ages of the cell wall would 
have different thickness and/or porosity. By transmission electron 
microscopy, S. aureus peripheral cell wall seems homogeneous in 
thickness40. The porosity of new and old cell wall may be different, as 
the former shows a series of concentric rings while the latter appears 
as a network of fibers with a large number of empty spaces between 
them, perhaps resulting from autolytic activity28,41. However, if this 
autolytic activity would occur across the entire cell surface multiple 
times, i.e., over several generations, in the absence of peptidoglycan 
synthesis, holes in older regions of the cell surface would presumably 
become larger, possibly endangering the integrity of the cell.  
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It therefore seems likely that peptidoglycan synthesis has to 
occur across the cell surface, concomitantly with autolysis. In fact, we 
were able to detect peripheral PBP activity through the incorporation 
of fluorescent derivatives of 3-amino-D-alanine24, mediated mostly by 
PBP4, in agreement with recent data by Gautam et al.42. It is possible 
that other PBPs also have a role in peripheral peptidoglycan 
synthesis, which is not detected in our assay given that PBP4 is the 
main responsible for incorporation of exogenous peptidoglycan 
synthesis probes42,43. It is important to note that these probes may be 
incorporated by PBPs in an exchange reaction that occurs outside the 
cell, and therefore do not necessarily reflect the sites of incorporation 
of lipid-linked peptidoglycan precursors. It is possible that PBP4 
activity is required, not (only) to incorporate new peptidoglycan 
precursor molecules, therefore increasing the amount of 
peptidoglycan material in the cell wall, but also to make new bonds 
in pre-existing material that was subjected to autolytic activity during 
cell expansion leading to an increased mechanical strength. In fact 
PBP4 was shown to be responsible for the very high levels of 
peptidoglycan crosslinking characteristic of S. aureus12,44 and required 
to increase the stiffness of the cell envelope13.  
Finally, we have also pondered over the question of the 
extremely fast process of septum reshaping into a curved 
hemisphere, namely if it was a purely mechanical process or if it 
required enzymatic activity. Previous reports using atomic force 
microscopy (AFM) imaging have shown the presence of perforation 
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holes around the bacterial circumference coincident with the outer 
edge of the division septum. These holes become larger, merge and 
form longer nicks in the peripheral wall as splitting of the septum 
proceeds41. These holes are most likely the result of activity of 
autolysins such as Atl, a protein required for cell separation, which 
localizes in rings at the division site8,9. Interestingly, Atl localizes 
exclusively at the external edge of the septum, not across the entire 
septal surface9, suggesting that its activity is only required at the 
initial steps of splitting. This would be in agreement with the 
suggestion by Matias and Beveridge that the septum of S. aureus has a 
middle zone that separates two adjacent septal cross walls45. Once the 
outer edge of the septum is cleaved by autolysins, cell separation 
could proceed through a merely mechanical process driven by turgor 
pressure on the two separate halves of the cross-wall, as no additional 
cleavage of peptidoglycan bonds would be required across the 
septum. The time required for splitting, which we have now shown 
to occur in less than two milliseconds, does indeed suggest a 
mechanical process, probably driven by turgor pressure, in 
agreement with our data showing that septum reshaping is impaired 
in high osmolarity conditions and with recent data published while 
this manuscript was under revision46. However, we have also shown 
that autolysins such as Sle1 and LytM have a role in reshaping of the 
flat septum, given that mutants lacking one of these proteins, 
particularly when exposed to medium with high osmolarity, generate 
daughter cells in which the previous septum remains flatter. 
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Nevertheless we cannot determine if Sle1 and LytM activities occur 
before or during splitting. Interestingly, Bailey and colleagues have 
recently shown that the new cell wall material in the flat septum is 
stiffer than the rest of the cell wall and becomes softer when fully 
expanded into a hemisphere47. Therefore, these authors suggest that 
reshaping of the flat septum cannot occur only through stretching (as 
this would require the flat septum to be thicker but softer than the 
rest of the cell wall), but instead requires partial degradation of the 
peptidoglycan by autolytic enzymes47.  
The increase in resolution resulting from advances in super-
resolution microscopy has allowed us to completely redefine the cell 
cycle of S. aureus, one of the most relevant bacterial pathogens, with 
important implications for current models of cell division in cocci. S. 
aureus cells divide in three orthogonal planes over three consecutive 
division cycles1,2, raising the question of how do the cells retain 
“memory” of the two previous planes of division, in order to define a 
third, perpendicular, division plane. Scars of previous divisions have 
been proposed to contain epigenetic information regarding the 
previous planes of division3. Junctions of these scars at the cell poles 
could be used as topological cues to drive chromosome segregation in 
an axis perpendicular to the next division plane48. The process of 
nucleoid occlusion, which prevents assembly of the divisome over 
the chromosome, would then restrict the localisation of the next 
division plane to a plane orthogonal to the two previous ones48. 
However, these models assume that scars of previous division planes 
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are placed precisely at the center of the cell (similar to the equator or 
meridians of earth, Fig. 11a), and therefore cross each other at poles of 
the cells. Our observation that lines dividing the S. aureus cell surface 
containing old/new cell wall material do not divide the cell in two 
equal parts (Fig. 11b), reopens the question of how staphylococci 
divide in orthogonal planes. Our findings may also be extended to 
other cocci which divide in orthogonal planes, such as Sporosarcina, 
and thus our observations described for S. aureus should have 
implications for the global understanding of cell division in other 
coccal bacteria. 
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Abstract 
 Survival of most bacteria depends on their ability to 
synthesize a robust cell wall to interface with the external milieu. 
Peptidoglycan (PG), the major component of the bacterial wall, is a 
macromolecule that envelops the cell in a tough but flexible mesh-like 
structure that can bear the mechanical stress resulting from high 
intracellular turgor. Bacilli and ovococcal species possess two distinct 
PG synthesis machineries, each dedicated exclusively to either cell 
elongation or septation. In contrast, coccoid bacteria like 
Staphylococcus aureus possess only one protein machinery that 
synthesizes PG, which has to be diverted from the periphery of the 
cell to the septum in preparation for division. The molecular cue that 
coordinates this transition has remained elusive. Here we 
investigated the localisation of most proteins involved in PG 
biosynthesis in S. aureus and showed that the putative lipid II flippase 
MurJ localizes exclusively to the septum during division. 
Furthermore, we determined that MurJ recruitment to the divisome is 
dependent on the assembly of the DivIB/DivIC/FtsL complex and 
drives PG incorporation to mid-cell. Our findings demonstrate an 
elegant mechanism by which the timely recruitment of a single 






 Biosynthesis of PG is a multi-enzymatic process that must be 
tightly coordinated with the cell cycle1 (see Fig. 1a and General 
Introduction for a review). It starts in the cytoplasm with the 
synthesis of the UDP-N-acetylmuramyl-pentapeptide precursor, 
which is linked to lipid carrier bactoprenol and converted into lipid II 
at the inner face of the membrane. In S. aureus, lipid II is then further 
modified by the addition of a pentaglycine bridge and amidation, 
before being flipped across the membrane. The last steps of PG 
synthesis take place at the outer face of the membrane, where lipid II 
is incorporated into the growing PG network by transglycosylation 
and transpeptidation reactions catalysed mainly by penicillin-binding 
proteins (PBPs) (Fig. 1a). The identity of the lipid II flippase has been 
a matter of debate over the years. The most recent evidence points to 
MurJ, a member of the MOP (multidrug/oligosaccharidyl-
lipid/polysaccharide) exporter superfamily, as the flippase in 
Escherichia coli2,3. Although strict MurJ homologs are exclusive to 
Gram-negative bacteria, in S. aureus the essential gene SAV1754 or 
SACOL1804 (which encodes a MOP protein that we have renamed 
MurJ) has been reported as a functional MurJ ortholog based on 
structural topology and genetic evidence4. An alternative protein 
suggested for the flippase function in E. coli is FtsW, a member of the 
SEDS (sporulation, elongation, division and synthesis) protein family. 
However, recent reports showed that SEDS family members are 
peptidoglycan transglycosylases that probably function together with 
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a cognate PBP during PG polymerization5,6. S. aureus encodes two 
SEDS proteins, SACOL1122 and SACOL2075 that show significant 
homology and similar genomic context to Bacillus subtilis SEDS 
proteins FtsW and RodA, respectively, as described before7. 
 
Figure 1. PG synthesis and cell cycle schematics for S. aureus. (a),, Scheme 
of the peptidoglycan synthesis pathway in S. aureus. (b), Scheme of the S. 
aureus cell cycle. Phase 1 cells have not initiated septum synthesis; Phase 2 
cells are undergoing septum synthesis; Phase 3 cells have a complete septum 
undergoing maturation in preparation for splitting. 
 
The biochemical steps of PG synthesis are very similar in all 
bacteria. Therefore, different bacterial shapes are mainly determined 
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by the spatial and temporal regulation of PG synthesis, rather than by 
different chemical compositions of PG8. Rod-shaped bacteria, such as 
Bacillus subtilis, achieve their shape through the action of two PG 
synthesis machineries that incorporate PG at the septum and at the 
lateral wall, in processes coordinated by cytoskeletal proteins FtsZ 
and MreB, respectively9,10. Ovococcal species such as Streptococcus 
pneumoniae or Lactococcus lactis also have two dedicated machineries, 
but they both localise to the septum and function in succession8. In 
contrast, cocci like S. aureus possess a single PG synthesis machinery, 
which is active mainly at the septum during division11, but also 
incorporates PG at the cell periphery during initial stages of the cell 
cycle, i.e., in new born cells which have not initiated septum 
synthesis, as shown in Chapter II (cells in Phase 1 of the cell cycle, 
Fig. 1b)12. When synthesis of the division septum is initiated (Phase 
2), PG synthesis is diverted from the cell periphery to the division 
site, by an unknown mechanism, where it continues to occur after 
septum closure (Phase 3), until the cell undergoes splitting, giving 
two identical daughter cells12. In this work, we aimed to identify the 
molecular cue that determines the shift of PG synthesis from the cell 
periphery to the septum in cocci.  
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Experimental Procedures 
Bacterial growth conditions 
Strains and plasmids used in this study are listed in Table 1. S. 
aureus strains were grown in tryptic soy broth (TSB, Difco) at 200 
r.p.m with aeration at 37 °C or on tryptic soy agar (TSA, Difco) at 30 
or 37°C. E. coli strains were grown in Luria–Bertani broth (Difco) with 
aeration, or Luria–Bertani agar (Difco) at 37 or 30°C. When necessary, 
antibiotics ampicillin (100  μg ml−1), erythromycin (10  μg ml−1), 
kanamycin (50  μg ml−1), neomycin (50  μg ml−1) or chloramphenicol 
(30  μg ml−1) were added to the media. 5-bromo-4-chloro-3-indolyl β-
D-galactopyranoside (X-gal, Apollo Scientific) was used at 
100 μg ml−1. Unless stated otherwise, isopropyl β-D-1-
thiogalactopyranoside (IPTG, Apollo Scientific) was used at 0.1 mM 
to induce expression of constructs under the control of the Pspac 
promoter. Cadmium chloride (Sigma-Aldrich) was used at 0.1 µM 
when required to induce expression of constructs under the control of 







Table 1. Strains and plasmids used in this study 
Strains Description Source or 
reference 
Escherichia coli   
DC10B Δdcm in the DH10B background; Dam methylation only 13 




COL HA-MRSA 14 
RN4220 Restriction-deficient derivative of NCTC8325-4 15 
ColMurB-GFP COL murB::murB-gfp; Eryr This Work 
ColMurD-GFP COL murD::murD-gfp; Eryr This Work 
ColMurF-GFP COL murF::murF-gfp; Eryr This Work 
ColMraY-sGFP COL pCN-mraYsgfp; Eryr This Work 
BCBMS001 RN4220 murG::murG-gfp; Eryr 16 
ColMurG-GFP COL murG::murG-gfp; Eryr This Work 
ColFemX-sGFP COL femX::femX-sgfp; Eryr This Work 
ColFemA-
mCherry 
COL femA::femA-mcherry This Work 
ColFemB-GFP COL femB::femB-gfp; Eryr This Work 
ColFtsW-
mCherry 
COL ftsW::ftsW-mCherry This Work 
ColFtsW-sGFP COL ftsW::ftsW-sgfp  This Work 
ColMurJ-
mCherry 
COL murJ::murJ-mCherry This Work 
ColMurJ-sGFP COL murJ::murJ-sgfp This Work 
ColRodA-sGFP COL rodA::rodA-sgfp This Work 
ColsGFP-PBP1 COL pbpA::sgfp-pbpA This Work 
BCBPM073 COL pbpB::sgfp-pbpB 17 
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Strains Description Source or 
reference 
ColsGFP-PBP3 COL pbpC::sgfp-pbpC This Work 
COLpPBP4-YFP COL pbpD::pbpD-yfp; Kanr 18 
BCBAJ020 COL spa::Pspac-ftsZ-cfp 17 
ColFtsZ-
mCherryi 
COL spa::Pspac-ftsZ-mcherry This Work 
ColDltC-sGFPi COL spa::Pspac-dltC-sgfp This work 
ColWZ COL ftsW::ftsW-mCherry, spa::Pspac-ftsZ-cfp This Work 
ColWZpEPSA COL ftsW::ftsW-mCherry, spa::Pspac-ftsZ-cfp, pEPSA; Cmr This Work 
ColWZpAS-FtsL COL ftsW::ftsW-mCherry, spa::Pspac-ftsZ-cfp, pAS-185; Cmr This Work 
ColWZpAS-FtsA COL ftsW::ftsW-mCherry, spa::Pspac-ftsZ-cfp, pAS-022; Cmr This Work 
ColP1Z COL pbpA::sgfp-pbpA, spa::Pspac-ftsZ-mcherry This Work 
ColP1ZpEPSA COL pbpA::sgfp-pbpA, spa::Pspac-ftsZ-mcherry, pEPSA; Cmr This Work 
ColP1ZpAS-FtsL COL pbpA::sgfp-pbpA, spa::Pspac-ftsZ-mcherry, pAS-185; Cmr This Work 
ColP1ZpAS-FtsA COL pbpA::sgfp-pbpA, spa::Pspac-ftsZ-mcherry, pAS-022; Cmr This Work 
ColJZ COL murJ::murJ-mCherry, spa::Pspac-ftsZ-cfp This Work 
ColJZpEPSA COL murJ::murJ-mCherry, spa::Pspac-ftsZ-cfp, pEPSA; Cmr This Work 
ColJZpAS-FtsL COL murJ::murJ-mCherry, spa::Pspac-ftsZ-cfp, pAS-185; Cmr This Work 
ColJZpAS-DivIB COL murJ::murJ-mCherry, spa::Pspac-ftsZ-cfp, pAS-DivIB; Cmr This Work 
ColJZpAS-DivIC COL murJ::murJ-mCherry, spa::Pspac-ftsZ-cfp, pAS-DivIC; Cmr This Work 
ColZIB COL spa::Pspac-ftsZ-cfp, pCN-yfpDivIB; Kanr This Work 
ColZZ COL spa::Pspac-ftsZ-cfp, pCN-ftsZmch; Kanr This Work 
ColJIB COL murJ::murJ-mCherry, pCN-yfpDivIB; Kanr This Work 
ColWgZm COL ftsW::ftsW-sgfp, spa::Pspac-ftsZ-mcherry This Work 
ColJgZm COL murJ::murJ-sgfp, spa::Pspac-ftsZ-mcherry This Work 
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Strains Description Source or 
reference 
ColWJ COL ftsW::ftsW-mCherry, murJ::murJ-sgfp This Work 
ColWJpEPSA COL ftsW::ftsW-mCherry, murJ::murJ-sgfp, pEPSA; Cmr This Work 
ColWJpAS-FtsL COL ftsW::ftsW-mCherry, murJ::murJ-sgfp, pAS-185; Cmr This Work 
AS-022 RN4220  pAS-022; Cmr 19 
AS-185 RN4220  pAS-185; Cmr 19 
 
Plasmids Description Source or 
reference 
pBCB4-chE S. aureus integrative vector for N- and C-terminal mCherry 
fusions; Ampr Eryr 
20 
pTRC99a-P7 Vector containing sgfp-p7; Ampr 21 
pMUTINYFPKa
n 
Vector containing yfp; Ampr Kanr 22 
pSG5082 S. aureus integrative vector that allows for C-terminal 
gfpmutP2 fusions; Ampr Eryr 
23 
pSG-murB pSG5082 derivative containing a 3' fragment of murB; Ampr 
Eryr 
This work 
pSG-murD pSG5082 derivative containing a 3' fragment of murD; Ampr 
Eryr 
This work 
pSG-murF pSG5082 derivative containing a 3' fragment of murF; Ampr 
Eryr 
This work 
pSG-femB pSG5082 derivative containing a 3' fragment of femB; Ampr 
Eryr 
This work 
pMAD E. coli-S. aureus shuttle vector with a thermosensitive origin 




pMAD derivative containing a femA-mCherry fusion and the 
downstream region of femA; Ampr Eryr 
This work 
pMAD-ftsWmch pMAD derivative containing an ftsW-mCherry fusion and 
the downstream region of ftsW; Ampr Eryr 
This work 
pMAD-ftsWsgfp pMAD derivative containing an ftsW-sgfp fusion and the 
downstream region of ftsW; Ampr Eryr 
This work 
pMAD-murJmch pMAD derivative containing a murJ-mCherry fusion and the 
downstream region of murJ; Ampr Eryr 
This work 
pMAD-murJsgfp pMAD derivative containing a murJ-sgfp fusion and the 




pMAD derivative containing a rodA-sgfp fusion and the 
downstream region of rodA, Ampr Eryr 
This work 




pMAD derivative containing an sgfp-pbpA fusion and the 




pMAD derivative containing an sgfp-pbpC fusion and the 
upstream region of pbpC, Ampr Eryr 
This work 
pBCB13 pMAD derivative with up- and downstream regions of the 
spa locus and Pspac-lacI, Ampr Eryr lacZ 
20 





pBCB13 derivative containing a dltC-sgfp fusion; Ampr Eryr This work 
pCN51 Shuttle replicative vector containing the cadmium inducible 
Pcad promoter; Ampr Eryr 
25 
pCN-mraYsgfp pCN51 derivative encoding a MraY-sGFP sandwich fusion; 
Ampr Eryr 
This work 
pCNX Replicative vector containing the cadmium inducible Pcad 
promoter; Ampr Kanr 
12 
pCN-ftsZmch pCNX derivative encoding an FtsZ-mCherry fusion; Ampr 
Kanr  
This work 
pCN-yfpDivIB pCNX derivative encoding an  YFP-DivIB fusion; Ampr Kanr This work 
pFAST3 S. aureus integrative vector that allows for C-terminal sgfp 
fusions; Ampr Eryr 
26 
pFAST-femX pFAST3 derivative containing a 5' fragment of femX; Ampr 
Eryr 
This work 
pEPSA5 E.coli/S. aureus shuttle replicative vector containing a xylose-
inducible promoter T5X; Ampr Cmr 
27 
pAS-022 pEPSA5 derivative encoding a xylose inducible anti-ftsA 
antisense RNA fragment; Ampr Cmr  
19 
pAS-185 pEPSA5 derivative encoding a xylose inducible anti-ftsL 
antisense RNA fragment; Ampr Cmr  
19 
pAS-DivIB pEPSA5 derivative encoding a xylose inducible anti-divIB 
antisense RNA fragment; Ampr Cmr  
This work 
pAS-DivIC pEPSA5 derivative encoding a xylose inducible anti-divIC 
antisense RNA fragment; Ampr Cmr  
This work 
 
Construction of S. aureus fluorescent strains 
Cloning of fluorescent fusions in S. aureus was done using the 
following general strategy: plasmids were propagated in E.coli strains 
DC10B or DH5α and purified from overnight cultures supplemented 
with the relevant antibiotics. Plasmids were then introduced into 
electrocompetent S. aureus RN4220 cells as described before28 and 
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transduced to COL using phage 80α29. Constructs were confirmed by 
PCR and sequencing of the amplified fragment. Table 2 describes the 
primers used in this study.  
Table 2. Oligonucleotides used in this work. 





murFg_P1 cgggtacccacatatgcaagatttagg  
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Underlined sequences correspond to restriction sites  
 
The ColMurB-GFP, ColMurD-GFP, ColMurF-GFP and 
ColFemB-GFP strains were constructed using the pSG5082 vector30. 
Briefly, DNA fragments with approximately 500 bp spanning the 3’ 
ends (minus stop codons) of the murB, murD, murF and femB genes 
from COL were amplified using primer pairs murBg_P1/murBg_P2; 
murDg_P1/murDg_P2; murFg_P1/murFg_P2 and 
femBg_P1/femBg_P2, respectively. Fragments were digested with 
KpnI and XhoI restriction enzymes and cloned into pSG5082 upstream 
and in frame with gfpmutP2, originating plasmids pSG-murB, pSG-
murD, pSG-murF and pSG-femB. These plasmids were then 
electroporated to RN4220, where they integrated in the genome by a 
single homologous recombination event and subsequently 
transduced to COL. Resulting strains contain the corresponding 
fluorescent fusions in each gene’s native locus under the control of its 
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native promoter, followed by the pSG5082 backbone and a truncated 
copy of the gene. The strategy to construct ColFemX-sGFP was 
essentially the same, except that the pFAST331 vector was used 
instead of pSG5082. A femX fragment was amplified from COL DNA 
with primers femXg_P1 and femXg_P2, digested with KpnI/XhoI and 
cloned into pFAST3 upstream and in frame with sgfp, giving pFAST-
femX, which was electroporated into RN4220 and transduced into 
COL. Strain ColMurG-GFP was obtained by transducing the murG-
gfp construct from BCBMS00132 into COL.  
Strains ColFemA-mCherry, ColFtsW-mCherry, ColMurJ-
mCherry, ColRodA-sGFP, ColsGFP-PBP1 and ColsGFP-PBP3 were 
constructed by allelic replacement strategies using the pMAD vector. 
In each case three DNA fragments (F1, F2 and F3 – see Table 3) 
containing overhangs complementary with adjacent fragments were 
amplified from COL DNA and joined by overlap PCR, giving F1-F2-
F3 fusion constructs. The full constructs were then amplified by PCR 
using up- and downstream primers (P1 and P6 in each case), digested 
with the corresponding restriction enzymes and cloned into pMAD. 
Integration and excision of the pMAD derivatives in COL by a double 
recombination event, leading to allelic exchange, was performed as 
described before24. The relevant information for the cloning steps for 












    








































































































































































Temp – template DNA used in the PCR reaction. 
In order to obtain strains ColFtsW-sGFP and ColMurJ-sGFP, 
plasmids pMAD-ftsWsgfp and pMAD-murJsgfp were first 
constructed. For pMAD-ftsWsgfp, three fragments (F1, F2 and F3), 
each flanked by restriction sites, were introduced into pMAD. F1, 
containing the 3’ end of ftsW minus the stop codon, was amplified 
from NCTC8325-4 DNA with primers ftsWg_P1/ftsWg_P2 and 
digested with SmaI/SalI; F2, containing sgfp, was amplified from 
Recruitment of MurJ to the divisome directs peptidoglycan synthesis to the septum 
151 
pTRC99a-P7 with primers ftsWg_P3/ftsWg_P4 and digested with 
SalI; F3, containing the downstream region of ftsW, was amplified 
from NCTC8325-4 DNA and digested with SalI/BamHI. Fragments 
were then sequentially cloned into pMAD (F1, followed by F3 and 
finally by F2) using the adjacent restriction sites, giving pMAD-
ftsWsgfp. For pMAD-murJsgfp the same strategy was used. F1, 
containing the 3’ end of murJ minus the stop codon, was amplified 
from COL DNA using primers murJg_P1/murJg_P2 and digested 
with SmaI/SalI; F2, containing sgfp, was amplified from pTRC99a-P7 
using primers murJg_P3/murJg_P4 and digested with SalI; F3, 
containing the last 26bp of murJ and its downstream region, was 
amplified from COL DNA using primers murJg_P5/murJg_P6 and 
digested with SalI/BamHI. Fragments were cloned into pMAD 
resulting in plasmid pMAD-murJsgfp. Plasmids pMAD-ftsWsgfp and 
pMAD-murJsgfp were then electroporated to RN4220, transduced to 
COL and following allelic replacement strains ColFtsW-sGFP and 
ColMurJ-sGFP were obtained.  
Strain ColFtsZ-mCherryi was constructed using the pBCB13 
plasmid20, a derivative of pMAD that allows allelic exchanges in the 
spa locus. Briefly, a DNA fragment containing the Ribosome Binding 
Site (RBS), the ftsZ gene without its stop codon and a 5 amino acid 
linker was amplified by PCR from COL with primers 
iftsZm_P1/iftsZm_P2. A second fragment containing mCherry was 
amplified from pBCB4che using primers iftsZm_P3/iFtsZm_P4. The 
two fragments were joined by overlap PCR using primers 
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iftsZm_P1/iftsZm_P4 and the resulting construct was digested with 
SmaI/XhoI and cloned into pBCB13, downstream of the Pspac 
promoter, giving pBCB13-ftsZmch. Similarly, to construct strain 
ColDltC-sGFPi a DNA fragment containing an RBS, the dltC gene 
without stop codon and a two amino acid linker was amplified by 
PCR from COL with primers idltCg_P1 and idltCg_P2. A second 
fragment containing sgfp was amplified from pTRC99a-P7 using 
primers idltCg_P3/idltCg_P4. The two fragments were joined by 
overlap PCR using primers idltCg_P1/idltCg_P4 and the resulting 
construct was digested with SmaI/XhoI and cloned into pBCB13 
downstream of the Pspac promoter, giving pBCB13-dltCsgfp. 
Following transduction to COL, plasmids integration/excision at the 
spa locus was performed as described before24.  
Strain ColMraY-sGFP was constructed using the pCN51 
replicative plasmid to express an MraY-sGFP sandwich fusion. 
Briefly, three DNA fragments (F1, F2 and F3) with overhangs were 
amplified in order to construct a fusion with sgfp inserted within the 
mraY coding sequence, between codons 220 and 221. F1, containing 
an RBS and the first 660 bp of mraY, was amplified from COL DNA 
using primers mraYg_P1/mraYg_P2; F2, containing sgfp minus the 
stop codon, was amplified from pTRC99a-P7 with primers 
mraYg_P3/mraYg_P4; F3, containing the last 306 bp of mraY, was 
amplified from COL using primers mraYg_P5 and mraYg_P6. The 
three fragments were joined by overlap PCR and digested with SmaI 
and cloned into pCN51, resulting in pCN-mraYsgfp.  
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Strains ColWZ and ColJZ were constructed by transducing 
plasmids pMAD-ftsWmch and pMAD-murJmch, respectively, into 
BCBAJ020. ColP1Z was constructed by transducing pMAD-sgfpPbp1 
into ColFtsZ-mCherryi. Strains ColWgZm and ColJgZm were 
constructed by transducing plasmids pMAD-ftsWsgfp and pMAD-
murJsgfp, respectively, into ColFtsZ-mCherryi. Strain ColWJ was 
obtained by transducing pMAD-murJsgfp to ColFtsW-mCherry. In 
each case, allelic replacement was performed as described above. In 
order to construct ColZZ, an ftsZ-mCherry fusion was amplified from 
genomic DNA of ColFtsZ-mCherryi with primers ftsZm_pCNX_P1 
and ftsZm_pCNX_P2, digested with BamHI/EcoRI and cloned in 
pCNX downstream of the Pcad promoter, giving plasmid pCN-
ftsZmch. This plasmid was then electroporated into RN4220 and 
transduced to BCBAJ020, giving strain ColZZ.  
To study co-localisation between DivIB with FtsZ or MurJ, an 
yfp-divIB fusion was constructed and cloned into pCNX. Briefly, a 
fragment containing yfp minus the stop codon and a 3’ terminal 
overhang was amplified from pMUTINYFPKan22 with primers 
ydivIB_pCNX_P1/ydivIB_pCNX_P2. A second fragment containing 
the full divIB gene with a 5’ overhang was amplified from COL DNA 
with primers ydivIB_pCNX_P3/ydivIB_pCNX_P4. The two 
fragments were then joined by overlap PCR, digested with SmaI/KpnI 
and cloned into pCNX downstream of Pcad, giving plasmid pCN-
yfpDivIB. This plasmid was transduced to BCBAJ020 and ColMurJ-
mCherry, giving strains ColZIB and ColJIB, respectively. 
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Construction of S. aureus strains containing antisense RNA vectors 
To construct strains carrying antisense RNA vectors, 250 bp 
fragments of divIB or divIC genes were amplified from COL DNA 
with primer pairs ASdivIB_P1/ASdivIB_P2 and 
ASdivIC_P1/AS_DivIC_P2, respectively, digested with EcoRI/BamHI 
and cloned in antisense direction into pEPSA5, relative to the xylose 
inducible T5X promoter, giving pAS-DivIB and pAS-DivIC. These 
plasmids were then transduced into ColJZ, giving ColJZpAS-DivIB 
and ColJZpAS-DivIC respectively. Additionally, phage lysates were 
obtained from AS-022 and AS-185 strains33 carrying antisense RNA 
pEPSA vectors pAS-022 and pAS-185 targeting ftsA and ftsL, 
respectively. pAS-022 was transduced to ColWZ and ColP1Z, giving 
strains ColWZpAS-FtsA and ColP1ZpAS-FtsA. pAS-185 was 
transduced to ColJZ, ColWZ, ColP1Z and ColWJ, giving strains 
ColJZpAS-FtsL, ColWZpAS-FtsL, ColP1ZpAS-FtsL and ColWJpAS-
FtsL, respectively. Control strains for these experiments were 
obtained by transducing the empty vector pEPSA5 into ColJZ, 
ColWZ, ColP1Z and ColWJ, giving strains ColJZpEPSA, 
ColWZpEPSA, ColP1ZpEPSA and ColWJpEPSA, respectively. 
Growth curves of S. aureus strains 
Overnight cultures of COL strains encoding fluorescent 
derivatives of PG synthesis enzymes were back-diluted to OD600nm 
0.02 in TSB and grown at 37C for 11 hours with OD600nm 
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measurements taken every hour. Doubling times were calculated for 
each strain during exponential growth phase.  
Minimum inhibitory concentration (MIC) assays 
MICs of relevant antimicrobial compounds were determined 
by broth microdilution in sterile 96-well plates. The medium used 
was TSB, containing a series of two-fold dilutions of each compound. 
Cultures of S. aureus strains and mutants were added at a final 
density of 5x105 CFU ml-1 to each well. Wells were reserved in each 
plate for sterility control (no cells added) and cell viability (no 
compound added). Plates were aerobically incubated at 37°C. 
Endpoints were assessed visually after 24 and 48 h. All assays were 
done in triplicate. 
Western Blotting 
S. aureus strains ColJZpEPSA, ColJZpAS-DivIB and 
ColJZpAS-DivIC were grown overnight, back-diluted 1:200 in fresh 
TSB and incubated at 37°C until an OD600nm of approximately 0.2. At 
this point, xylose was added to the medium at 4% to allow the 
expression of the antisense RNA fragments. After 1 hour of antisense 
expression, cells were harvested and broken with glass beads in a 
FastPrep FP120 cell disrupter (Thermo Electro Corporation). Samples 
were centrifuged to remove unbroken cells and debris and total 
protein content of the clarified lysates was determined using the 
Bradford method and bovine serum albumin as a standard (BCA 
Protein Assay Kit, Pierce). Equal amounts of total protein from each 
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sample were separated on 10% SDS-PAGE at 80V and then 
transferred to Hybond-P PVDF membrane (GE Healthcare) using a 
Semi-dry transfer cell (Biorad), according to standard western 
blotting techniques. Membranes were cut to separate PBP2A region 
from DivIB or DivIC region. DivIB and DivIC proteins were detected 
using specific polyclonal antibodies at 1:5000 and 1:10000 dilutions, 
respectively. PBP2A was detected using the antibody from a Slidex 
MRSA detection kit (Biomerieux) at 1:500 dilution. Protein bands 
were visualised using the ECL Prime Detection Reagents (GE 
Healthcare), following manufacturer’s instructions.   
S. aureus imaging by fluorescence microscopy 
Super-resolution Structured Illumination Microscopy (SIM) 
imaging was performed using an Elyra PS.1 microscope (Zeiss) with 
a Plan-Apochromat 63x/1.4 oil DIC M27 objective. SIM images were 
acquired using five grid rotations, unless stated otherwise, with 
34 μm grating period for the 561 nm laser (100 mW), 28 μm period for 
488 nm laser (100 mW) and 23 μm period for 405 nm laser (50 mW). 
Images were captured using a Pco.edge 5.5 camera and reconstructed 
using ZEN software (black edition, 2012, version 8.1.0.484) based on a 
structured illumination algorithm, using synthetic, channel specific 
optical transfer functions and noise filter settings ranging from −6 to 
−8. Wide-field fluorescence microscopy was performed using a Zeiss 
Axio Observer microscope with a Plan-Apochromat 100x/1.4 oil Ph3 
objective. Images were acquired with a Retiga R1 CCD camera 
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(QImaging) using Metamorph 7.5 software (Molecular Devices). For 
fluorescence microscopy experiments, unless stated otherwise, 
overnight cultures of S. aureus strains were back-diluted 1:200 in fresh 
media with appropriate inducers and allowed to grow until OD600nm ~ 
0.6 before being harvested and washed with phosphate buffer saline 
(PBS). Cells were then placed on microscope slides covered with a 
thin layer of agarose (1% in PBS) and imaged by SIM or wide-field 
microscopy. 
To assess if MurJ localisation was dependent on interaction 
with its substrate, strain ColMurJ-mCherry was grown until OD600nm 
of 0.4 and incubated with 3-{1-[(2,3-
Dimethylphenyl)methyl]piperidin-4-yl}-1-methyl-2-pyridin-4-yl-1H-
indole (DMPI, gift from Merck) at 3 µg ml-1 for 30 minutes and then 
imaged by wide-field fluorescence microscopy as described above. 
For antisense RNA experiments, strains were grown until OD600nm of 
0.1-0.2 at which point expression of the antisense RNA fragments was 
induced with xylose (Apollo Scientific) at a final concentration of 4% 
for 1 hour. Cells were then harvested and washed with PBS to 
remove xylose, mounted on microscope slides as described above 
and imaged by wide-field fluorescence microscopy. Assays were 
done in triplicate. To evaluate localisation of peptidoglycan synthesis 
activity, S .aureus cells were given a pulse of fluorescent D-amino-acid 
HADA34 (250 μM) for 1 min and then washed two times with PBS. 
Cells were then placed on an agarose pad and visualised by wide-
field microscopy. Assays were done in triplicate. To label S. aureus 
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membranes, cells were incubated with Nile Red (Invitrogen) at a final 
concentration of 10 µg ml-1 for 5 minutes at room temperature, 
washed with PBS and then mounted on microscope slides.  
HADA incorporation microscopy assay 
To assess if MurJ activity was required for HADA 
incorporation, strains COL and ColDltC-sGFPi (which expresses a 
cytoplasmic DltC-sGFP fusion and therefore can be easily 
distinguished from COL under the microscope) were grown to an 
OD600nm of 0.4 at which point each culture was separated into two 
flasks and either DMPI (3 µg ml-1 in DMSO) or DMSO (0.2 % final 
concentration) were added to the cultures. Following 25 minutes of 
incubation, HADA (500 µM) was added to each culture for 5 minutes. 
Cells were then harvested, washed twice with PBS (supplemented 
with DMPI when applicable) and DMSO-treated COL cells were 
mixed with DMPI-treated ColDltC-sGFPi cells. To exclude the 
possibility that the expression of DltC-sGFP affected the results, a 
reverse experiment was performed where cells of DMSO-treated 
ColDltC-sGFPi were mixed with DMPI-treated COL. These mixtures 
of two strains were then imaged by fluorescence microscopy as 
described above. 
Inhibition of the cell cycle assays 
An overnight culture of strain COL was back-diluted 1:200 
and grown until OD600nm ~ 0.4 at which point either DMPI35 (3 µg ml-1), 
PC19072336 (2.5 µg ml-1), oxacillin (1000 µg ml-1, Sigma-Aldrich) or 
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DMSO (0.2 %) were added to the medium. Cells were then grown for 
30 minutes with each inhibitor, harvested and labelled with Nile Red, 
as described above, before being imaged by SIM. Cells were sorted 
into each phase of the cell cycle (Phase 1, Phase 2 or Phase 3), as 
previously described 12. Assays were done in triplicate. 
 
Automatic cell imaging analysis 
Analysis of phase-contrast and fluorescence images was 
performed using in-house developed software eHooke. For cell 
segmentation, eHooke uses phase-contrast images and applies the 
isodata algorithm37 for automatic thresholding to find a pixel 
intensity value that separates the pixels corresponding to the 
background from those corresponding to cells. Using this threshold, 
the software then creates a binary mask which is used to compute the 
Euclidean Distances38 of each pixel in order to find the centres of 
individual regions inside the mask. The software then expands those 
centres to define individual cell regions using the watershed 
algorithm39. In order to measure cell areas and volumes, eHooke first 
defines each individual cell region, computes the area by counting 
the number of pixels inside the region and the volume by measuring 
the long and short axes of the cell. Cell volume is then derived 
assuming a prolate spheroid shape as described before12. 
To calculate fluorescent ratios (FR) between septal and 
membrane signal, eHooke was used to define the different regions of 
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the cell, namely membrane, cytoplasm and septum in images 
obtained by wide-field fluorescence microscopy. The membrane is 
defined by dilating the outline of the cell towards its inside. To 
separate the septum from the cytoplasm the software uses the isodata 
algorithm37 to find the brightest region inside the cell. This region is 
then defined as the septum. To measure the median fluorescence, 
only the 25% brightest pixels of the septum were considered, in order 
to remove possible misidentified pixels from the measurement. Only 
cells with a closed septum were selected for measurements. FR values 
were then calculated according to the equation: 




In order to measure the Pearson’s Correlation Coefficient 
(PCC) between two fluorescent proteins in a strain, images of each 
fluorescence channel were aligned and loaded side-by-side in 
eHooke. Following automatic cell segmentation, cells showing an 
FtsZ signal at the septum were selected for PCC measurements. The 
pixels corresponding to each cell were isolated and PCC values 
between channels were then calculated using the following equation, 
adapted from 40: PCC =  






 , where Xi and Yi 
correspond to each pixel intensity for two fluorescence channels and 
?̅? and Y̅ correspond to the mean intensities of those channels. 
Code availability 
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Code is available online at Github: 
https://github.com/BacterialCellBiologyLab/Bruno-Saraiva-2017. 
Statistical Analysis 
Statistical analyses were done using GraphPad Prism 6 
(GraphPad Software). Unpaired student’s t-tests were used to 
evaluate the differences of cellular volumes as well as to compare 
fluorescence ratios between peripheral and septal wall signal 
intensity. Mann-Whitney U tests were used to compare differences 
between PCC non-normal distributions obtained in co-localisation 
experiments. P values ≤0.05 were considered as significant for all 
analysis performed and were indicated with asterisks: *P≤0.05, 





Localisation of peptidoglycan synthesis proteins during division 
We posited that the molecular cue for septal PG synthesis 
could be the recruitment of a key protein involved in PG biosynthesis 
to mid-cell during the assembly of the divisome. Therefore, we 
determined the localisation of most proteins that are involved in PG 
synthesis in S. aureus. We constructed a set of strains in the 
background of MRSA COL, expressing fluorescent derivatives of 
MurB, MurD, MurF, MraY, MurG, FemX, FemA, FemB, FtsW, MurJ, 
RodA, PBP1, PBP217, PBP3 and PBP420 (see Fig. 2 and Table 4). All 
fluorescent fusions were expressed from their native locus under the 
control of their native promoter, as the sole copy of the gene in the 
cell, with the exception of MraY-sGFP. Most of these proteins are 
either essential to cell viability or auxiliary factors required for 
oxacillin resistance41,42. As growth rates and minimum inhibitory 
concentration (MICs) to oxacillin and D-cycloserine were similar to 
the parental strain COL (except for MraY-sGFP), fluorescent 
derivatives of PG synthesis enzymes seemed functional (Table 4). 
Despite several attempts, we were unable to construct a strain 
harbouring a functional fluorescent fusion to MraY. Thus, despite the 
inherent limitations, we used a strain expressing the native MraY 
protein from the native locus, and an sGFP sandwich MraY fusion 
(see methods) as a second copy, expressed from replicative plasmid 
pCN51, under the control of a cadmium-inducible promoter. Live 
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cells of all strains expressing fluorescent fusions of PG synthesis 
enzymes were imaged by Super Resolution Structured Illumination 
Microscopy (SIM) (Fig. 2a).  
 
Figure 2. Localisation of PG synthesis proteins during division in S. aureus 
(a), Structured Illumination Microscopy (SIM) images of S. aureus cells 
expressing fluorescent derivatives of PG synthesis proteins. Scale bars, 0.5 
µm. (b,) Fluorescence ratios (FR) between fluorescence signal at the septum 
versus the peripheral membrane measured in cells with a complete septum 
(Phase 3). Blue bars: membrane proteins with FR~2, similar to Nile Red 
staining of COL membrane, expected as the septum contains two 
membranes versus one in the cell periphery. Green bars: septal enriched 
proteins with 2.5<FR<3.5. Red bars: septal proteins with FR>4. Data are 
represented as column graphs where the height of the column is the mean 
and whiskers are standard deviation.  
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Table 4. Strains used to study localisation of peptidoglycan synthesis in 
Staphylococcus aureus. 








































fmhB FemX sGFP Transfer of gly to lys 














ftsW FtsW mCh Putative 
transglycosylase - 




murJ MurJ mCh Putative lipid II 
membrane translocase 





rodA RodA sGFP Putative 
transglycosylase - 




pbpA PBP1 sGFP Transpeptidase 33 250 






pbpC PBP3 sGFP Peptidoglycan 
transpeptidase 
34 500 




pbpD PBP4 YFP Peptidoglycan 
transpeptidase 
35 500 
COL --- --- --- --- 36 500 
 
As expected MurB, MurD and MurF fusions, which act on 
cytoplasmic PG precursors, showed cytoplasmic localisation. Also 
consistent with their substrate localisation, the remaining fusions 
localized to the membrane, including FemXAB proteins which do not 
have canonical membrane-targeting domains. Given that during 
septum synthesis most PG synthesis activity occurs at that place11, we 
were expecting all membrane PG synthesis enzymes in dividing cells 
to be greatly enriched at the septum. However, MraY, MurG, and the 
FemXAB proteins were evenly distributed throughout the membrane 
(including the septum) suggesting that the key step for spatial 
regulation of PG synthesis was not the synthesis of lipid I or lipid II, 
as could perhaps be expected. Only later steps, namely those 
catalysed by FtsW, MurJ and RodA, as well as PBPs 1-4, seemed 
enriched at the septum. This was confirmed using an in-house 
developed software – eHooke - to measure the fluorescence ratio (FR) 
of septal versus peripheral membrane fluorescence signal in cells 
(n>400 cells for each strain) imaged by wide-field fluorescence 
microscopy. Membrane-bound PG synthesis proteins fell into three 
classes: Class 1 (Fig. 2b, blue bars and Table 5) included MraY, MurG, 
FemX, FemA and FemB proteins which were dispersed over the 
entire membrane and had FR values close to 2, similar to membrane 
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dye Nile Red; Class 2 (Fig. 2b, green bars and Table 5) included 
RodA, PBP2, PBP3 and PBP4, which were enriched at the septum 
(2.5<FR<3.5) but could also be observed at the peripheral membrane; 
Class 3 (Fig. 2b, red bars and Table 5) included PBP1, FtsW and MurJ, 
seen as septal proteins for which virtually no signal could be 
observed in the peripheral membrane during septum synthesis 
(FR>4). These data suggested that the first steps in PG synthesis that 
occur specifically at the septum are those catalyzed by the 
hypothetical lipidII flippase MurJ, the hypothetical transglycosylase 
FtsW and/or the transpeptidase PBP1.  
Table 5. Fluorescent ratios between septal and peripheral signal measured 
for PG synthesis proteins. 
 
FR 25% (A.U.) 
COL NR 1.70±0.16 (n = 439) 
MraY-sGFP 1.96±0.27 (n = 533) 
MurG-GFP 2.03±0.70 (n = 516) 
FemX-sGFP 1.96±0.27 (n = 533) 
FemA-mCherry 1.97±0.81 (n = 513) 
FemB-GFP 1.74±0.27 (n = 622) 
MurJ-mCherry 6.54±3.12 (n = 503) 
FtsW-mCherry 5.47±1.97 (n = 517) 
sGFP-PBP1 4.28±1.80 (n = 503) 
RodA-sGFP 2.73±0.64 (n = 689) 
sGFP-PBP2 3.16±1.35 (n = 1321) 
sGFP-PBP3 2.88±1.11 (n = 488) 
PBP4-YFP 2.68±0.77 (n = 516) 
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In order to clarify which protein(s) was responsible for 
directing PG synthesis to the septum, newly synthesised PG was 
labelled with the fluorescent D-amino acid HADA, which is 
specifically incorporated into PG34, in a strain expressing both FtsW-
mCherry (which co-localises with PBP1, see below) and MurJ-sGFP. 
HADA incorporation appeared to co-localise with both proteins in 
cells in Phase 1 of the cell cycle and in most Phase 2 cells (Fig. 4a; see 
Fig. 1b for cell cycle phases). However, MurJ/HADA septal co-
localisation was more frequent than FtsW/HADA co-localisation (88% 
vs 70% of cells, N=200), as cells with septal FtsW but peripheral MurJ 
had peripheral HADA incorporation (see asterisk in Fig. 4a). This 
suggested that septal PG synthesis was dependent on the presence of 
MurJ. If this was the case, preventing MurJ recruitment to mid-cell 
should abolish septal PG synthesis. We therefore investigated the 
mechanism of MurJ localisation so that we could selectively prevent 
its septal recruitment, while maintaining correct FtsW/PBP1 septal 
localisation.  
We initially tested if MurJ, PBP1 or FtsW were recruited to the 
septum through substrate recognition, i.e. through affinity to an 
intermediate of PG biosynthesis. This mechanism of localisation has 
been observed for PBP243. To deplete PG precursors from the cells, we 
treated ColsGFP-PBP1, ColFtsW-mCherry and ColMurJ-mCherry 
with different PG synthesis inhibitors, namely D-cycloserine, oxacillin 
and tunicamycin and used strain BCBPM07317, which expresses 
sGFP-PBP2, as a control. As expected, treatment with the three 
Chapter III 
168 
antibiotics led to the delocalisation of sGFP-PBP2 throughout the cell 
membrane. On the contrary, localisation of sGFP-PBP1, FtsW-
mCherry, or MurJ-mCherry was unaffected (Fig. 3), showing that 
these proteins do not localise via substrate recognition. 
 
Figure 3. PBP1, FtsW and MurJ recruitment to the septum is independent 
of peptidoglycan intermediates. COL strains harbouring sGFP-PBP1, FtsW-
mCherry, MurJ-mCherry or sGFP-PBP2 functional fusions were treated with 
PG synthesis inhibitors D-cycloserine, oxacillin or tunicamycin at 10X MIC 
for each compound for 30 minutes before being imaged by SR-SIM. Scale 
bars = 2 µm. D-cyc, D-cycloserine; Oxa, oxacillin; Tun, tunicamycin. 
An alternative mechanism for recruitment of these proteins to 
the septum could be protein-protein interaction with divisome 
components. For that purpose, we determined the timings of MurJ, 
FtsW and PBP1 arrival to the septum, as localisation of divisome 
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proteins is often dependent on the presence of earlier localising 
proteins44,45. 
 
Order of arrival of peptidoglycan synthesis proteins to mid-cell 
In B. subtillis divisome assembly is a two-step process, with 
proteins such as FtsA, ZapA and EzrA arriving very early, 
concomitantly with FtsZ followed, after a time delay, by a second 
group of proteins including DivIB, DivIC, FtsL, GpsB, DivIVA, FtsW 
or PBP2B46. While describing the hierarchy of divisome assembly in S. 
aureus was beyond the scope of this work, we wanted to assess the 
time of recruitment of S. aureus PBP1, FtsW and MurJ to the septum, 
to determine which protein arrives first. This was done by comparing 
their localisation with that of FtsZ. We also compared the localisation 
of DivIB with FtsZ, as a control for later arrival to the divisome. For 
that purpose we constructed a set of strains expressing FtsZ-CFP or 
FtsZ-mCherry fusions together with a second fluorescent fusion, 
either sGFP-PBP1, FtsW-mCherry, MurJ-mCherry or YFP-DivIB (Fig. 
4b). These strains were imaged by wide-field microscopy and cells 
showing FtsZ localisation at mid-cell were selected for analysis. Co-
localisation between each fusion pair was determined by measuring 
Pearson’s Correlation Coefficient (PCC) values between the 
fluorescence signals in the two channels, as we reasoned that proteins 
arriving to the septum exactly at the same time should have a PCC 
close to 1 and this value should decrease for proteins that arrive to 
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the septum at later stages of divisome assembly. As a positive control 
for co-localisation we constructed a strain expressing two fusions of 
the same protein with two different tags – FtsZ-CFP and FtsZ-
mCherry (Fig. 4b). 
 
Figure 4. Hierarchy of arrival of key PG synthesis proteins to the 
divisome. (a), PG synthesis in strain ColWJ was labelled with HADA. 
Asterisk shows cell with septal FtsW and peripheral MurJ and HADA 
labelling. (b), Fluorescence microscopy images of strains (from top) ColZZ 
(positive control), ColZIB, ColP1Z, ColWZ and ColJZ. (c), Pearson’s 
correlation coefficient (PCC) for pairs of fluorescent proteins expressed in 
the same strain. PCC=1 would indicate perfect co-localisation. Negative PCC 
values are represented as 0. Data are represented as box-and-whisker plots 
where boxes correspond to the first to third quartiles, lines inside the boxes 
indicate the median, ends of whiskers and outliers follow a Tukey 
representation. Statistical analysis was performed using a two-sided Mann-
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Whitney U test (***P<0.001; ns, not significant). (d), Fluorescence microscopy 
images of strain ColJIB. Cells with septal YFP-DivIB localisation but MurJ-
mCherry still not at the septum (peripheral) are highlighted in insets i and ii, 
where the brightness of fluorescence signal was increased to allow 
visualisation of MurJ localisation. Scale bars, 1 µm.  
 
Table 6. Pearson’s Correlation Coefficient values between fluorescent 
protein pairs. 
Strain Name Protein 1 Protein 2 PCC 
COLZZ FtsZ-CFP FtsZ-mCherry 0.92±0.07, N = 312 
COLZIB FtsZ-CFP YFP-DivIB 0.81±0.11, N = 391 
COLP1Z FtsZ-CFP sGFP-PBP1 0.81±0.13, N = 337 
COLWZ FtsZ-CFP FtsW-mCherry 0.80±0.11, N = 330 
COLJZ FtsZ-CFP MurJ-mCherry 0.59±0.24, N = 334 
COLWgZc FtsZ-mCherry FtsW-sGFP 0.83±0.10, N = 136 
COLJgZc FtsZ-mCherry MurJ-sGFP 0.62±0.23, N = 139 
COLJZpAS-FtsL FtsZ-CFP MurJ-mCherry 0.44±0.34, N = 227 
COLJZpEPSA FtsZ-CFP MurJ-mCherry 0.61±0.27, N = 300 
 
Co-localisation between FtsZ-CFP and YFP-DivIB was 
significantly lower than between control pair FtsZ-CFP and FtsZ-
mCherry (P<0.001), suggesting that DivIB arrives to the divisome 
later than FtsZ as expected, possibly during a second stage of 
assembly. Co-localisation between FtsZ-mCherry and sGFP-PBP1 and 
between FtsZ-CFP and FtsW-mCherry was not significantly different 
from FtsZ-CFP and YFP-DivIB, suggesting that PBP1 and FtsW are 
recruited to the divisome at approximately the same time as DivIB. In 
contrast, the FtsZ-CFP and MurJ-mCherry PCC was much lower than 
for the pairs above, indicating that MurJ arrives to the divisome at a 
later stage than DivIB, PBP1 and FtsW (Fig. 4c and Table 6). It is 
unlikely that the nature of each individual fluorescent tag used could 
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influence the co-localisation results as tagging the pairs FtsZ/FtsW 
and FtsZ/MurJ with different fluorescent proteins, did not alter the 
results (Fig. 5 and Table 6). To confirm that MurJ arrives to the 
divisome later than DivIB, we looked at a strain expressing YFP-
DivIB and MurJ-mCherry. A subpopulation (20%, N = 200) of cells of 
this strain showing YFP-DivIB septal localisation had MurJ-mCherry 
dispersed around the membrane (Fig. 4d, insets) suggesting later 
arrival, while every cell with septal MurJ-mCherry had septal YFP-
DivIB localisation. 
 
Figure 5. Switching fluorescent tags has no effect on protein co-
localisation data. COL strains expressing FtsZ-mCherry/FtsW-sGFP (a) or 
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FtsZ-mCherry/MurJ-sGFP (b) were compared to strains expressing FtsZ-
CFP/FtsW-mCherry or FtsZ-CFP/MurJ-mCherry, respectively (described in 
Fig. 4b and c). Scale bars, 2 µm. (c), Pearson’s correlation coefficient (PCC) 
values between fluorescence channels for each protein fusion pair were 
calculated for cells showing septal FtsZ localisation. Negative PCC values 
are represented as 0. Data are represented as box-and-whisker plots where 
boxes correspond to the first to third quartiles, lines inside the boxes indicate 
the median and ends of whiskers and outliers follow a Tukey representation. 
Statistical analysis was performed using a two-sided Mann-Whitney U test 
(ns, not significant).  
Our data therefore indicates that PBP1 and FtsW arrive to the 
divisome before MurJ. This was surprising since MurJ is likely the 
flippase of the PG precursor and therefore its activity should precede, 
and be required for, both transglycolysation (a predicted function of 
FtsW) and transpeptidation (performed by PBP1)47. This 
inconsistency could be explained if PBP1 had a second function 
during cell division in addition to its transpeptidase activity as 
previously suggested47, which could be required early in divisome 
assembly.  
 
MurJ recruitment to the divisome triggers peptidoglycan 
incorporation at mid-cell 
As shown above, arrival of PBP1/FtsW to the divisome seems 
to occur approximately at the same time as DivIB, while arrival of 
MurJ seems to occur after DivIB and therefore could theoretically be 
dependent on the presence of the DivIB/DivIC/FtsL sub-complex. In 
order to test this, we depleted expression of DivIB, DivIC and FtsL 
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using antisense RNA fragments expressed from pEPSA-based 
plasmids19 (Table 7) and determined the effect of the absence of the 
corresponding proteins on the recruitment of MurJ to the septum. 
Given that inhibition of divisome assembly causes the enlargement of 
S. aureus cells11,48, we assessed the efficiency of each antisense RNA by 
the increase in cell volume (Fig. 6a) and by Western blot (Fig. 7). 
Upon expression of the antisense RNA targeting divIB, divIC or ftsL, 
we observed a reduction in septal co-occurrence between FtsZ-CFP 
and MurJ-mCherry (Fig. 6c), with the appearance of large cells where 
FtsZ-CFP was properly localized to the septum but MurJ-mCherry 
appeared dispersed throughout the cell surface (Fig. 6c, arrows).  
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Figure 6. MurJ recruitment to the divisome is dependent on the assembly 
of DivIB/DivIC/FtsL complexes. (a), Cell volumes in populations of S. 
aureus strains treated with antisense RNA fragments targeting divisome 
genes divIB (ColJZpAS-DivIB, N = 279), divIC (ColJZpAS-DivIC, N = 379) or 
ftsL (ColJZpAS-FtsL, N = 361), when compared to untreated control 
(ColJZpEPSA, N = 421). (b) Localisation of FtsZ-CFP and MurJ-mCherry in 
cells treated with antisense RNA. Large cells were observed where FtsZ-CFP 
was localized to the division septum but MurJ-mCherry was dispersed 
throughout the cell surface (white arrows). (c), Frequency of FtsZ-CFP and 
MurJ-mCherry colocalisation in cells treated with antisense RNA when 
compared to untreated cells (N = 200 for each strain). Ellipses crossed with 
colored lines represent septal localisation. Colored ellipses represent 
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peripheral localisation. Scale bars = 1 µm. Data in (a) are represented as 
column bar graphs where the height of the bar corresponds to the mean and 
end of whisker corresponds to standard deviation. Statistical analysis was 
performed using the unpaired t-test (***P<0.001). 
 
Figure 7. Antisense RNA fragments targeting the DivIB/DivIC/FtsL 
complex decreased protein expression. (a), Western blot showing total 
protein extracts of ColJZpAS-DivIB following 1 hour of antisense induction 
and control ColJZpEPSA probed with antibodies against either PBP2A 
(loading control - upper bands) or DivIB (lower bands). (b), Western blot 
showing total protein extracts of ColJZpAS-DivIC following 1 hour of 
antisense induction and control ColJZpEPSA probed with antibodies against 
either PBP2A (loading control – upper bands) or DivIC (lower bands).  
 
These results suggest that recruitment of MurJ to the divisome 
is dependent on the presence of the DivIB/DivIC/FtsL complex, and 
that lack of any of these proteins impairs MurJ septal localisation. 
However, in all strains, large cells constituted only a sub-population. 
It is likely that antisense RNA expression did not completely deplete 
DivIB/DivIC/FtsL in every cell and/or did not have an effect in cells 
where the complex was already assembled. This could be the reason 
for the presence of cells with correctly localized MurJ.  
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Contrasting with MurJ, FtsW and PBP1 localisation was not 
dependent on the DivIB/DivIC/FtsL complex. Septal recruitment of 
FtsW-mCherry or sGFP-PBP1 was observed even in very large cells 
with open FtsZ-CFP rings, implying that destabilization of the 
complex had no effect on FtsW or PBP1 recruitment to the divisome 
(Fig. 8c and d). In contrast, inhibition of divisome assembly at a very 
early step, namely by depletion of FtsA, caused FtsW and PBP1 de-
localisation, concomitant with FtsZ de-localisation (Fig. 8e and f).  
 
Figure 8. FtsW and PBP1 recruitment to the divisome is independent of 
DivIB/DivIC/FtsL complexes. Strains ColWZpAS-FtsL and ColP1ZpAS-
FtsL, harbouring FtsZ-CFP/FtsW-mCherry and FtsZ-mCherry/sGFP-PBP1 
fluorescent fusion pairs, respectively, were depleted of FtsL expression 
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using antisense RNA and imaged by wide-field fluorescence microscopy. 
(a), Frequency of FtsZ-CFP and FtsW-mCherry co-occurrence in ColWZpAS-
FtsL when compared to control ColWZpEPSA (N=200 for each). (b), 
Frequency of FtsZ-mCherry and sGFP-PBP1 co-occurrence in ColP1ZpAS-
FtsL and in control ColP1ZpEPSA (N=200 for each). Very large FtsL-
depleted cells were observed where either FtsW-mCherry (c) or sGFP-PBP1 
(d) co-localised with the FtsZ fusion at the septum (arrows). (e,f), Inhibition 
of divisome assembly at an early stage by depletion of FtsA expression in 
either ColWZpAS-FtsA or ColP1ZpAS-FtsA prevented the recruitment of 
FtsW-mCherry (e) or sGFP-PBP1 (f) to the septum, concomitant with FtsZ 
destabilisation. Scale bars, 1 µm. 
Having a tool to specifically delocalise MurJ (but not PBP1 or 
FtsW) allowed us to test if this protein was required for septal PG 
synthesis. Therefore, we introduced plasmid pAS-185, encoding 
antisense RNA against FtsL in order to delocalize MurJ (but not 
FtsW). Induction of the FtsL antisense RNA, followed by a short 
pulse of HADA, revealed that HADA was only incorporated at the 
septum when MurJ-sGFP was present at the septum as well (Fig. 9a, 
asterisks and 9b). Strikingly, large cells of ColWJpAS-FtsL (Fig. 9a, 
arrows and 9b) with FtsW-mCherry correctly localized to the division 
plane but MurJ-sGFP dispersed around the cell surface, incorporated 
HADA throughout the cell periphery, indicating that recruitment of 
MurJ to the divisome by the DivIB/DivIC/FtsL complex is necessary 
for septal HADA insertion. Finally, we showed that inhibiting MurJ 
activity using DMPI4, a MurJ inhibitor that does not prevent its 
recruitment to the divisome (Fig. 10a), drastically reduced HADA 
incorporation (i.e. PG synthesis) at the septum (Fig. 10d and e). Our 
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data strongly indicates that MurJ is likely the molecular cue directing 
PG synthesis specifically to the septum during division.  
 
Figure 9. MurJ recruitment to the divisome is required for PG 
incorporation at mid-cell. (a) HADA septal incorporation in FtsL-depleted 
cells was only observed in cells with septal MurJ-sGFP (asterisks). Septal 
FtsW-mCherry was not sufficient to ensure HADA septal incorporation 
(arrows). Scale bar, 2 µm. (b), Co-localisation between FtsW-mCherry, MurJ-
sGFP and HADA labelling in FtsL-depleted (ColWJpAS-FtsL) or control 
(ColWJpEPSA) cells with septal FtsW-mCherry (N=100 cells for each strain, 




Figure 10. Inhibition of MurJ activity does not prevent its recruitment to 
mid-cell but impairs PG synthesis. (a), Fluorescence microscopy images of 
ColMurJ-mCherry cells grown in the presence (left) or absence (right) of 
DMPI for 30 minutes at 2X MIC. Scale bar, 2 µm. b,c Fluorescence 
microscopy images showing mixed cultures of either (b) DMPI-treated 
ColDltC-sGFPi cells mixed with COL cells or (c) DMPI-treated COL cells 
mixed with ColDltC-sGFPi cells, following incubation with HADA. The two 
cultures, which can be easily distinguished due to GFP expression in 
ColDltC-sGFPi, were mixed on the same slide to decrease fluorescence 
variation of HADA signal due to imaging conditions. Phase contrast/GFP 
channel overlays are shown on the left and phase contrast/HADA channel 
overlays are shown on the right. Scale bars, 1 µm. d, e HADA fluorescence 
signal measured at the mid-cell (Mid-cell), the periphery (Peripheral) or over 
the entire cell (Total) of DMPI-treated ColDltC-sGFPi cells mixed with COL 
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cells (d) or DMPI-treated COL cells mixed with ColDltC-sGFPi cells (e). 
Images in a-c are representative of three biological replicates. Data in (d,e) 
are represented as column plots (N=100 for each column) where the height 
of the column is the mean and the whiskers indicate standard deviation. 
Statistical analysis was performed using two-sided unpaired t-tests (***, 
P<0.001).  
Given these findings, we would expect MurJ to be essential 
for the transition from Phase 1 to Phase 2 during the cell cycle, i.e, to 
initiation of septum synthesis. Therefore, preventing MurJ 
recruitment to the septum or inhibiting its activity should lead to the 
accumulation of Phase 1 cells, unable to progress to Phase 2. Phase 2 
cells, which are synthesizing the septum, may also be halted by lack 
of MurJ, as translocation of the PG precursor across the membrane is 
essential for PG synthesis to occur. However, Phase 3 cells, which 
have a complete septum, may be able to split and progress to Phase 1, 
which would lead to a decrease of this population upon MurJ 
inhibition (Fig. 11a-(i)).  
We treated S. aureus cells with DMPI, which inhibits MurJ4, 
for the duration of one cell cycle and characterized the distribution of 
cells in the three phases of the cell cycle. For comparison we also 
tested other inhibitors, namely PC19072317 (targets FtsZ) and oxacillin 
(inhibits PG transpeptidation catalysed by PBPs). We reasoned that 
treatment with PC190723 would lead to cell cycle arrest at Phase 1, as 
FtsZ is essential for assembly of the divisome (Fig. 11a-(ii)), while 
oxacillin would lead to cell cycle arrest at P2 because most of the PG 
is synthesized during that phase (Fig. 11a-(iii)). COL cells were 
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treated with 2X MIC of each compound for the duration of a cell cycle 
(30 minutes), labelled with membrane dye Nile Red and imaged by 
SIM (Fig. 11b). Consistent with previous data12, in the absence of 
inhibitors approximately half (58%) of the cells were in Phase 1, with 
the other half split evenly between Phase 2 (21%) and Phase 3 (21%). 
Inhibition of MurJ by DMPI resulted in the accumulation of Phase 1 
cells (70%), indicating that MurJ is crucial to entry in Phase 2. In 
contrast, incubation with oxacillin led to a decrease in the proportion 
of cells in Phase 1 (36%) concomitant with an increase of the 
proportion of cells in P2 (37%), suggesting that PBP activity is critical 
for the completion of Phase 2 (Fig. 11c). 
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Figure 11. Inhibition of MurJ leads to cell cycle arrest at Phase 1. (a), 
Representation of the effect of antibiotics on the cell cycle. (i) If an inhibitor 
of the cell cycle blocks the transition from P1 to P2 as well as the progression 
of P2 then the fraction of the cell population in P2 should remain the same 
while the fraction in P1 should increase. (ii) If the transition from P1 to P2 is 
blocked then the cell population should be enriched in P1. (iii) In case an 
inhibitor blocks the progression of P2, then the fraction of the cell population 
in P2 should increase (b), SIM images of Nile Red stained COL cells treated 
with DMPI (inhibits MurJ), PC190723 (inhibits FtsZ), oxacillin (inhibits 
PBPs), DMSO or TSB (mock controls) for the duration of a cell cycle (30 min). 
Scale bars, 2 µm. (c), COL cells treated with inhibitors were sorted into each 
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cell cycle phase based on Nile Red staining and the frequency of each phase 
in the cell population was expressed as a percentage of the total cells 
measured. N = 1415 for DMPI, N = 1226 for PC190273, N = 1652 for Oxacillin, 
N = 1542 for DMSO and N = 1876 TSB control cells. 
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Discussion 
 The spatial and temporal coordination of PG synthesis is of 
the utmost importance to the bacterial cell. Unlike rod-shaped and 
ovococcal species that have two dedicated machineries to synthesise 
peripheral and septal PG, cocci like S. aureus make do with just one. 
Its sole machinery has to work in two locations, shifting its activity 
from the periphery of the cell to the middle when it is time to build 
the septum. The timing of the shift has to be precise, perfectly 
synchronized with the cell cycle, as premature septation could have 
disastrous consequences for the cell. In this work we have identified 
that the molecular cue that signals this transition from peripheral to 
septal synthesis is the recruitment of the MurJ translocase to the 
divisome.  
We propose a model where the S. aureus PG synthesis 
machinery continuously incorporates PG at the periphery of the cell 
during initial stages of the cell cycle. In preparation for division and 
following Z-ring assembly, the DivIB/DivIC/FtsL complex recruits 
MurJ to the divisome, which ensures that translocation of lipid II 
occurs exclusively at mid-cell. Substrate affinity43 then diverts PBP2 
from the periphery to the mid-cell, where it incorporates lipid II into 
the growing PG network (Fig. 12). This mechanism forgoes the need 




Figure 12. Proposed model for how recruitment of MurJ to the divisome 
directs PG synthesis to mid-cell.(i), Cells in Phase 1 of the cell cycle (before 
septal synthesis is initiated) incorporate new PG all around the cell 
periphery. (ii), In preparation for division, FtsZ and early components of the 
divisome assemble at mid-cell. (iii), The DivIB/DivIC/FtsL complex recruits 
MurJ to the divisome, which initiates specific translocation of lipid II at mid-
cell (iv), The major PG synthase PBP2 accumulates at mid-cell via substrate 
affinity to translocated lipid II, initiating major PG incorporation at mid-cell, 
together with the other PBPs.  
 
The requirement for an assembled DivIB/DivIC/FtsL complex 
for the recruitment of MurJ and, by extension, PG synthesis to the 
septum, is interesting because these proteins seemingly do not have 
an enzymatic activity, despite being widely conserved in bacteria that 
have cell walls49. It has been suggested that DivIB, DivIC and FtsL in 
Gram-positives and their orthologues FtsQ, FtsB and FtsL in Gram-
negatives function as a checkpoint system that mediates between Z-
ring formation and PG synthesis44. Furthermore, assembly of this 
complex at the septum in E. coli seems to be dependent on the prior 
recruitment of the multifunctional DNA translocase FtsK50, which has 
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been shown to have an important role in synchronizing segregation 
of the chromosomes with cell division in bacteria51-53. Having MurJ 
recruitment to the septum dependent on the assembly of the 
DivIB/DivIC/FtsL complex could be a topological cue to ensure that 
DNA segregation is occurring prior to septum synthesis, avoiding the 
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Abstract 
 Infections caused by multi-drug resistant bacteria constitute a 
major challenge to global public health. In particular, the prevalence 
of methicillin-resistant Staphylococcus aureus (MRSA) strains remains 
high in several parts of the world, urging the development of new 
and efficient countermeasures. S. aureus builds its cell wall using 
peptidoglycan (PG) layers crosslinked by pentaglycine bridges. 
Crossbridge synthesis is done by the Fem protein family of 
transferases: FemX adds the first glycine to PG precursor lipid II, 
FemA adds the second and the third and FemB adds the fourth and 
fifth glycines. FemA and FemB are exclusive to S. aureus, making 
these proteins interesting candidates for pathogen-specific drug 
design. In order to explore this possibility, we constructed a 
conditional mutant of the femAB operon in the background of 
community-acquired MRSA strain (CA-MRSA) MW2. Depletion of 
femAB expression was lethal, with cells appearing as 
pseudomulticellular forms that eventually lysed due to extensive 
membrane rupture. Furthermore, we investigated key residues 
present in the putative transferase pocket and the α6 helix of FemA 
by site-directed mutagenesis. Expression of FemA point mutants 
KR180AA and Y315A, with wild-type FemB, failed to fully 
complement the depletion of femAB. Furthermore, we determined 
that transferase activity was lower in mutants KR180AA and Y315A 
when compared to wild-type FemA, using an in vitro lipid II assay. 
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Our data implies that FemA would be a good target for the 
development of anti-staphylococcal therapies. 
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Introduction 
 Decades of research into the discovery and development of 
antibiotics to treat bacterial infections have resulted in a wide variety 
of molecules that target diverse biosynthetic pathways required for 
cell viability. Nevertheless, heavy antibiotic misusage has 
progressively caused a surge of bacterial strains which have evolved 
resistance against multiple drugs1,2. Of particular note are methicillin-
resistant Staphylococcus aureus (MRSA) strains, which cause invasive, 
often fatal, infections that are notoriously difficult to treat and can 
quickly spread, through contact between individuals or contact with 
contaminated surfaces3-5. Traditionally associated with debilitated or 
immunocompromised patients in healthcare settings, infections of 
highly virulent MRSA strains have also emerged in the communities 
(community acquired MRSA, CA-MRSA), affecting individuals 
without predisposing risk factors. Despite efforts to contain their 
spread, MRSA infections are now a global problem and account for 
>40% of nosocomial isolates in a variety of countries, including 
Southern Europe where the prevalence of MRSA is particularly high 
(2016 ECDC annual report). Bacterial resistance to antibiotics is 
poised to become the major public health challenge of the 21st 
century, with MRSA at the tip of the spear, prompting the need to 
develop new strategies effective against this (and other) pathogens. 
 Most of the widely used, and more potent, antibiotics target 
steps in the biosynthesis of peptidoglycan (PG), the core component 
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of the bacterial wall. PG is a macromolecule composed of glycan 
chains, where each unit is constituted of N-acetylmuramic acid 
(MurNAc) and N-acetylglucosamine (GlcNAc) sugars, with a stem 
peptide attached to MurNAc. Glycan chains are connected 
(crosslinked) through flexible species-specific peptide bridges, 
creating a mesh-like structure that envelops the cell6,7. The structural 
features of PG therefore confer both robustness and flexibility to the 
cell envelope, which are necessary to withstand high pressure 
derived from intracellular turgor8. During PG synthesis, both the 
incorporation of each monomer to the growing glycan chains 
(transglycosylation, TG) and the crosslinking between chains 
(transpeptidation, TP) are usually catalysed by penicillin-binding 
proteins (PBPs)9,10. 
The ongoing wave of infectious MRSA strains is resistant to 
all classes of β-lactams currently in use (penicillins, cephalosporins, 
carbapenems), which irreversibly acylate the TPase site of PBPs1. In 
these strains, the major determinant of methicillin resistance is the 
acquired mecA gene, which encodes for PBP2A, an enzyme 
insensitive to β-lactam acylation11. However, high-level β-lactam 
resistance is in fact dependent on several elements, which were 
identified by transposon mutagenesis and termed fem (factor essential 
for methicillin resistance) or aux (auxiliary) genes12,13. Approximately 
30 fem/aux determinants have been identified so far and most are 
housekeeping genes, involved in a variety of cellular processes and 
probably present in every S. aureus strain14. Three closely related 
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factors - fmhB and the co-transcribed femA and femB genes, encode for 
the FemX, FemA and FemB proteins, respectively, transferases which 
synthesise the pentaglycine bridges used to crosslink glycan chains in 
S. aureus15,16. During the inner membrane steps of PG synthesis (see 
General Introduction), the Fem proteins sequentially transfer five 
glycine residues to PG precursor lipid II using glycyl-charged tRNA 
molecules17. Importantly, in vivo and in vitro studies have shown that 
each Fem has strict substrate specificity: FemX adds the first glycine, 
FemA adds the second and the third and FemB adds the fourth and 
fifth glycines, and each Fem cannot substitute for another18,19. 
Although fmhB was shown to be an essential gene20, mutants carrying 
a Tn551 inactivated femA or femB genes grew poorly but were viable, 
suggesting that S. aureus can survive with a PG composed of 
monoglycine crossbridges15,21. HPLC analysis of the PG composition 
in these mutants revealed an overall reduction, but not absence of 
crosslinked species and, importantly, monoglycyl-substituted 
oligomers were never found22. Moreover, the Tn551 insertion in the 
femA gene occurred in the promoter region of the femAB operon, 
which led to a 90% decrease in femAB transcription, while Tn551 
insertion in the femB locus presumably led to the complete knockout 
of the gene21. These findings still raised questions of whether residual 
femA activity in the femA mutants was responsible for a minimal 
degree of crosslinking that would still ensure cell viability, or 
alternatively, whether strains had acquired compensatory mutations 
allowing for cell survival with shortened crossbridges.  
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A second study on the essentiality of femAB was done by 
Strandén and colleagues who constructed a femAB mutant, AS145, by 
allelic replacement of the femAB operon by a tetracycline resistance 
marker23. AS145 showed impaired growth, methicillin 
hypersusceptibility and drastically reduced crosslinking of glycan 
strands, when compared to the parental strain23,24. Cis-
complementation of the femAB mutation in AS145 with wild-type 
femAB restored synthesis of the pentaglycine crossbridge and 
methicillin resistance, although the growth rates remained low25. 
Therefore the authors postulated that survival of AS145 required a 
compensatory or suppressor mutation which still remains 
unidentified25. Transcriptional analysis revealed that AS145 
underwent severe metabolic adaptations to survive, including 
upregulation of membrane transporters associated with glycerol 
uptake (an osmoprotectant), upregulation of the arginine-deiminase 
pathway (an alternative for ATP production) and downregulation of 
nitrogen metabolism. Collectively these data suggested that femAB 
mutants adapted to survive with shortened crossbridges by 
drastically decreasing metabolic activity to alleviate internal turgor25.  
FemA folds into a globular domain with two antiparallel 
coiled-coil helical arms extending into the solvent26. The globular 
domain contains a deep L-shaped channel proposed to be a binding 
cavity suitable for an extended conformation of the stem peptide 
moiety in lipid II-Gly1. If correct, an amino-acid charged tRNA 
molecule could then be held at the junction between the L-shaped 
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channel and the arms26, a mechanism similar to what was previously 
described for the Tetrahymena termophyla seryl-tRNA synthetase 
protein27. More recently, Maillard and colleagues performed site-
directed mutagenesis on selected residues located in the putative 
substrate binding cavity of Weisella viridescens FemX, which is 
structurally similar to S. aureus FemA. In particular, substitution of 
Arg211 by methionine (corresponding to Arg220 in S. aureus FemA) 
led to a severe decrease in transferase activity, without affecting 
protein folding28, suggesting that this residue could be crucial for 
substrate binding.  
 The femAB operon and pentaglycine crossbridges are unique 
features of S. aureus among prokaryotes. This makes FemAB proteins 
potentially interesting targets for MRSA-specific drug design. In this 
work we wanted to investigate if full depletion of the femAB operon is 
lethal in an MRSA strain and to determine the phenotypic defects 
associated with lack of femAB expression. Furthermore, we wanted to 
identify key residues essential for FemA activity, towards the future 





Bacterial growth conditions 
Strains and plasmids constructed for this study are listed in 
Table 1. S. aureus strains were grown in tryptic soy broth (TSB, Difco) 
at 200 r.p.m with aeration at 37 °C or on tryptic soy agar (TSA, Difco) 
at 30 or 37 °C. Escherichia coli strains were grown in Luria–Bertani 
broth (Difco) with aeration, or Luria–Bertani agar (Difco) at 37 or 30 
°C. When necessary, antibiotics ampicillin (100  μg/ml), erythromycin 
(10  μg/ml), kanamycin (50  μg/ml), neomycin (50  μg/ml) or 
chloramphenicol (30  μg/ml) were added to the media. Unless stated 
otherwise, isopropyl β-D-1-thiogalactopyranoside (IPTG, Apollo 
Scientific) was used at 500 µM to induce expression of constructs 
under the control of the Pspac promoter. Cadmium chloride (Sigma-
Aldrich) was used at 1 µM when required to induce expression of 
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DC10B Δdcm in the DH10B background; Dam methylation only 29 
BL21 (DE3) 
BL21-FemX 
B F− dcm ompT hsdS(rB− mB−) gal λ(DE3) 





BL21(DE3) expressing full length C-ter His-tagged GlyS; Kanr 




BL21(DE3) expressing mutant C-ter His-tagged FemAKR180AA; 
Kanr This work 
BL21-FemARF220AA 
BL21(DE3) expressing mutant C-ter His-tagged FemARF220AA; 
Kanr This work 
BL21-FemAY327A BL21(DE3) expressing mutant C-ter His-tagged FemAY327A; Kanr This work 
S. aureus 
  
RN4220 Restriction-deficient derivative of NCTC8325-4 30 
MW2 CA-MRSA; SCCmec type IV, ST1, pbla+ 31 
MW2-iFemAB MW2 femAB::Pspac-femAB pMGPII; Eryr Cmr This work 
MW2pFemAwt MW2 femAB::Pspac-femAB pMGPII pFemABwt; Eryr Cmr Kanr This work 
MW2pFemAKR180AA 
MW2 femAB::Pspac-femAB pMGPII pFemAKR180AAB; Eryr Cmr 
Kanr This work 
MW2pFemARF220AA 
MW2 femAB::Pspac-femAB pMGPII pFemARF220AAB; Eryr Cmr 
Kanr This work 









pMUTIN4 S. aureus integrative vector containing an IPTG-inducible Pspac 
promoter; Ampr  Eryr  
32 
pMGPII S. aureus replicative plasmid containing lacI; Ampr  Cmr 33 
pCNX Replicative vector containing a cadmium inducible Pcad 
promoter; Ampr Kanr 
34 
pFemABi pMUTIN4 derivative containing a femA-femB DNA fragment 
under Pspac; Ampr  Eryr 
This 
work 
pMADfemAmch Vector containing a femA-mCherry-STOP-femB DNA fragment; 
Ampr Eryr 
35 
pFemABwt pCNX derivative expressing a FemA-mCherry fusion and 
FemB, both under the control of Pcad; Ampr Kanr 
This 
work 
pFemAKR180AAB pCNX derivative expressing a mutant FemA(K180A, R181A)-




pFemARF220AAB pCNX derivative expressing a mutant FemA(R220A, F224A)-




pFemAY327AB pCNX derivative expressing a mutant FemA(Y327A)-mCherry 
fusion and FemB, both under the control of Pcad; Ampr Kanr 
This 
work 
pET-24b E. coli replicative vector for the expression of proteins with a 
His6 fusion at the C-terminus, under the Pspac promoter; Kanr 
Novagen 
pET-GlyS pET-24b derivative encoding a GlyS-His6 fusion; Kanr 19 
pET-FemX pET-24b derivative encoding a FemX-His6 fusion; Kanr 19 




pET-24b derivative encoding a mutant FemA(K180A, R181A)-
His6 fusion; Kanr 
This 
work 
pET-FemARF220AA pET-24b derivative encoding a mutant FemA(R220A, F224A)-
His6 fusion; Kanr 
This 
work 





Construction of S. aureus strains 
 In order to construct an S. aureus strain with the femAB operon 
under the control of an inducible promoter, a fragment containing the 
first 400 bp of femA was amplified from S. aureus MW2 DNA with 
primer pair spacfemab_P1 EcoRI/spacfemab_P2 BamHI (Table 2), cut 
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with EcoRI and BamHI restriction enzymes and cloned into 
pMUTIN432, downstream of the Pspac promoter, giving plasmid 
pFemABi, which was sequenced. pFemABi was then propagated in 
DC10b cells, electroporated into electrocompetent RN4220 cells, and 
transduced (using phage 80α) to MW2, where it integrated in the 
femAB locus by homologous recombination. The resulting strain 
contains a truncated copy of femA under the control of the femAB 
native promoter, and the femAB operon under the control of Pspac. 
Multicopy plasmid pMGPII33, which encodes Pspac repressor LacI, 
was then transduced into this strain, giving rise to MW2-iFemAB 
 To construct S. aureus strains expressing mutated alleles of 
FemA-mCherry together with wild-type FemB, first femA-mCherry-
STOP codon-femB was amplified from pMADfemAmch35 using 
primers pcnfemab_P1 BamHI and pcnfemab_P2 EcoRI. This fragment 
was cut with BamHI and EcoRI and cloned into replicative vector 
pCNX, under the control of Pcad, giving plasmid pFemABwt. 
pFemABwt was then used as the template for site-directed 
mutagenesis. Primers fema_kr180aa_fw/ fema_kr180aa_rev were 
used to generate pFemAKR180AA, containing both K180A and R181A 
mutations; Primers fema_rf220aa_fw/fema_rf220aa_rev were used to 
generate pFemARF220AA, containing both R220A and F224A mutations; 
and primers fema_Y327a_fw/fema_Y327a_rev were used to generate 
pFemAY327A, containing an Y327A mutation (Table 2). Site-directed 
mutagenesis was performed with Phusion polymerase (Thermo 
Scientific) following manufacturer’s instructions, and each plasmid 
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was sequenced to confirm the presence of the mutations. pFemABwt, 
pFemAKR180AA, pFemARF220AA and pFemAY327A were propagated in 
DC10b, transformed to RN4220 and transduced to MW2-iFemAB, 
giving strains MW2pFemABwt, MW2pFemAKR180AA, 
MW2pFemARF220AA and MW2pFemAY327A, respectively. 
Table 2. Oligonucleotides used in this study. 
Primer Name Sequence (5’-3’) 
spacfemab_P1 EcoRI GCGCGAATTCATGAAGTTTACAAATTTAACAGC 










































Underlined sequences correspond to restriction sites 
Construction of E.coli strains 
 In order to construct protein expression vectors, primers 
femaexpress_P1 BamHI and femaexpress_P2 EcoRI (Table 2) were 
used to amplify the wild-type femA gene from pFemABwt or femA 
mutant alleles from pFemAKR180AA, pFemARF220AA and pFemAY327A. The 
resulting fragments were digested with EcoRI and BamHI and cloned 
into pET-24b, giving plasmids pET-FemAwt, pET-FemAKR180AA, pET-
FemARF220AA and pET-FemAY327A, respectively. These plasmids, along 
with pET-GlyS and pET-FemX were then propagated in DC10b and 
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transformed to BL21 (DE3) cells, giving strains BL21-FemAwt, BL21-
FemAKR180AA, BL21-FemARF220AA, BL21-FemAY327A, BL21-GlyS and 
BL21-FemX, respectively. 
Growth curves of S. aureus strains 
 To assess whether the femAB operon is essential for viability, 
cells from an overnight culture of MW2 and MW2-iFemAB 
(supplemented with erythromycin and chloramphenicol and grown 
in the presence of IPTG at 500 µM) were collected and washed three 
times with fresh TSB to remove IPTG. Cells were then back-diluted to 
OD600nm 0.001 in TSB supplemented with erythromycin and 
chloramphenicol and containing 0, 10, 25 or 500 µM of IPTG (for 
MW2-iFemAB) and grown for 10 hours with OD600nm measurements 
taken every hour.  
To evaluate morphological defects and peptidoglycan 
composition changes caused by the depletion of the femAB operon, 
overnight cultures of MW2 and MW2-iFemAB grown in TSB with 500 
µM of IPTG, erythromycin and chloramphenicol were back-diluted 
1:500 in the same medium until the cultures reached an OD600 of 0.7. 
At this point the cultures were washed three times to remove the 
IPTG and back-diluted 1:500 in fresh TSB with 0, 25 and 500 µM of 
IPTG and growth was monitored. When growth of the non-induced 
culture was arrested (approximately 4 hours after incubation), cells 
were collected for microscopy or cell wall analysis (described below). 
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To assess the effects of FemA mutations on growth rates, 
peptidoglycan composition and fluorescence microscopy overnight 
cultures of MW2, MW2pFemABwt, MW2pFemAKR180AA, 
MW2pFemARF220AA and MW2pFemAY327A, supplemented with 
erythromycin, chloramphenicol and kanamycin (when applicable, at 
the concentrations described above) plus 500 µM of IPTG were 
harvested and washed to remove IPTG. Cells were then back-diluted 
to OD600nm 0.001 in the same medium without IPTG and CdCl2 was 
added at 1 µM, to drive the expression of either wild-type or mutant 
femA alleles from the pCNX-based plasmids.  
Minimum inhibitory concentration (MIC) assays 
MICs of lysostaphin and oxacillin were determined by broth 
microdilution in sterile 96-well plates. The medium used was TSB, 
containing a series of two-fold dilutions of each compound. Cultures 
of S. aureus strains and mutants were added at a final density of 
~5x105 CFU ml-1 to each well. Wells were reserved in each plate for 
sterility control (no cells added) and cell viability (no compound 
added). Plates were incubated at 37°C. Endpoints were assessed 
visually after 48 h. All assays were done in triplicate. 
Purification and analysis of S. aureus muropeptides 
Peptidoglycan was purified from exponentially-growing 
cultures of S. aureus as described by Filipe et al.36. Muropeptides were 
prepared from PG samples by digestion with mutanolysin (0.135 
U/µg of PG, from Sigma-Aldrich) and analysed by reverse phase 
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HPLC using a Hypersil ODS (C18) column (Thermo-Fisher Scientific). 
Muropeptide species were eluted in 0.1 M sodium phosphate, pH 2.0, 
with a gradient of 5–30% methanol for 155 minutes and detected at 
206 nm. 
S. aureus imaging by fluorescence microscopy 
Super-resolution Structured Illumination Microscopy (SIM) 
imaging was performed using an Elyra PS.1 microscope (Zeiss) with 
a Plan-Apochromat 63x/1.4 oil DIC M27 objective. SIM images were 
acquired using five grid rotations, unless stated otherwise, with 
34 μm grating period for the 561 nm laser (100 mW), 28 μm period for 
488 nm laser (100 mW) and 23 μm period for 405 nm laser (50 mW). 
Images were captured using a Pco.edge 5.5 camera and reconstructed 
using ZEN software (black edition, 2012, version 8.1.0.484) based on a 
structured illumination algorithm, using synthetic, channel specific 
optical transfer functions and noise filter settings ranging from −6 to 
−8. 
To evaluate defects in cell morphology, cells were incubated 
with membrane dye Nile Red (10 µg/ml, Invitrogen), Hoechst 33342 
(10 µg/ml, Invitrogen) and a mixture containing equal amounts of 
vancomycin (Sigma) and a BODIPY FL conjugate of vancomycin 
(Van-FL, Molecular Probes) to a final concentration of 0.8 µg/ml, for 5 
minutes at room temperature. Subsequently, cells were washed with 
phosphate buffer saline (PBS), mounted on microscope slides covered 
with a thin layer of 1% agarose in PBS and imaged by SIM.  
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Overexpression and purification of recombinant His-tagged proteins 
Recombinant proteins were purified essentially as described 
by Rohrer et al.37, with some modifications. Single colonies of BL21 
(DE3) expression strains were isolated from LA plates with 
kanamycin and used to inoculate LB (1 L) containing kanamycin. 
Cultures were grown to an OD600nm of approximately 0.6 at which 
point IPTG was added (final concentration 1 mM) and incubated for 3 
hours with shaking (150 rpm) at 30 oC. Cells were harvested by 
centrifugation and washed with 50 mM sodium phosphate buffer 
(pH 7.5) containing 300 mM NaCl and 20% glycerol. Afterwards, cells 
were suspended in the same buffer, containing PMSF (final 
concentration, 0.1 mM) and lysozyme (final concentration, 1 mg/mL), 
and incubated on ice for 30 min. Cells were then disrupted three 
times in an ultrasonicator and centrifuged for 30 min at 4°C to 
precipitate cell debris. The resulting supernatant was purified by 
affinity chromatography using a Ni-NTA column (Qiagen), following 
manufacturer’s instructions. Protein concentration was assessed 
using a BCA Protein Assay Kit (Pierce).  
Synthesis and purification of lipid II and lipid II-Gly1 
 Lipid II was prepared by reacting undecaprenyl phosphate 
(Larodan), UDP-MurNAc-pentapeptide from Staphylococcus simulans, 
UDP-GlcNAc (Sigma) and membrane proteins of Micrococcus luteus as 
previously described19,38. Monoglycyl lipid II was synthesised by 
reacting lipid I with tRNA preparations, in the presence of enzymes 
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FemX and GlyS, according to the method described by Schneider et 
al.19. Lipid intermediates were extracted from reaction mixtures with 
an equal volume of butanol/pyridine acetate (2∶1; vol∶vol; pH 4.2). 
Extracts were then purified by anion-exchange chromatography 
using a Hi-Trap DEAE FF-agarose column (Amersham Biosciences) 
by reverse-phase HPLC and eluted in a linear gradient from 
chloroform–methanol–water (2∶3∶1) to chloroform–methanol-300 mM 
ammonium bicarbonate (2∶3∶1). The fractions containing lipid species 
were identified by thin layer chromatography with chloroform–
methanol–water–ammonia (88∶48∶10∶1) as solvent39. The 
concentration of purified lipids was calculated by measuring 
inorganic phosphates released after the treatment with perchloric 
acid, as described previously40. 
FemA enzymatic activity assay 
 In order to compare the activity of wild-type FemA to selected 
FemA mutants, enzymatic reactions were performed as described 
previously19. Briefly, 100 µl reactions were prepared containing 2.5 
nmol of lipid II-Gly1, 10 µg of glycyl-tRNA synthetase (GlyS), 25 µg 
of tRNA, 2 mM ATP and 50 nmol [14C]-glycine in Tris buffer (100 mM 
Tris-HCl, 20 mM MgCl2, pH 7.5, and 0.8% Triton X-100). Then 2.7 µg 
of wild-type FemA or FemA mutant protein was added and the 
reaction mixtures were incubated for 30, 60 or 90 minutes at 30 oC. 
Lipid intermediates were then extracted and analysed by thin layer 
chromatography, as described above. Finally, the amount of [14C]-
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glycine transferred to lipid II-Gly1 was quantified using 
phosphoimaging in a STORM system (GE Healthcare). Enzymatic 
assays were done in triplicate. 
Identification of FemA residues involved in tRNA binding 
 Identification of FemA residues which could bind glycyl-
charged tRNA was performed using DP-Bind41,42 
(http://lcg.rit.albany.edu/dp-bind/), a sequence-based web server 
which predicts DNA/RNA binding domains in proteins based on 
biochemical proteins of amino acids and evolutionary information. 
Probability maps were generated using PSI-BLAST position-specific 
scoring matrix (PSSM) and three distinct machine learning methods 
that use evolutionary information: support vector machine (PSSM-
SVM), kernel logistic regression (PSSM-KLR), and penalized logistic 
regression (PSSM-PLR). FemA residues K180 and R181 were 
identified as DNA-binding domains based on strict consensus 
between the three methods. SwissPdb viewer/Deep view43 
(http://www.expasy.org/spdbv/) was used to evaluate the structure of 
FemA, using file 1LRZ (doi: 10.2210/pdb1LRZ/pdb) deposited in the 
RCSB PDB by Benson et. al.26.  
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Results and Discussion 
The femAB operon is essential for the viability of S. aureus 
 S. aureus femAB null mutants have been previously 
constructed21,22,44,45. Inactivation of femAB led to altered cell 
morphology, but cells survived, suggesting that this operon is not 
essential for cell viability. However, complementation of femAB 
deficient mutants with intact femAB copies did not restore normal 
bacterial growth, suggesting the presence of compensatory mutations 
and/or metabolic adaptations that allowed for survival25. In order to 
evaluate the essentiality of femAB as well as phenotypes resulting 
from femAB depletion in a background without the existence of 
compensatory mutations, we decided to construct a conditional 
femAB mutant. The femAB operon of the clinically relevant CA-MRSA 
strain MW2 was placed under the control of the IPTG inducible Pspac 
promoter. As the Pspac promoter is known to be leaky46, several 
copies of the lacI repressor gene were provided to decrease the basal 
transcription of femAB. The resulting strain was named MW2-
iFemAB.  
 Growth of MW2-iFemAB in liquid medium supplemented 
with IPTG at 0, 10, 25 and 500 µM was followed for 10 hours. In the 
presence of 500 µM of IPTG, growth of the conditional mutant was 
similar to the parental strain MW2, therefore this concentration of 
inducer was used in subsequent assays. The growth rate of MW2-
iFemAB decreased with decreasing IPTG concentrations and, 
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surprisingly, no bacterial growth was observed in the absence of 
IPTG, indicating that this operon is essential for survival (Fig. 1a). To 
assess the effects on peptidoglycan composition due to loss of FemAB 
activity, we analysed the cell wall of MW2-iFemAB cells incubated 
with 500, 25 or 0 µM of IPTG until bacterial growth was arrested in 
the non-induced culture (see Experimental Procedures). As expected, 
the muropeptide profiles (see Fig. 1c for peak assignment) in cells 
depleted of FemAB show a massive accumulation of peak 4, which 
was previously identified as the monomeric pentapeptide substituted 
with a single glycine residue47, the substrate of FemA (Fig.1b, [IPTG] 
0 µM). This was in contrast to cells where FemAB was fully induced 
(Fig.1b, [IPTG] 500 µM), where the major monomeric form present 
was the pentaglycine substituted monomer (peak 5). Accordingly, the 
loss of FemAB also prevented the formation of pentaglycine 
crosslinked forms such as dimers (peak 11), trimers (peak 15), 
tetramers (peak 16) and higher order forms, which co-elute near the 
end of the run (Fig. 1b, arrow). Low FemAB expression levels, just 
enough to sustain bacterial growth ([IPTG] 25 µM), resulted in the 
presence of some pentaglycine crosslinked forms (peaks 11, 15, 16, 
etc.) and the accumulation of a previously identified species47 with 
unknown chemical composition (peak 10), which could constitute a 
monoglycine substituted dimer. This degree of peptidoglycan 
structural organisation might be the minimum to ensure cell viability. 
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Figure 1. femAB is essential for cell viability in S. aureus. (a), Growth rates 
of MW2-ifemAB strain with IPTG-inducible femAB operon. In the presence 
of high IPTG concentrations ([IPTG] 500 µM), growth was identical to the 
parental strain (MW2 parental). In the absence ([IPTG] 0 µm) or with low 
concentrations of IPTG ([IPTG] 10 µM), no cell growth was detected. (b), 
Muropeptide HPLC profiles of MW2-iFemAB induced with different levels 
of IPTG. Depletion of FemAB led to the accumulation of monomeric 
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pentapeptides substituted with one glycine (peak 4), in contrast to 
pentaglycine forms (peak 5) seen in fully induced ([IPTG] 500 µM) or 
parental (MW2 parental) profiles. Loss of FemAB activity also impaired the 
formation of pentaglycine crosslinked forms such as di-, tri-, tetra- and 
pentamers (peaks 11, 15, 16 and 17, respectively) and higher order oligomers 
(black arrow). (c), Proposed structures of the peaks in PG muropeptide 
chromatographic analysis, according to de Jonge and Tomasz47. 
Muropeptides are numbered according to increasing retention times. G= N-
acetylglucosamine; M = N-acetylmuramic acid. 
 
Loss of FemAB activity leads to cellular lysis 
 The morphology of cells depleted from FemAB was analysed 
by super resolution structured illumination microscopy (SIM). MW2-
iFemAB was grown with or without IPTG (500 µM). Immediately 
following growth arrest of the non-induced culture (Fig. 2a, black 
arrow), cells were stained with membrane dye FM 4-64, with 
peptidoglycan dye Van-FL (to show cell wall and septum 
positioning) and with DNA dye Hoechst 33342 (to give an indication 
of cell cycle phase). In the presence of IPTG, MW2-iFemAB cells 
divided normally with DNA segregation preceding the synthesis of a 
division septum at mid-cell (Fig. 2b, top panels), and cells containing 
multiple septa were not observed (Fig. 2c, left panel). In contrast, 
FemAB depleted cells often appeared as pseudomulticellular forms 
with two or more perpendicular septa, suggesting that the second 
round of division is starting before daughter cell separation is 
completed (Fig. 2c, right panel arrows). Furthermore, in FemAB 
depleted cells nucleoid morphology was altered, with cells containing 
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condensed DNA (Fig. 2b, bottom panels). Our results are in 
agreement with previous reports that suppressed fem mutants show 
irregular placement of cross walls and retarded cell separation21. This 
phenotype can be a consequence of either multiple septation or 
defective splitting.  
 
Figure 2. Loss of FemAB activity inhibits daughter cell separation during 
division. (a), Growth curves of MW2-iFemAB in the presence ([IPTG] 500 
µM) or absence ([IPTG] 0 µM) of IPTG, to determine the timing of growth 
arrest in the non-induced condition (see Experimental Procedures). Cells 
were collected for SIM imaging at the indicated time point (black arrow). (b), 
SIM images of MW2-iFemAB cells growing in the presence (+) or absence (-) 
of IPTG and stained with membrane dye FM 4-64, peptidoglycan dye Van-
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FL and DNA dye Hoechst 33342 (c), 3D-SIM images of MW2-iFemAB cells 
growing in the presence (+) or absence (-) of IPTG and stained with 
peptidoglycan dye Van-FL. IPTG-induced cells divide normally with DNA 
segregation preceding the synthesis of the division septum at mid-cell (Panel 
b, top row and Panel c, left column). In contrast, FemAB depleted cells often 
had condensed nucleoids (Panel b, bottom row) and appeared as pseudo 
multicellular forms with two perpendicular septa (Panel c, white arrows). 
Scale bars, 1 µm. 
When cells depleted of FemAB were incubated for longer 
periods, we noticed a decrease in culture density, suggesting cell lysis 
(Fig. 2a). We therefore imaged cells 2 hours after growth arrest and 
observed extensive membrane damage, characterized by holes, 
bulges and invaginations and the presence of anucleate cells (Fig. 3). 
These results suggest that the inability of S. aureus to survive with a 
shortened crossbridge structure, may be because the three-
dimensional structure of a monoglycine crosslinked peptidoglycan 
does not confer sufficient robustness to bear the internal osmotic 
pressure, in the conditions tested, causing the cells to rupture. This is 
in agreement with data from Hübscher and colleagues25, which have 
shown by transcriptome analysis that femAB null mutant AS145 
adapted to the femAB deficit by overhauling its metabolic pathways, 
probably to alleviate internal turgor25. It is also possible that 
monoglycine crossbridges are not suitable substrates for 
transpeptidation by S. aureus PBPs in vivo and thus crosslinking of 
glycan chains was stalled after FemAB depletion. This is in agreement 
with solid-state NMR data obtained by Kim et al.48, which indicates 
that monoglycyl crossbridges would be too short to connect the 
Building Bridges: the pentaglycine crosslinks in S. aureus peptidoglycan are 
required for cell integrity 
219 
glycan chains of the S. aureus PG, and that crosslinking with such a 
reduced bridge length would require a major rearrangement of the 
tertiary structure of PG48. In this way, the femA mutants generated in 
the past probably adapted to life with shortened crossbridges 
through changes in PG architecture. Accordingly, analysis of the 
average glycan chain length in femAB mutant AS145 revealed the 
presence of longer sugar chains when compared to parental strain 
BB903. Cis-complementation with a wild-type femAB copy did not 
restore normal glycan chain length in the femAB mutant, indicating 
that changes in PG structure was an adaptive response required for 
AS145 to survive with poorly crosslinked cell wall. 
 
Figure 3. FemAB depletion leads to cellular lysis. MW2-iFemAB cells 
depleted of FemAB activity for a period of 2 hours following growth arrest 
were stained with membrane dye FM 4-64, peptidoglycan dye Van-FL and 
DNA dye Hoechst 33342 and imaged by SIM. FemAB depleted cells (b) 
show loss of membrane integrity characterized by holes (asterisk), bulges 
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(white arrow) and invaginations (dashed white arrow) as well as absence of 
DNA staining (asterisk), indicative of lysis, when compared to IPTG-
induced cells (a). Scale bars, 1 µm. 
 
Structure-based site directed mutagenesis of FemA 
FemA is not only a good target for compounds that are 
synergistic with β-lactams49 but also, as we show in this work, a lethal 
target by itself. As FemA is a protein unique to S. aureus, the 
development of anti-FemA compounds would be a potent tool for 
pathogen specific treatment strategies. To provide useful information 
for the studies of inhibitors of FemA, we identified putative key 
regions in the protein required for activity, based on the known 
crystal structure of FemA26 and on homology to the FemX protein 
from Weisella viridescens28,50. We decided to focus on the putative 
transferase pocket (Fig. 4a – in blue) that contains Arg220, Phe224 
(Fig. 4a – red circles) and Tyr327 (Fig.4a – orange circle), which are 
conserved across the Fem family. We also mined the sequence of 
FemA for regions which could bind DNA/RNA using DP-Bind41,42, in 
order to identify the putative tRNA-binding site. We found that the 
region with the highest probability corresponded to the α6 helix (aa 
176-188) of FemA, rich in Lys/Arg residues with polar and charged 
sidechains exposed to the solvent26, which could stabilise the entering 
tRNA (Fig. 4a – in green). Specifically, amino acids Lys180 and 
Arg181 showed >96% probability of binding DNA/RNA in each of 
three individual prediction algorithms performed by DP-Bind (see 
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Experimental Procedures), and therefore we selected them for 
mutagenesis (Fig. 4b).  
 
Figure 4. Targeting FemA for site-directed mutagenesis. (a), 3D 
representation of S. aureus FemA showing the globular subdomain 1B (in 
blue), proposed to fold into a channel suitable for binding of the 
dissacharide hexapeptide lipid substrate26. This channel contains amino 
acids Y327 (orange circle) and R220 and F224 (red circles), that were selected 
for mutagenesis. Binding of glycyl-charged tRNA is proposed to occur at the 
junction between the antiparallel coiled-coil arms (in red) and the globular 
domain (in blue)26. (b), Close-up view of the α6 helix of FemA (in green), 
which is rich in polar and charged amino acids (Lys, Arg). Residues Lys180 
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and Arg181 (in yellow), containing positively charged side chains exposed to 
the solvent and predicted to bind DNA/RNA, were selected for mutagenesis. 
To construct the FemA mutants we used the backbone of 
pFemABwt, encoding femAB, and performed site-directed mutagenesis 
on selected residues of the femA gene and replaced them with 
alanines, thus generating pFemARF220AAB and pFemAY327AB, in order to 
target the transferase domain and pFemAKR180AAB to target the 
predicted tRNA binding helix. These expression plasmids were 
transformed into MW2-iFemAB, allowing us to deplete native femAB 
expression (in the absence of IPTG) and express mutant alleles (in the 
presence of cadmium).  
We were able to complement the lack of femAB expression 
from the native locus by expressing femAB from pFemABwt in the 
presence of cadmium (1 µM), as assessed by growth rates, 
lysostaphin and oxacillin MICs, fluorescence microscopy and 
muropeptide profiles (Table 3). Expression of the catalytic site 
mutants FemARF220AA and FemAY327A caused a delay in entry into 
exponential phase (Fig. 5a) and a reduction of the pentaglycine 
substituted monomer content in peptidoglycan (Fig. 5b), although 
morphology was similar to wild-type and no significant differences 
in lysostaphin and oxacillin MICs were observed (Table 3). In 
contrast, the mutations in the α6 helix of FemA caused severe loss of 
FemA activity. The FemAKR180AA mutant showed a marked reduction 
in growth rate (Fig. 5a), increased lysostaphin and decreased oxacillin 
resistances and a pseudomulticellular morphology when observed by 
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microscopy (Table 3), similar to what was observed when depleting 
FemAB expression. Furthermore, analysis of the muropeptide content 
in this mutant revealed a pronounced accumulation of monoglycyl 
substituted pentapeptides and concomitant reduction in pentaglycine 
crosslinked species (Fig. 5b and Table 3). 
 
Figure 5. Selected mutations decrease FemA activity in vivo. MW2-iFemAB 
cells with ectopically expressed wild-type femAB (FemA wt) or femAB alleles 
with mutations in femA (encoding FemA KR180AA, FemA RF220AA and 
FemA Y327A) from a cadmium-inducible promoter Pcad. FemA activity was 
assessed by determining growth rates (a) and muropeptide profiles (b). 
Expression of FemAB wt fully complemented the lack of native femAB 
activity, while expression of FemAKR180AA led to a pronounced growth defect 
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and accumulation of mono-glycine monomer species (peak 4) with 
concomitant reduction in higher-order pentaglycine crosslinked species 
(peaks 11, 15, 16 and arrow). We also observed the accumulation of peak 10 
in this mutant, which could be a monoglycine substituted dimer. Expression 
of FemAY327 and FemARF220 mutants led to similar phenotypes, albeit to a 
lesser extent.  
 















MW2pFemAKR180AA 52 2,5 0,4 femA 1:3 
MW2pFemARF220AA 30 0,15 1,6 wt 2:1 
MW2pFemAY327A 27 0,08 0,8 wt 2:1 
MW2pFemAwt 27 0,08 3,2 wt 6:1 
Parental MW2 25 0,08 1,5 wt 6:1 
 
Next we tested the activity of FemA mutants in vitro. For this 
purpose, we purified recombinant FemAwt , FemAKR180AA, FemARF220AA 
and FemAY327A with C-terminal histidine tags and synthesised the 
FemA substrate lipid II-Gly1 in vitro (see Experimental Procesures). 
As recombinant FemARF220AA was very unstable and readily 
precipitated, we could not use it for further assays. LipidII-Gly1 was 
trapped in Triton X-100 micelles and incubated with either FemAwt, 
FemAKR180AA or FemAY327A in the presence of [U-14C]-glycine charged 
tRNA. After 30, 60 or 90 minutes the lipid fraction was extracted and 
separated by thin layer chromatography and radioactive glycine 
transfer to lipid II-Gly1 was measured. Both mutant forms 
FemAKR180AA and FemAY327A transferred less [U-14C]-glycine to their 
substrate when compared to FemAwt, consistent with a reduction in 
Building Bridges: the pentaglycine crosslinks in S. aureus peptidoglycan are 
required for cell integrity 
225 
protein activity (Fig. 6). Taken together, in vivo and in vitro data show 
that the KR180AA and Y327A mutations caused a decrease in FemA 
transferase activity but did not impair the viability of S. aureus. This is 
in agreement with studies by Koyama and colleagues on the effects of 
cyslabdan, a molecule which partially inhibits FemA and does not 
impair growth 49. 
 
Figure 6. FemA mutants show reduced activity in vitro. Recombinant 
FemAwt, FemAKR180AA and FemAY327A were incubated with lipid II-Gly1 in the 
presence of [U-14C]-glycine charged tRNA, for either 30, 60 or 90 minutes. 
Both FemAKR180AA and FemAY327A showed decreased [U-14C]-glycine transfer 
to lipid II-Gly1 when compared to FemAwt. Columns denote mean values 






 The structural features of the staphylococcal peptidoglycan 
seem remarkably unique in nature, as pentaglycine crosslinks have 
not been observed outside of the genus. These long bridges likely 
confer high flexibility to S. aureus peptidoglycan which allows the cell 
to withstand intense internal turgor, as femAB mutants isolated in the 
past adapted to life with shortened crossbridges by drastically 
reducing metabolic activity25. Moreover, the nature and length of PG 
branching has been implicated in playing a role in resistance to β-
lactams, not only in S. aureus but other bacteria23,44,51,52. It has been 
proposed that besides adaptation of metabolic pathways, previously 
isolated femAB mutants also contain compensatory or suppressor 
mutations that allow for survival with reduced cross bridges, 
however these remain uncharacterised25,45,53.  
We have shown that at least in CA-MRSA strain MW2, 
depletion of the femAB operon is lethal, leading to the disruption of 
the cell envelope, causing cells to lyse. This suggests that monoglycyl-
substituted muropeptides are not valid substrates for 
transpeptidation in vivo, either because TPases fail to recognise them 
or because different S. aureus glycan strands are too far apart to be 
crosslinked via crossbridges with only one glycine. Nevertheless, 
these data indicate that inhibitors of FemA activity would be effective 
to treat MRSA infections, either acting on their own or in combination 
therapy with β-lactams that are already in use. Towards this 
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possibility, we have identified specific residues present in the 
putative transferase and tRNA-binding domains of FemA which are 
important for protein activity and thus good candidate targets for 
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 The increasing prevalence of life-threatening infections caused 
by emerging drug-resistant bacteria constitutes a significant burden 
on global public health. There is a clear need for the development and 
characterisation of new antibiotics which can be effective alone or in 
combination with existing drugs on the market. Recent guidelines for 
antibacterial drug development from the Food and Drug 
Administration (FDA) clearly states that the mechanism of action of 
investigational drugs should be evaluated. Towards this end, cell 
biology tools provide a new way of studying the effects of antibiotics 
on bacterial cells. Here we describe the study of the mode of action of 
two novel molecules that are effective against methicillin-resistant 
Staphylococcus aureus (MRSA) – PC190723 and DNAC-1. The FtsZ-
specific inhibitor PC190723 was shown to act synergistically with β-
lactam antibiotics in vitro and in vivo. Using fluorescence microscopy 
we show that synergy between these agents is likely to be elicited by 
the concomitant delocalisation of their cognate drug targets (FtsZ and 
PBP2) in MRSA. DNAC-1 was identified in a loss-of-viability screen, 
using small molecules against MRSA. Treatment with DNAC-1 
caused the disruption of cellular membrane structures and the 
appearance of mesosome-like projections into the cytosol, as assessed 
by fluorescence and transmission electron microscopy. Membrane 
permeation was accompanied by a rapid loss of membrane potential, 
as monitored by the use of the DiOC2 (3,3′-diethyloxacarbocyanine 
iodide) dye. Furthermore, DNAC-1 inhibits staphylococcal cell wall 
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synthesis by preventing the polymerization of FtsZ at mid-cell and 






 After the discovery of penicillin, β-lactam antibiotics (and the 
broad-spectrum derivatives cephalosporins and carbapenems) 
significantly improved public health during the 20th century, and still 
constitute the most heavily used class of antibiotics1. β-lactam 
antibiotics target penicillin-binding proteins (PBPS), enzymes 
involved in peptidoglycan synthesis in bacteria, and have been the 
drugs of choice against bacterial infections for many decades due to 
low toxicity and relatively low dosage requirements for treatment, 
when compared to other classes1. Worryingly, drug resistance to β-
lactams has consistently emerged in bacteria, appearing as early as 
one year following the introduction of a new antibiotic into the 
clinic2. Drug resistance has also emerged against other classes of 
antibiotics which are currently used, including drugs that target cell 
wall synthesis3 (such as glycopeptides), DNA/RNA synthesis4 
(quinolones), protein synthesis5 (macrolides) or that target the 
bacterial membrane6 (daptomycin, nisin).  
Infections caused by drug resistant bacteria are a major 
challenge to contemporary public health and, despite efforts to 
contain them, are predicted to escalate in the future2. Of significant 
note are infections caused by methicillin resistant Staphylococcus 
aureus (MRSA) strains, which are resistant to all classes of β-
lactams3,7. Recently emerging MRSA isolates have also become 
resistant to last resort antibiotics, such as vancomycin and linezolid3. 
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S. aureus is a Gram positive bacterial human pathogen that can cause 
serious infections, including pneumonia, sepsis, osteomyelitis and 
endocarditis. Traditionally, MRSA infections were confined to 
hospitals and long-term care facilities (hospital-acquired MRSA [HA-
MRSA] strains), where they affect debilitated patients. However, 
highly virulent and epidemiologically distinct MRSA strains that 
affect individuals without predisposing risk factors have appeared 
outside of the hospital, the so-called community-associated MRSA 
(CA-MRSA). Compounding this issue is a severe lack of new drugs 
introduced to the market, as large pharmaceutical companies have 
progressively abandoned the fields of antibiotic research and 
development for more profitable ventures, such as chemotherapy 
against cancer and chronic diseases8. A viable approach to 
circumvent bacterial resistance is towards the development of 
synergistic therapies, for example using a combination of an existing 
β-lactam with a second, novel, agent that potentiates its effect9. 
Synergistic therapy also has the benefit of allowing a lower dosage of 
the primary antibiotic, since its effect is augmented by the adjuvant10.  
Since the development of new drugs is dwindling, it is 
imperative that a concerted effort is made towards better 
understanding the existing ones, as well as selectively searching for 
new efficient drugs that can either act alone or in combination with 
existing antibiotics. A vital part in the discovery and development of 
antibacterial drugs is the evaluation of the mechanism of action 
(MOA) of any given drug. In general terms, our knowledge of how 
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antibiotics induce bacterial cell death is focussed on identifying the 
essential cellular function that is disrupted by the primary target of a 
drug10. However, antibiotic mediated cell death is a multi-layered 
process, where the molecular interaction between drug and target is 
often merely the beginning. What follows is a cascade of alterations to 
the bacterial cell, which can include perturbations of biochemical 
pathways, disruption of cellular structures and the generation of toxic 
molecules10. For example, it has been shown that β-lactam induced 
cell lysis in Streptococcus pneumoniae11 and Escherichia coli12 is mediated 
by autolysins, hydrolases that cleave chemical bonds in 
peptidoglycan. As PG synthesis and degradation are concurrent 
processes during the bacterial cell cycle, inhibiting PG synthesis with 
a β-lactam creates an imbalance which leads to autolysin-driven 
degradation of the whole PG layer and subsequent lysis11.  
This chapter contains data pertaining to the characterisation of 
the mode of action of two molecules that are potential candidates 
effective against MRSA, either alone or in combination with β-
lactams – PC190723 and DNAC-1. We found that although these 
molecules have distinct chemical structures and different molecular 
targets in the S. aureus cell, both impair the proper assembly of the 
division machinery, which in turn prevents peptidoglycan synthesis 
at the septum.  
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Experimental Procedures 
Bacterial growth conditions 
Unless stated otherwise, S. aureus strains were grown in 
tryptic soy broth (TSB, Difco) at 200 r.p.m with aeration at 37 °C or 
30 °C or on tryptic soy agar (TSA, Difco) at 30 or 37°C. E. coli strains 
were grown in Luria–Bertani broth (Difco) with aeration, or Luria–
Bertani agar (Difco) at 37 or 30°C. When necessary, antibiotics 
ampicillin (100  μg/ml), erythromycin (10  μg/ml), kanamycin (50 
 μg/ml), neomycin (50  μg/ml) were added to the media. 5-bromo-4-
chloro-3-indolyl β-D-galactopyranoside (X-gal, Apollo Scientific) was 
used at 100 μg/ml. Unless stated otherwise, isopropyl β-D-1-
thiogalactopyranoside (IPTG, Apollo Scientific) was used at 0.1 mM 
to induce expression of constructs under the control of the Pspac 
promoter.  
Construction of S. aureus fluorescent strains 
The primer sequences used to construct strains are described 
in Table 1. To construct an S. aureus COL strain where the native pbpB 
gene, encoding PBP2, was replaced by a sfgfp-pbpB fusion, we 
constructed a plasmid where we introduced the sfgfp gene, encoding 
the P5 superfolder GFP variant13, between the recU and the pbpB 
genes. For that purpose, we first amplified the upstream region of 
pbpB (primers BCBP5 and BCBP6) and the 5′ region of the pbpB gene 
(primers BCBP7 and BCBP8). The sfgfp gene was amplified from 
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plasmid pTRC99a-P513 (primers BCBP9 and BCBP10). A sequence 
encoding a 12–amino acid linker was introduced between the sfgfp 
and the pbpB genes. The three fragments were joined by overlap 
polymerase chain reaction (PCR) in two steps and cloned into 
pBCBPM016, resulting in plasmid pBCBPM061. The pBCBPM016 
plasmid is a derivative of the pMAD vector14, in which the 
erythromycin resistance cassette was replaced by a kanamycin 
resistance cassette obtained from the pDG792 plasmid15. Plasmid 
pBCBPM061 was sequenced, electroporated into S. aureus RN4220 
strain and transduced into S. aureus COL strain with phage 80α16. 
Insertion and excision of pBCBPM061 into the chromosome of COL 
were performed as previously described14. The replacement of the 
native pbpB gene by the sfgfp-pbpB gene fusion was confirmed by PCR 
(with primers BCBP11 and BCBP12). The resulting strain, named 
BCBPM073, expresses an sGFP fusion to PBP2, from its native 
chromosomal locus, under the control of its native promoter. To 
construct an S. aureus COL strain ectopically expressing an FtsZ-CFP 
fusion from the spa locus of the S. aureus chromosome, under the 
control of the Pspac promoter, we transduced the pBCBHV003 
plasmid17 into strain COL. Insertion and excision of pBCBHV003 into 
the chromosome of COL allowed the replacement of the spa gene by 
the ftsZ-cfp fusion, generating strain BCBAJ020.  
In order to detect cell wall active compounds, we constructed 
a strain expressing a vraSR promoter fusion to sfgfp. Briefly, a 779-bp 
fragment encompassing the coding region of sgfp-p7 was amplified 
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from pTRC99a-P713 using the primers sgfp P3 EcoRV and sgfp P2 
NotI, digested with EcoRV and NotI, and used to replace the 
gfpmutP2 gene in pSG508218, giving pFAST3. An 844-bp fragment 
containing the vraSR promoter region was amplified from COL using 
the primers PvraSRP1KpnI and PvraSRP2XhoI, digested with KpnI 
and XhoI, and cloned into the KpnI/XhoI restriction sites of pFAST3, 
upstream of sfgfp-p7, resulting in pPvraS, as confirmed by DNA 
sequencing. pPvraSR was electroporated into the S. aureus RN4220 
strain to enable chromosomal integration at the vraSR promoter by 
homologous recombination, as confirmed by PCR and sequencing; 
the resulting strain was named RNpPVra. Strain COLpPVra was 
obtained by transducing the integrated plasmid pPvraSR from 
RNpPVra to COL using phage 80α, as previously described16. 
Table 1. Primer sequences used in this work 









sgfp P3 EcoRV gcgcgatatcataaggaggattcgtatgagtaaaggagaagaacttttc 
sgfp P2 NotI gcttagcggccgcttaatggtgatgatggtgatggtcgactttgtatag 
PvraSRP1KpnI gctgcggtacccggtgctatttctgcgcc 
 PvraSRP2XhoI gctgcctcgagacgttcaacatagttcataac 
 




Minimum inhibitory concentration (MIC) assays 
MICs of relevant antimicrobial compounds were determined 
by broth microdilution in sterile 96-well plates. The medium used 
was TSB, containing a series of two-fold dilutions of each compound. 
Cultures of S. aureus strains were added at a final density of 5x105 
CFU/ml to each well. Wells were reserved in each plate for sterility 
control (no cells added) and cell viability (no compound added). 
Plates were aerobically incubated at 37°C. Endpoints were assessed 
visually after 24 and 48 h. All assays were done in triplicate. 
Fluorescence microscopy experiments with PC190723 
To analyse the mode of action of PC190723 by fluorescence 
microscopy, S. aureus strains BCBPM073 (expressing sGFP-PBP2) and 
BCBAJ020 (expressing FtsZ-CFP) were inoculated in TSB at 37°C for 
18 hours. The cultures were then diluted 1:200 into fresh TSB 
supplemented with 0.1 mM IPTG when required and further 
incubated in the same conditions. At mid-exponential phase (OD600 
0.6 to 0.8 nm), cultures were divided into pre-warmed flasks and 
either PC190723 or nalidixic acid (Sigma-Aldrich) were added at 1× or 
10× the corresponding MIC values. Flasks to which no antibiotic was 
added were used as controls for the experiment. Bacterial cultures 
were then incubated for 30 min, after which aliquots were collected, 
pelleted, and washed with phosphate-buffered saline (PBS). Cells 
were mounted on a microscope slide covered with a thin film of 1% 
agarose in PBS and observed by fluorescence microscopy with a Zeiss 
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Axio observer Z1 microscope. Image acquisition was performed with 
a Photometrics CoolSNAP HQ2 camera (Roper Scientific) and 
MetaMorph 7.5 software (Molecular Devices).  
Fluorescence microscopy experiments with DNAC-1 
To analyse the mode of action of DNAC-1 by fluorescence 
microscopy, we used strains expressing fluorescent fusions in the 
background of MRSA COL. BCBPM073 (expressing sGFP-PBP2), 
BCBPM16219 (expressing PBP4-YFP), BCBAJ020 (expressing IPTG-
inducible FtsZ-CFP from the spa locus) and COLpPVra (expressing a 
sGFP fusion to PvraSR) were incubated overnight in TSB 
supplemented with either erythromycin (10 μg/ml) or kanamycin 
(200 μg/ml), when required, at 37°C, back-diluted to fresh TSB and 
allowed to grow until mid-exponential phase (OD600 ∼0.6). In each 
case, the cultures were divided among five flasks, and DNAC-1 (in 
DMSO) was added at either 0.5× (2 μg/ml), 2× (8 μg/ml), or 10× MIC 
(40 μg/ml); the two remaining flasks were kept as controls with 
DMSO (0.2%) or TSB alone. The cultures were incubated for 15 min or 
1 hour, after which the cells were pelleted, washed in PBS buffer, and 
mounted on microscope slides with pads of 1% agarose in PBS. To 
analyse the activation of the cell wall stress stimulon, a control with 
vancomycin at 2× MIC (6 μg/ml) was used. The displayed values 
were adjusted for each image for visualization purposes.  
To assess morphology, COL cells were incubated with 2 
μg/ml FM 4-64 [N-(3-triethylammoniumpropyl)-4-(p-
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diethylaminophenyl-hexatrienyl) pyridinium dibromide], Bodipy FL-
vancomycin (2 μg/ml), and Hoechst 33342 (4 μg/ml) (all from 
Molecular Probes) for 5 min at room temperature with shaking and 
washed before being imaged. To assess cell viability, cells were 
stained with propidium iodide (0.5 μg/ml; Invitrogen) as described 
above. The cells were imaged using a Zeiss Axio Observer 
microscope equipped with a Photometrics CoolSNAP HQ2 camera 
(Roper Scientific) and Metamorph 7.5 software (Molecular Devices), 
or by structured illumination microscopy (SIM) or laser wide-field 
microscopy in an Elyra PS.1 microscope (Zeiss) with a scientific 
complementary metal oxide semiconductor (sCMOS) camera and 5 
grating rotations for each channel. SIM images were reconstructed 
and analysed with ZEN software (black edition, 2012; version 
8.1.0.484). For the quantification of the signal of fluorescent 
derivatives of PBPs at the septum, five images were analysed per 
condition using ImageJ20. Only cells with a complete septum were 
analysed. 
Macromolecular analysis of cell wall synthesis 
To assay for cell wall synthesis, we measured the 
incorporation of [3H]lysine into peptidoglycan in the presence of 
chloramphenicol (25 μg/ml final concentration), which inhibits 
protein synthesis but allows peptidoglycan synthesis to continue, 
thus enabling us to judge pentapeptide synthesis of lipid II, a 
precursor of peptidoglycan, in the presence of DNAC-1 at 10× MIC. 
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Ampicillin was used as a cell wall active antibiotic control. The effects 
of DNAC-1 and ampicillin on peptidoglycan synthesis were 
measured using the radiolabelled precursor [3H]lysine (2.5 μCi/ml 
final concentration) added to mid-exponential-phase cultures (~108 
CFU/ml) of S. aureus strain ATCC 29213 in chemically defined 
medium, as previously described21. The radiolabelled precursor was 
added to the bacterial culture immediately before the antibiotics were 
added. The negative controls for the macromolecular assays consisted 
of all reaction components with no antibiotics added, with the 
resulting counts used as the 100% values. After an additional 20 min 
of incubation at 37°C in the presence or absence of antibiotics, the 
samples were removed for trichloroacetic acid precipitation and 
subsequent scintillation counter analyses to determine radioactive 
incorporation into the cell wall; the data were expressed as the 
percent inhibition of incorporation in comparison to a drug-free 
control. 
Transmission electron microscopy 
S. aureus USA300 cells grown in MHC at 37°C were treated 
with either DNAC-1 (2× MIC) or DMSO for 90 min, washed twice 
with phosphate-buffered saline (PBS), and processed for electron 
microscopy (EM) by fixing with a 10× volume of 2% glutaraldehyde-
tannic acid (GTA)–1% paraformaldehyde in 0.1 M Na-cacodylate 
buffer (pH 7.4), post-fixed in 1% OsO4 in cacodylate buffer (pH 7.4), 
embedded, and serially dehydrated in ethanol. The samples were 
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sectioned and stained with uranyl acetate and imaged using a JEOL 
transmission electron microscope (TEM) 1010 at 100 kV and 20,000× 
magnification. Thirty fields of each strain with nearly equatorial-cut 
surfaces were measured for cell wall thickness, and the results were 
expressed as the means ± standard deviations. Statistical significance 
was determined using the Kruskal-Wallis test, with a P value of <0.05 
considered significant. 
Membrane potential assays 
The carbocyanine dye DiOC2 (3,3′-diethyloxacarbocyanine 
iodide; Life Technologies) was used to assess membrane potential. S. 
aureus USA300 cultures were grown to the early exponential phase 
(OD620 = 0.3) in MHB, incubated with 10 μM DiOC2 in PBS with 1% 
glucose at 24°C for 30 min in the dark, and then transferred to a 384-
well plate. The cells were analysed using a plate reader, Tecan M1000 
(excitation, 485 nm; emission, 680 nm). After establishing a baseline 
reading, either carbonyl cyanide m-chlorophenyl hydrazone (CCCP) 
(positive control) or DNAC-1 was added to the wells, and the drop in 
red fluorescence was monitored over time. 
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Results 
PC190723 prevents correct Z ring placement 
Chemical-genetic interaction networks have been used to 
predict compound synergy between cognate inhibitors of targets and 
their corresponding companion antibiotic22,23. These approaches have 
led to the identification of genes whose downregulation potentiates 
β-lactam activity against MRSA strains. Most β-lactam susceptibility 
determinants functionally participate in cell wall peptidoglycan 
biosynthesis (glm, mur, mra, fem, pbp, and SAV1754 genes), other 
aspects of cell wall biogenesis (tarL, spsB, and SAV1892), or wall 
stress signal transduction pathways (SAV1220)22-25. An additional 
group of β-lactam susceptibility determinants included components 
of the cell division Z ring, an ancestral tubulin-like macromolecular 
structure required for the assembly of the divisome. FtsZ is a self-
activating guanosine triphosphatase (GTPase) that polymerizes into 
cytoskeletal Z ring filaments that localise to the future division site at 
the mid-cell early in the cell cycle26. Perturbations in Z ring assembly 
impair cell wall assembly27. PBP2, the target of several β-lactam 
antibiotics including oxacillin and imipenem, is itself delocalised 
from the septum in S. aureus upon genetic depletion of FtsZ28. 
Accordingly, the small-molecule PC190723, which targets the GTPase 
domain of FtsZ29,30, displayed synergy in combination with a wide 
variety of β-lactam antibiotics against MRSA. Importantly, PC190723 
also produced strong microbiological activity as a single agent, 
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displaying a lower MIC90 (0.5 µg/ml; minimum inhibitor 
concentration against 90% of clinical strain isolates tested) than the 
standard-of-care antibiotics linezolid and vancomycin (MIC90 for both 
antibiotics is 2 µg/ml). PC190723 also has potent activity against 
linezolid-resistant, vancomycin intermediate resistant (VISA), and 
vancomycin-resistant (VRSA) S. aureus. PC190723 has been reported 
to have a bactericidal mode of action30, meaning that drug-treated 
cells rapidly lose viability rather than show arrested growth (that is, a 
bacteriostatic effect). 
On the basis of the central role of FtsZ in cell division, and the 
prominent synergy between PC190723 and β-lactam antibiotics, we 
wondered if the mode of action of PC190723 involved the 
destabilisation of the assembly of the Z ring, which would prevent 
septal PG synthesis. To study localisation of FtsZ, we used a 
previously described fluorescent derivative of FtsZ [FtsZ–cyan 
fluorescent protein (FtsZ-CFP)]17. When expressed in MRSA COL, 
FtsZ-CFP correctly localised to the mid-cell and division septum (Fig. 
1a)17,31. However, FtsZ-CFP localisation in MRSA COL was markedly 
altered in cells treated with PC190723 (at 10 times MIC for PC190723 - 
10 µg/ml) for 30 min. FtsZ-CFP appeared as multiple rings and arcs 
without being specifically restricted to the future septum (Fig. 1a). 
MRSA COL bacteria treated with PC190723 also exhibited extensive 
enlargement as previously reported30, indicative of FtsZ-mediated 
disruption of localised cell wall synthesis at the septum28. Consistent 
with a direct effect of PC190723 on FtsZ localisation, similar 
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delocalisation of FtsZ-CFP was also observed in cells treated for 30 
min with PC190723 at its MIC value of 1 µg/ml (not shown). In a 
control experiment, bacteria treated with nalidixic acid (an antibiotic 
targeting DNA gyrase) under the same growth inhibitory conditions 
did not show altered FtsZ-CFP localisation (Fig. 2a). We also 
determined the localisation of PBP2 in PC190723-treated MRSA COL 
using a newly constructed functional superfolder green fluorescent 
protein (sfgfp)–pbpB fusion gene integrated at the native pbpB locus 
and regulated by its native promoter (see Experimental Procedures). 
sGFP-PBP2 correctly localised to the division septum in mock-treated 
cells in the same way as that observed for endogenous PBP2 protein28 
or for a previous GFP-PBP2 construct31 (Fig. 1b). However, sGFP-
PBP2 was extensively delocalised in cells treated with PC190723 at 1× 
or 10× MIC for 30 min (Fig. 1b), with discrete patches of sGFP-PBP2 
accumulating throughout the plasma membrane. Like FtsZ-CFP, 
sGFP-PBP2 was correctly localised to the division site in MRSA COL 
cells treated with nalidixic acid (Fig. 2b). Collectively, these data 
demonstrate that FtsZ and PBP2 are delocalised from the division site 
of MRSA cells treated with PC190723. Because the proper function of 
FtsZ and PBP2 requires precise septum localisation to coordinate cell 
division and peptidoglycan biosynthesis, their extensive 
delocalisation in PC190723-treated cells provides insight into the 
molecular basis for the chemical synergy between compounds 
targeting these two proteins. Mechanistically, PC190723 and β-lactam 
antibiotics are likely to be synergistic against MRSA because of the 
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combined effects of (i) GTPase inhibition29,30 and FtsZ delocalisation, 
and (ii) concomitant PBP2 delocalisation such that only a small 
amount of β-lactam antibiotic presumably is required to inactivate 
the residual and functional PBP2 enzyme localised at the septum. 
 
Figure 1. Septal localisation of fluorescent derivatives of FtsZ and PBP2 is 
lost in PC190723-treated MRSA cells. (A), MRSA COL cells expressing 
FtsZ-CFP were grown in the absence (top panels) or presence of PC190723 
(10 µg/ml) (bottom panels) for 30 min and analysed by fluorescence 
microscopy. FtsZ-CFP localises to the division site in control cells but 
appears in multiple rings and arcs seen drug-treated cells. Right panels are 
companion phase-contrast images. (B), MRSA COL cells expressing sGFP-
PBP2 were grown in the absence (top panels) or presence (bottom panels) of 
PC190723 as described in (A) and similarly processed for fluorescence 
microscopy. sGFP-PBP2 localises at the division site in control cells but in 
broad patches of sGFP-PBP2 fluorescence around the cell periphery in drug-
treated cells. Right panels are companion phase-contrast images. Scale bars, 
1 µm. 
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Figure 2. Septal localisation of FtsZ-CFP and sGFP-PBP2 is unaltered in 
nalidixic acid-treated MRSA cells. (A), MRSA COL cells expressing FtsZ-
CFP were grown in the absence (left) or presence (right) of 100 μg/ml 
nalidixic acid (1X MIC) for 30 min and analysed by fluorescence microscopy. 
(B), MRSA COL cells expressing sGFP-PBP2 were identically grown in the 
absence (left) or presence (right) of nalidixic acid and analysed by 
fluorescence microscopy. Arrows indicate examples of FtsZ-CFP (A) and 
sGFP-PBP2 (B) localisation to the division site. Scale bar: 1 µm. 
 
DNAC-1 impairs cell wall synthesis in MRSA 
A mechanistically unbiased viability screen was done at the 
New England Regional Centers of Excellence (NERCE) to identify 
small molecules that have an inhibitory activity either alone or in 
combination with a β-lactam32. One of the most promising 
compounds identified was DNAC-1 (Fig.3a), which had the lowest 
MIC (4 µg/ml) against CA-MRSA strain USA300. DNAC-1 was found 
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to potentiate the effects of different classes of antibiotics but is 
synergistic only with cell wall targeting antibiotics against MRSA32. 
Furthermore, DNAC-1 was shown to be bactericidal against MRSA 
on its own but was more effective in combination with oxacillin, as a 
combination of 4× MIC of DNAC-1 with 0.25× MIC of oxacillin led to 
the complete eradication of all viable cells in a culture of USA300 in 4 
hours32. Based on the observed synergy between DNAC-1 and β-
lactams, we decided to investigate if the mode of action DNAC-1 was 
related to the inhibition of cell wall synthesis. To this end, we used an 
assay which measures the incorporation of [3H]lysine into 
peptidoglycan in the presence of chloramphenicol (which inhibits 
protein synthesis) while allowing the incorporation of radiolabeled 
lysine into the pentapeptide of the peptidoglycan chain. Ampicillin 
was used as a positive control. As shown in Fig. 3, treatment with 
DNAC-1 led to a reduction in lysine incorporation into the nascent 
cell wall compared to the untreated control, at a level comparable to 
that with β-lactam antibiotic ampicillin. 
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Figure 3. Structure of DNAC-1 (a) and percent inhibition of cell wall 
biosynthesis of S. aureus by DNAC-1 (b), as measured by inhibition of 
radiolabeled lysine incorporation into nascent peptidoglycan. In (b), 
bacteria were treated with either DNAC-1 or ampicillin (positive control) for 
20 min in the presence of radioactive cell wall precursors. The data are 
presented as the percent inhibition compared to the untreated control. 
 
To further assess the effect of DNAC-1 on cell wall 
morphology, USA300 cells were treated with DNAC-1 (2× MIC) for 
90 min, fixed, dehydrated, and observed under transmission electron 
microscopy (TEM). The cell wall thickness of the treated cells, 
evaluated in up to 30 different fields, was found to be increased 
compared to that of the untreated cells (Fig. 4), with mesosome-like 
invaginations16 of the cell membrane into the cytosol along the cell 




Figure 4. Effect of DNAC-1 on cell wall, as observed by TEM. USA300 cells 
were grown to mid-log phase and treated with DNAC-1 for 90 min or left 
untreated (control). The cells were then collected and processed for EM, as 
described in Experimental Procedures. (A), Mesosome-like invaginations are 
seen both along the peripheral cell wall (arrow, center) and along the 
septum (arrow, right). (B), DNAC-1-treated cells have a significantly thicker 
cell wall, as demonstrated in the box-and-whisker plot showing the standard 
deviation. The asterisk represents a statistically significant difference, at a P 
value <0.05, comparing the control to DNAC-1-treated cells. 
 
DNAC-1 causes mislocalisation of PBP2/4 and FtsZ  
The results of the macromolecular synthesis assay and 
increased cell wall thickness in the TEM studies prompted us to 
question whether DNAC-1 affects the enzymes involved in cell wall 
synthesis. Accordingly, we examined the localisation of PBP2 and 
PBP4, both of which are known to be involved in cell wall synthesis 
and antibiotic resistance31,33. A lack of PBP4 activity is also known to 
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result in thickened cell walls34,35. To study localisation, we used 
MRSA COL strains expressing functional sGFP-PBP2 or PBP4-YFP 
fluorescent fusions9,33. Exposing actively growing cells to DNAC-1 at 
either 0.5× or 2× MIC for 15 min prevented the localisation of PBP2 
and PBP4 to the septum, where they normally localise in dividing 
cells (Fig. 5a, left and centre). We quantified PBP localisation and saw 
that only 3% (n = 696) of the DNAC-1-treated cells had PBP2 correctly 
localised at the septum versus 36% (n = 493) of the untreated cells, 
while 13% (n = 652) of the DNAC-1-treated cells had septal PBP4, 
compared to 27% (n = 591) of the untreated cells. Since PBP2 
localisation has been shown to depend on the polymerization of FtsZ 
at mid-cell28, we thus determined if the delocalisation of PBP2 upon 
DNAC-1 treatment was due to impaired Z ring formation. 
Accordingly, exposure of a strain containing CFP-tagged FtsZ9 to 0.5× 
MIC of DNAC-1 for 15 min resulted in aberrant placement of FtsZ 




Figure 5. Delocalisation of PBPs and FtsZ and activation of cell wall stress 
stimulon by DNAC-1. (A), Localisation of PBP2, PBP4, and FtsZ was 
assessed using strains expressing either GFP-PBP2, PBP4-YFP, or FtsZ-CFP 
after treatment with 0.5× MIC of DNAC-1 for 15 min. Scale bars, 1 µm. (B), 
Activation of the vraSR operon was tested using strains containing a vraSR 
promoter driving sfGFP expression. In the presence of 2× MIC of DNAC-1, 
the mean ± standard deviation (SD) cell fluorescence was 3,594 ± 1,344 
arbitrary units (a.u.) (n = 468), while in the presence of 2× MIC of 
vancomycin (positive control), the mean ± SD cell fluorescence was 23,911 ± 
8,318 a.u. (n = 465). The left panel corresponds to cells in the absence of 
antibiotics, which showed a mean ± SD cell fluorescence of 2,196 ± 447 a.u. (n 
= 511). The P values were <0.0001 between the DMSO control and 
vancomycin-treated cells and <0.05 between the control and DNAC-1-
treated cells. Scale bars, 10 µm. 
 
Characterising the mode of action of novel small molecules effective against MRSA 
259 
Cell wall-active compounds have also been known to trigger 
the cell wall stress stimulon (CWSS) by upregulating the vraSR 
operon36,37. To assess if DNAC-1 would trigger a CWSS response, we 
constructed a COL strain encoding a transcriptional fusion between 
the vraSR promoter and the gene encoding a fast-folding variant of 
GFP, sfGFP. We found that upon treatment with 2× MIC of DNAC-1 
for 30 min, the sfGFP fluorescence signal in the cells was increased 
approximately 1.6 times compared to that with the mock-treated 
cells, indicating that the CWSS was triggered (Fig. 5b). However, the 
vraSR response to DNAC-1 was considerably weaker than the 
response triggered by vancomycin at 2× MIC (Fig. 5b, centre), a 
known activator of the cell wall stress stimulon37. 
DNAC-1 disrupts the bacterial membrane 
The membrane disruption seen in the EM study prompted us 
to further examine the effect of DNAC-1 on the membrane. To reduce 
any artefacts that may have been introduced into samples during 
TEM processing, we employed super-resolution fluorescence 
microscopy of unfixed MRSA cells to investigate membrane defects. 
Within 15 min of exposure to DNAC-1 at 2× MIC, membrane staining 
of MRSA strain COL with FM 4-64 revealed numerous membrane 
spots and bulges into the cell cytosol compared to the untreated cells 
(Fig. 6a). These findings are in agreement with the mesosome-like 
structures visualized by TEM. No changes were observed in cell wall 
staining (Fig. 6b) using fluorescently labelled vancomycin. We also 
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monitored changes in membrane permeability with propidium 
iodide staining upon treatment with DNAC-1 at 2× MIC. The cells 
treated with DNAC-1 were rapidly permeabilised, as after 1 hour of 
exposure, ∼55% of the bacterial cells showed propidium iodide 
staining, indicating a loss of cell membrane integrity (not shown). 
 
 
Figure 6. Disruption of the cellular membrane integrity by DNAC-1. Cells 
were either untreated (control) or treated with 2× MIC of DNAC-1 for 15 min 
and stained with FM 4-64 to visualize the membrane (A) and Bodipy-FL-
vancomycin (green) to visualize the cell wall and Hoechst 33342 dye (blue) 
to see the DNA (B). DNAC-1 treated cells showed extensive membrane 
damage and condensation of the nucleoid. Scale bar, 1 µm. 
To investigate if DNAC-1 disrupts membrane potential, we 
used the dye DiOC2, which typically aggregates as a function of 
membrane potential. Upon treatment of USA300 with 2× to 8× MIC of 
DNAC-1 (8 to 32 μg/ml), there was gradual dissipation of the 
membrane potential, as monitored by the loss of red fluorescence, 
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due to a loss of aggregation of DiOC2 (Fig. 7). However, this decrease 
in membrane potential was less than that caused by the positive 
control, CCCP, a known proton translocator. Loss of cell viability 
paralleled the decrease in membrane potential, as confirmed by the 
colony forming units (CFU) counts at appropriate time points in the 
DNAC-1-treated cells compared with those of the untreated control 
(data not shown). 
 
Figure 7. DNAC-1 causes rapid membrane depolarization. Actively 
growing USA300 cells were back-diluted, resuspended in PBS with glucose, 
and treated with DiOC2 for 30 min in the dark at 25°C. A loss of fluorescence 
was monitored over time upon the addition of increasing concentrations of 





 Resistance to last resort antibiotics vancomycin, daptomycin 
and linelozolid is emerging in MRSA8. Despite this, large 
pharmaceutical companies have decreased investment in research 
and development of new antimicrobials, due to low financial returns. 
As the pharmaceutical pipeline is waning, understanding the 
activities of the few novel antibiotics that reach the market and the 
propensity of bacteria to evolve resistance against them is of the 
utmost importance. Therefore it is essential to investigate the mode of 
action of novel antibiotics, i.e. the effects that a certain inhibitor has 
on the viability of the bacterial cell as a whole10. This type of studies 
may also reveal previously unidentified relationships between 
biochemical pathways in the cell, which allows for more efficient 
future drug design38,39. Towards this goal, we have used a cell biology 
approach to contribute to the characterisation of the mode of action of 
two novel small molecules that are efficient against MRSA either on 
their own or in combination with commonly used β-lactam 
antibiotics.  
 Previous studies identified that the potent and selective FtsZ 
inhibitor PC190723 showed strong synergy against MRSA COL, 
specifically in combination with β-lactam imipenem. The molecular 
basis for this synergy is difficult to address, because FtsZ has a central 
role during the bacterial cell cycle, as it directly or indirectly recruits 
to the mid-cell most proteins that constitute the divisome26,40. 
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Consequently, inhibiting FtsZ activity with PC190723 disrupts all cell 
wall biogenesis processes including peptidoglycan synthesis, cross-
linking and hydrolytic peptidoglycan degradation26,28,41,42. 
Nevertheless, it has been shown that the molecular targets of β-
lactams, the PBPs, depend on the presence of FtsZ at mid-cell for 
recruitment28,43,44. Therefore we decided to investigate if PC190723 
would prevent the correct assembly of the Z-ring at mid-cell with 
concomitant delocalisation of the major S. aureus PG synthase PBP2 in 
COL.  
Treatment with PC190723 prevented correct FtsZ localisation, 
in accordance to what had been previously observed in Bacillus 
subtillis, although in these bacteria FtsZ appeared as multiple foci30, 
whereas we observed multiple rings and arcs of FtsZ in COL. 
Importantly, PBP2 was also delocalised in PC190273-treated cells. As 
β-lactam resistance in MRSA is mediated through the cooperation 
between PBP2 and β-lactam insensitive PBP2A45, PBP2 delocalisation 
in PC190723-treated cells is expected to result in deleterious effects to 
the cell. Therefore we postulate that the synergy between PC190723 
and β-lactam antibiotics is partly due to the delocalisation of FtsZ 
which in turn prevents the recruitment of PBP2 to the septum, so that 
a substantially reduced concentration of the β-lactam is sufficient to 
inhibit any residual correctly localised PBP2. This synergy is likely 
amplified by a network of other factors. For example, mid-cell 
recruitment of MurJ, the enzyme likely responsible for translocating 
the peptidoglycan precursor lipid II across the membrane, also 
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requires the assembly of a functional FtsZ ring46. Because PBP2 
localisation to the septum is also dependent on peptidoglycan 
precursor recognition31, FtsZ-mediated delocalisation of MurJ would 
similarly enhance β-lactam activity. The intricacies of chemical 
synergy between PC190723 and β-lactam antibiotics are highly 
complex but it is exactly the complexity of this network of 
interactions between FtsZ and downstream divisome components, 
including PBPs, which can be exploited towards developing 
combination strategies against MRSA.  
 The second compound studied, DNAC-1, was identified in a 
mechanistically unbiased screen to search for small molecules that 
work in conjunction with a β-lactam antibiotic, by the A. Cheung 
laboratory. DNAC-1 demonstrated potent inhibitory activity, not 
only in combination with β-lactams, but also on its own, against 
many Gram-positive bacteria, including MRSA. Moreover, DNAC-1 
also potentiated the effects of ceftriaxone against resistant Gram-
negative clinical isolates, suggesting it could be a viable option for 
broad spectrum antibiotic therapy. As DNAC-1 showed synergy with 
β-lactams we hypothesised that it could be inhibiting cell wall 
synthesis. Treatment with DNAC-1 resulted in decreased 
incorporation of radiolabelled lysine into nascent peptidoglycan and 
induced the cell wall stress response operon vraSR in MRSA COL, 
albeit to low levels, suggesting cell wall damage. Additionally, 
DNAC-1 also prevented the correct placement of the FtsZ ring at 
mid-cell, with concomitant delocalisation of PG synthases PBP2 and 
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PBP4, similarly to the effects observed following PC190723 treatment, 
as described above. However, in contrast to PC190723, we found that 
S. aureus cells exposed to DNAC-1 rapidly became permeabilised 
(within 15 minutes), as indicated by uniform propidium iodide 
staining throughout the cell population.  
Because bactericidal activity due to cell wall synthesis 
inhibition is generally a slow process10, we wondered whether 
DNAC-1 would elicit direct membrane damage in cells. Accordingly, 
we noticed extensive membrane damage in treated cells, 
characterised by lipid bulges and invaginations, as seen in SIM 
images, and mesosome-like structures when cells observed by TEM, 
reminiscent of membrane disruption caused by cationic antimicrobial 
peptides47. Analysis of the cell membrane potential revealed a quick 
depolarization of the membrane, coinciding with a loss of viability. 
These data led us to suggest that DNAC-1 may exert a bimodal 
molecular mechanism on the bacterial membrane and cell wall, 
similarly to what has been described for daptomycin48.  
We propose that the bactericidal effect of DNAC-1 occurs in 
two stages, in which the first stage involves permeabilisation of the 
membrane, followed by the inhibition of cell wall synthesis due to 
impaired divisome assembly and subsequent lack of recruitment of 
PG synthases, including PBP2 and PBP4. This model suggests that the 
combined use of a β-lactam and DNAC-1 would increase the 
antibacterial efficiency, by further decreasing PG synthesis. The 
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identification of the exact molecular target of DNAC-1 in the bacterial 
membrane would be an interesting pursuit, as it could reveal novel 
interactions between membrane and divisome components.  
It is also possible that the rapid permeabilisation of the 
membrane by DNAC-1 is by itself sufficient to suspend all 
biochemical pathways in the cell, in which case the observed halt in 
divisome assembly comes as a consequence of a multitude of 
pathways failing. While DNAC-1 was shown to potentiate the effects 
of other classes of drugs, including those that affect DNA synthesis 
(norfloxacin, levofloxacin) and protein synthesis (tetracycline), 
synergy was only observed with cell wall active antibiotics32, which 
support a direct role for DNAC-1 in PG synthesis inhibition. 
Nevertheless, we cannot discard the possibility that this synergistic 
relationship is merely a result of facilitated access of DNAC-1 to its 
target in the membrane, due to the peptidoglycan layer being 
compromised. Alternatively, loss of proton motive force (PMF) 
following membrane depolarization triggered by DNAC-1 may 
indirectly lead to cellular death through impairment of essential 
cellular functions, as it has been shown that dissipation of the PMF 
alone is not bactericidal49. For example, it has been reported that in B. 
subtilis the acidification of the cell wall during growth regulates 
autolytic murein hydrolases50. In this way, loss of PMF may cause 
increased autolytic activity and consequent cell death due to 
degradation of the cell wall. 
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 PC190723 and DNAC-1 are chemically distinct small 
molecules with different targets in the bacterial cell. Nevertheless 
both ultimately impair the assembly of the division machinery and 
consequently peptidoglycan synthesis at the septum, which has a 
bactericidal effect. PC190723 was well tolerated and highly efficient in 
combination with imipenem in a murine model of MRSA infection9. 
However, the frequency of resistance to PC190723 was very high, 
therefore it should not be considered a viable option for single agent 
therapy. DNAC-1 toxicity was assessed in cells of Candida albicans, 
cultured human bronchial epithelial cells and sheep erythrocytes, and 
did not perturb eukaryotic cell membranes at concentrations suitable 
for therapy32. As such, pending clinical trials both of these small 
molecules seem potentially viable options as therapeutic agents 
against MRSA, preferably in synergy with existing β-lactams. 
 The work described in this chapter demonstrates the 
usefulness of a cell biology approach, in combination with 
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New approaches to study an old foe 
 The pathogen Staphylococcus aureus constitutes one of the 
major human afflictions. Nearly a century of research into antibiotic 
development has resulted in a myriad of drugs efficient against S. 
aureus infections. Nevertheless this pathogen continues to adapt its 
biological processes to develop resistance to treatment. Great efforts 
have been made to develop antibiotics against a single target, but the 
frequency of acquisition of resistance to these types of drugs tends to 
be high. Nearly all of the most useful antibiotics discovered so far 
have various targets (different PBPs, ribosomal proteins encoded by 
deveral genes, membrane motifs), which makes development of 
resistance more difficult for bacteria. There is a clear need for new 
strategies to deal with MRSA (and other emerging drug-resistant 
bacteria) and I firmly believe that continued research into the 
biological processes of bacterial cells will provide knowledge of many 
potential pathways that can be exploited for drug development, with 
more success than single targets. 
Despite its clinical relevance, less is known about the 
fundamental biology of the S. aureus cell than of laboratory 
workhorses Escherichia coli and Bacillus subtilis. This is partly because 
the small size of S. aureus cells (which average 1 µm in diameter1, 
corresponding to only four times the resolution limit of conventional 
light microscopy) has hindered attempts to precisely measure 
morphological changes during the cell cycle; and partly due to 
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limited availability of molecular biology tools to study protein 
localisation in vivo2. In recent years the advent of Super-Resolution 
Microscopy techniques coupled with the development of new vectors 
to study protein localisation coming from our laboratory2, and 
others3,4, has allowed us to characterise in detail how S. aureus grows 
and divides and how it coordinates peptidoglycan synthesis with its 
cell cycle. 
When investigating the S. aureus cell cycle I have often looked 
back at the earliest attempts, specifically the observations of Tzagoloff 
and Novick1, during the late 70s. Using time-lapse microscopy to 
follow single S. aureus cells during their lifecycle, the authors made 
two astute observations: firstly that “the cells began to swell in 
preparation for division” and secondly that “the separation of the 
two daughter cells occurs with a rather abrupt popping motion”1. 
Taking advantage of the increase in imaging resolution provided by 
SIM, we could elaborate on past observations. S. aureus cells grow 
continuously throughout their cell cycle, effectively doubling their 
size from an average initial volume of 0.47 µm3 to a final volume of 
0.91 µm3, and this growth is accompanied by slight cell elongation5. 
Therefore cell growth in S. aureus is more similar to rod-shaped 
bacteria than what was previously thought, as B. subtillis6 and E.coli7 
also increase in cell volume continuously throughout the cell cycle. 
However, the increase of cell volume in rods is strictly due to cell 
elongation, as the width of the cell remains constant6, whereas in S. 
aureus both cell length and width increase with the cell cycle5. We 
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characterised the S. aureus cell cycle by assigning cells to three phases 
– Phase 1 (P1) cells have recently divided and have not started 
synthesising the septum; Phase 2 (P2) cells are synthesising the 
septum; Phase 3 (P3) cells have finished septum synthesis, which is 
undergoing maturation, and are going to generate two identical 
daughter cells. Cells spend half of their cell cycle in P1 and the other 
half equally on P2 and P35. Cell growth is more pronounced during 
P3 (0.008 µm3/min), corresponding to the swelling observed by 
Tzagaloff and Novick1, and only Phases 1 and 3 are periods of cell 
elongation.  
We then wondered about the mechanisms behind this 
increase in cell volume. This could simply be a mechanical process, 
where the doubling of the cell’s internal contents in preparation for 
division (including DNA replication and protein synthesis) would 
cause an increase in internal turgor pressure8, which would exert an 
outward force stretching the bacterial membrane and cell wall, 
leading to cell enlargement9. While peptidoglycan could be flexible 
enough to bear the stretching of the membrane10, it would ultimately 
lead to the overall thinning of the bacterial surface in tandem with the 
progression of the cell cycle. This was never observed in transmission 
electron microscopy imaging of S. aureus, where the peripheral cell 
wall appears homogeneous in thickness11,12. It is therefore more likely 
that both peptidoglycan synthesis and autolysis are necessary during 
the cell cycle, to retain cell surface integrity.   
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We considered two hypotheses for the increase in surface area 
during the cell cycle: i) the new wall material (which came from the 
septum of the mother cell) is selectively remodelled and enlarged 
during the cell cycle; or ii) the septum quickly reshapes into a curved 
surface during division and then the entire cell surface is remodelled 
during the cell cycle. We found that the latter hypothesis is correct 
based on two pieces of evidence. Firstly we saw that upon splitting of 
the mother cell and reshaping of the flat septum to a curved surface, 
the material coming from the septum only constitutes approximately 
40% of each daughter cell surface5. With the progression of the cell 
cycle and concomitant cell growth, this percentage did not change i.e. 
the “new” wall material still constituted 40% of the cell surface at the 
end of the life cycle5. This showed that new wall material was not 
selectively remodelled to increase in surface area, compared to the 
rest of the cell wall, because if that was the case the new wall would 
expand to occupy an increased fraction of the cell surface. The second 
piece of evidence came when we used a fluorescent derivative of D-
alanine that is incorporated in the stem peptide of PG precursors 
during PG synthesis13. We found that PG is incorporated all around 
the cell surface, particularly during Phase 1, and is dependent on the 
activity of the major PG synthases, the PBPs, similarly to septal PG 
insertion. When we deleted the non-essential PBP4, cells incorporated 
less peripheral PG5, in agreement with Gautam et al.14, and took a 
longer time to complete P1, suggesting that at least PBP4 is involved 
in this process.  
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Although we mostly focussed on the dynamics of PG 
incorporation, PG remodelling through autolytic activity is likely as 
important during the progression of the cell cycle, because chemical 
bonds in the existing structure must be broken to allow for the 
insertion of new material15. For example, the cytoskeleton machinery 
of B. subtillis includes LytE, a hydrolase that promotes cell 
elongation16; and LytM is required for the helical shape of Helicobacter 
pylori17. Accordingly, we saw that an S. aureus Atl mutant generated 
larger and less elongated cells than wild-type, implicating a function 
for Atl in cell size homeostasis and shape maintenance. 
Understanding how PG synthesis and remodelling are coordinated 
during the cell cycle is an exciting area of research with many open 
questions. One challenge is to explain how autolysins such as Atl 
specifically act on old glycan layers while leaving the nascent glycans 
intact. Perhaps autolysins localise to the outer layers of the cell wall 
and are unable to reach the inner layers or, alternatively, it is possible 
that new glycans are chemically modified to prevent premature 
autolysin activity and this modification is progressively removed 
during the cell cycle.  
Dynamics of septum reshaping in S. aureus 
Taken together, our data challenged the previous model for 
cellular growth in S. aureus stating that cocci only synthesised new 
PG at the septum during division, and that the doubling of the cell 
volume occurred upon splitting of the mother cell, when the flat 
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septum is reshaped into a curved hemisphere18. We therefore decided 
to revisit this question and investigate the dynamics of the reshaping 
of the flat septum, which correspond to the “popping” motion1 
described above. We used a fast camera to determine the timescale of 
this event and found that it is an extremely rapid process, occurring 
in less than 2 ms, which is the time resolution limit of our camera. 
Moreover, we found that there was no substantial increase in cell size 
immediately after popping, with each daughter cell having 
approximately half of the volume of their mother cell5. Because 
popping is so quick, we wondered whether this is purely a 
mechanical process driven by internal turgor or whether it requires 
enzymatic activity. 
Previous studies using atomic force microscopy have revealed 
the presence of perforation holes around the outer edge of the 
septum, which become larger as synthesis of the septum proceeds19. It 
has been suggested that these holes result from the activity of 
autolysins, including Atl, which localises at the external edge of the 
septum and is important for cell splitting20,21. Autolysins Sle1 and 
LytN were also shown to localise to the septum through their LysM 
domains, as reported by Frankel and Schneewind22, who proposed 
that autolysin-mediated processive cleavage of the septum is 
required for cell separation. Alternatively, it has been suggested that 
cell splitting can be independent of hydrolase activity and simply 
result from high circumferential mechanical stress, which generates a 
crack that propagates throughout septal PG23. We have shown that a 
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mutant deficient of amidase Sle1 takes much longer to complete 
Phase 3 of the cell cycle, (corresponding to the period of septum 
maturation) with future daughter cells initiating the next division 
cycle before the complete splitting of the mother cell, suggesting that 
Sle1 has a role in cell separation5.  
Even though autolysin activity is likely required for daughter 
cell splitting, it was still unclear whether it was necessary for the 
reshaping of the flat septum, as these could be two separate events. 
We found that popping is dependent on both internal turgor and 
autolytic activity, as we observed the presence of D-shaped cells (that 
is cells in which the flat septum failed to expand) in mutants deficient 
of autolysins Sle1 and LytM, which increased in frequency in high 
osmolarity conditions5. We proposed that during Phase 3 of the S. 
aureus cell cycle, autolysin activity creates nicks in septal 
peptidoglycan, which both facilitates daughter cell detachment and 
structurally loosens peptidoglycan, allowing turgor-driven expansion 
of the flat septum surface once cells separate5.  
 
One peptidoglycan synthesis machinery - two locations 
 Our studies of the cell shape dynamics during the S. aureus 
cell cycle revealed that peptidoglycan synthesis and incorporation 
occurs continuously during the lifecycle of these bacteria. One 
interesting observation was that the incorporation of PG precursors 
shifts from the periphery of the cell during Phase 1 of the cell cycle to 
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almost exclusively at mid-cell for initiation of the synthesis of the 
septum5. The rod-shaped organisms E.coli and B. subtilis possess two 
PG synthesis machineries dedicated to either peripheral or septal PG 
synthesis. In these organisms, peripheral PG synthesis is coordinated 
by the actin-like cytoskeletal protein MreB, while septal synthesis is 
coordinated by the tubulin homologue FtsZ. In contrast, S. aureus has 
a single machinery that must ensure PG incorporation at both the cell 
periphery and the septum18. Therefore the next question we asked 
was: what is the molecular cue that signals for the transition from 
peripheral to septal PG synthesis? 
PG synthesis is one of the most conserved biochemical 
synthesis pathways in bacteria18. Most proteins involved in PG 
synthesis are essential, particularly those which catalyse the 
cytoplasmic24 and inner membrane steps25. We reasoned that shifting 
PG synthesis from the periphery to mid-cell could be as simple as 
redirecting one core protein (or step) of PG synthesis to the right 
place at the right time. If this was true then this protein would have 
to localise exclusively to mid-cell in preparation for division, in order 
to direct PG incorporation there. We studied the localisation pattern 
of most PG synthesis proteins and found three possible candidates 
which strictly localised to the septum during division – the putative 
flippase MurJ, the putative transglycosylase FtsW and the 
transpeptidase PBP126. Further, it seemed likely that the candidate 
protein would arrive early to the division site and therefore could be 
recruited to mid-cell during the assembly of the divisome, which has 
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been shown to occur in two stages in B. subtillis27. We performed co-
localisation experiments with FtsZ and DivIB, as markers for the first 
and the second stages of divisome assembly, respectively, and found 
that FtsW and PBP1 arrive to the divisome approximately at the same 
time as DivIB, while MurJ arrived later than the remaining proteins. 
We showed that MurJ recruitment to the divisome was dependent on 
the assembly of the FtsL/DivIB/DivIC subcomplex, as depleting the 
expression of either protein prevented the recruitment of MurJ to the 
mid-cell26. Initially we were expecting the arrival of FtsW or PBP1 (or 
both) to the mid-cell to be the molecular cue directing PG synthesis to 
the septum, rather than of MurJ, due to their earlier recruitment to 
the divisome. On the contrary, PG incorporation at mid-cell was only 
observed when MurJ was present at mid-cell as well, indicating that 
MurJ is the PG synthesis protein that determines the shift from 
peripheral to mid-cell PG synthesis.  
This led us to propose a model where the sole PG synthesis 
machinery of S. aureus incorporates lipid II all around the cell surface 
during the initial stages of the cell cycle. During divisome assembly, 
the DivIB-DivIC-FtsL complex recruits MurJ to the mid-cell which 
ensures that all lipid II translocation is occurring in that region. 
Substrate affinity28 then diverts the major synthase PBP2 to mid-cell 
where it incorporates lipid II specifically in that region, leading to 
septal PG synthesis. This allows S. aureus to bypass the need for a 
cytoskeletal MreB-like machinery dedicated to peripheral PG 
synthesis and constitutes a novel mechanism in prokaryotes, where 
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PG is incoporated at two locations using the same multi-protein 
machinery. 
 The timing of MurJ arrival to the divisome is particularly 
interesting. It has been shown that the DivIB-DivIC-FtsL complex 
only assembles after FtsK localises to the divisome29. FtsK is part of a 
family of DNA translocases which pump DNA away from the 
division site, preventing bisection of the nucleoid by the septum30,31. 
The function of the DivIB-DivIC-FtsL complex can therefore 
constitute a checkpoint system that signals that DNA segregation is 
underway and, through MurJ recruitment, allows PG incorporation 
to initiate at the septum. Nevertheless, we did not investigate direct 
protein-protein interactions between the subcomplex and MurJ. It is 
therefore possible that another unknown factor is involved in the 
divisome hierarchy between the two proteins. It would also be 
interesting to explore the mechanisms of membrane synthesis at mid-
cell. Similarly to PG synthesis, phospholipid incorporation at mid-cell 
must be coordinated by the assembly of the divisome, as we never 
observed septal membrane in cells where FtsZ polymerization was 
impaired26,32 or in cells depleted of DivIB/DivIC/FtsL26. Perhaps both 
peptidoglycan and phospholipid incorporation have to occur 
precisely at the same time in order to maintain the integrity of the 
septum. 
The functions of the SEDS putative TGase FtsW and 
transpeptidase PBP1 are still unclear. Our data shows that FtsW and 
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PBP1 are recruited to the divisome at approximately the same time, 
suggesting they could function together as a cognate SEDS/PBP pair 
involved in PG incorporation26. This would be similar in function to 
the RodA/PBPH and FtsW/PBP2B pairs, which were proposed by 
Meeske et al.33 to be involved in PG polymerization during elongation 
and septation in B. subtilis, respectively. However, recruitment of 
FtsW/PBP1 to the divisome precedes that of MurJ and their activity 
presumably requires a flipped substrate. If MurJ is the sole flippase in 
the cell, why are FtsW/PBP1 recruited first to the divisome? It has 
been shown that FtsW can translocate lipid-linked precursors in 
purified E.coli membrane vesicles34, but flippase activity was not 
observed in vivo35. It is possible that the S. aureus FtsW/PBP1 pair 
functions in an early stage of septal synthesis where it both flips and 
incorporates a small initial pool of lipid II that provides a skeleton for 
subsequent mass PG incorporation, mediated by MurJ and PBP2. 
Accordingly, when we inhibited MurJ activity using DMPI we saw a 
drastic reduction in septal HADA incorporation but it was not 
completely abolished26, suggesting the presence of a MurJ-
independent mechanism for HADA septal incorporation. However, it 
has been shown that PBP4 activity can directly exchange D-Ala 
termini by HADA in the stem peptides of mature PG14,36, which could 
explain why DMPI did not completely abolish HADA incorporation.  
 One curious aspect we noticed when investigating antibiotic 
effects on cell cycle progression of S. aureus was that cells treated with 
the FtsZ inhibitor PC190723 were uniformly and specifically stalled in 
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Phase 1 of the cell cycle26. While it was expected that cells that were in 
Phase 1 would not be able to synthesise a septum in the absence of a 
proper FtsZ ring and thus progress in the cell cycle, we were 
surprised to observe that the majority of cells in Phase 2 were 
perfectly able to complete the cell cycle. These data suggested that 
FtsZ treadmilling during septum synthesis (P2) was not required for 
cytokinesis, which contrasted with existing models. It has been 
proposed that the force for cytokinesis is provided by FtsZ, which 
generates a contractile force that, through membrane anchor FtsA, 
pulls the bacterial membrane inwards37,38. Alternatively it has been 
suggested that the force that drives cytokinesis could come from PG 
synthesis at the septum37,39. To investigate this, subsequent work done 
in our lab focussed on measuring the constriction rates of FtsZ rings 
during cytokinesis in the presence or absence of PC190723. In the 
absence of inhibitor, it was observed that FtsZ rings constrict in two 
stages, an initial slow stage and a second faster stage26. Inhibiting 
FtsZ treadmilling with PC19023 blocked constriction only of rings 
that were at the initial slow stage, indicating that another force 
independent of FtsZ treadmilling was responsible for the constriction 
of second stage Z-rings. Accordingly, the onset of the fast constriction 
step coincided with the arrival of MurJ (and PBP2) to the divisome. 
Furthermore, inhibition of MurJ halted the constriction of Z rings at 
all stages and prevented cytokinesis26. Taken together it seems that 
cytokinesis in S. aureus occurs in two steps: a slow first step where 
FtsZ treadmilling organises the assembly of the divisome and a 
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second, faster step, where MurJ recruitment to the divisome drives 
PG incorporation to the mid-cell, providing constrictive force 
required for cytokinesis. 
 
Peptidoglycan crossbridges as targets for drug design 
 The integrity of the peptidoglycan layer is paramount to the 
viability of most bacterial cells10. The PG layer protects the cell from 
environmental factors, including variations in osmolarity, pH and 
temperature. One of the main roles of PG is to withstand the cell’s 
internal turgor, which is only possible due the flexibility of its cross-
linked glycan chains10. In essence PG is akin to a mesh, or a spider 
web, in the sense that it is strong but flexible enough to dilate as the 
cell grows and expands its size without breaking.  
We have shown that the pentaglycine crossbridges in S. aureus 
PG are required to withstand the cell’s internal turgor. When we 
depleted expression of FemAB, the enzymes that add glycines 2-5 to 
lipid II-Gly1, we observed extensive membrane damage resulting in 
cell lysis, suggesting that in the absence of pentaglycine crosslinks PG 
loses structural integrity and the cell bursts. S. aureus femAB mutants 
have been isolated in the past through selective antibiotic pressure40. 
While a secondary suppressor or compensatory mutation was never 
found, it was shown that femAB mutants were are able to survive by 
severely adapting their biochemical processes, presumably to 
alleviate turgor, including upregulating the expression of 
General Discussion and Conclusions 
287 
transporters for osmoprotectant molecules such as glycerol and 
glycine betaine, or downregulating nitrogen metabolism41. It would 
be interesting to directly measure turgor pressure inside wild-type 
and adapted femAB mutant cells to determine the decrease in internal 
pressure required for the cell to survive without pentaglycine 
crosslinks.  
In any case, modulation of metabolic pathways is apparently 
not sufficient by itself for the cell to survive without pentaglycine 
crosslinks. Adapted femAB null mutants also seem to have a starkly 
different PG structural organisation than wild-type, with longer 
glycan chains and lower percentage of cross-linked glycans40,42,43. 
When we depleted femAB expression, which results in the synthesis 
of lipid II species substituted with one glycine instead of five, we did 
not detect the appearance of extra peaks which could correspond to 
monoglycyl-substituted crosslinked di-, tri-, tetra- or pentamers. 
Rather we observed an overall decrease of all pentaglycine 
crosslinked species, suggesting that lipid II-gly1 is not a valid 
substrate for PBP transpeptidation (TP). However, recent data from 
Suzanne Walker’s group44 has shown that PBP2 can use lipid II-gly1 
(and lipid II-gly3) as a substrate for TP in vitro, albeit to a lesser extent 
than lipid II-gly5. This was in contrast to other TPases such as PBP2A 
and PBP4 which did not act on lipid II-gly144. In light of this evidence 
we decided to revisit our data and noticed that in PG profiles of i) a 
conditional femAB mutant grown with low femAB expression and of 
ii) a femA point mutant carrying a KR180AA mutation (with reduced 
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FemA activity), there was a marked accumulation of a dimer species 
that had been previously detected in low amounts in S. aureus45, but 
with unknown chemical composition. This species could be a 
monoglycine substituted dimer resulting from PBP2 TP activity. 
Nevertheless, as mentioned above, we did not observe alternative 
higher order crosslinked species, indicating that perhaps PBP2 is able 
to crosslink monoglycine substituted monomers but loses activity on 
dimers, trimers, tetramers, etc.  
Given the importance of pentaglycine crossbridges for the 
structural stability of the S. aureus peptidoglycan and since the femAB 
operon is exclusive to these bacteria, Fem proteins seem good 
candidates for MRSA-specific drug design. We have shown that 
depletion of FemAB effectively causes cell lysis due to loss of 
membrane integrity in CA-MRSA strain MW2, indicating that a 
FemA inhibitor could be potent against infections caused by MRSA. 
However, femAB mutants which have developed adaptations to 
survive with reduced crossbridges have been isolated in the past41,46-
48, raising concerns that the same adaptation and, consequently, 
emergence of resistance could occur during therapy with a FemA 
inhibitor. The upside is that MRSA femAB mutants become 
hypersusceptible to β-lactams46,49, most likely because resistance 
determinant PBP2A is unable to crosslink monoglycyl substituted 
species44, even after rearrangements of PG tertiary structure42. 
Therefore a possible strategy would be to supply FemA inhibitors in 
combination therapy with a β-lactam antibiotic to treat MRSA 
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infections. To my knowledge the only FemA inhibitor which has been 
described so far is cyslabdan, a small nonantibiotic produced by 
Streptomyces K04-0144 isolated in Okinawa50. Although cyslabdan 
potentiated the effect of imipenem against MRSA, it was non-lethal 
by itself and HPLC analysis of muropeptides revealed no changes in 
higher order cross-linking, which are indicative of reduced FemA 
activity51. Similarly to the in vivo effects, incubation of lipid II-gly1 
with FemA in the presence of cyslabdan led to a modest reduction of 
protein activity, indicating that cyslabdan is only a partial inhibitor of 
FemA51. Towards the future development of a more potent FemA 
inhibitor we have observed that mutations in the α6 helix and in the 
1B subdomain of FemA led to a severe decrease in transferase 
activity. We posited that the former region stabilises the entering 
glycyl –charged tRNA molecules while the latter has been previously 
suggested to be the binding channel for the lipid II-gly1 substrate52,53. 
One possible avenue for specific FemA drug development could be 
the design of an analogue of a glycyl-charged tRNA molecule which 
would compete for the FemA active site, as presumably these are 
exclusively used by Fem proteins in the cell54. Such an analogue could 
be modelled to bind at the junction between the coiled-coil arms of 
FemA and the globular domain, stabilised by interactions with polar 
charged amino acids in the α6 helix, which we have identified as 




Mode of action of antibiotics and drug synergy 
 In the face of increasing bacterial resistance to antibiotics 
coupled with a generalised disinvestment towards research and 
development of new drugs to treat bacterial infections55, a clear 
understanding of the mechanisms behind antibiotic activity becomes 
essential. Part of this understanding comes from determining the 
mode of action of antibiotics, or in other words, what happens to the 
bacterial cell when faced with an inhibitor of a cellular function. 
Insights into antibiotic modes of action will allows us to predict (to 
some extent) which molecules will be more effective and the 
likelihood of bacteria developing resistance against different 
compounds56.  
The effects of a direct drug-target interaction are relatively 
simple to characterise. For example, linezolid binds ribosomes and 
stalls protein synthesis57, which is essential to the cell; ciprofloxacin 
inhibits DNA gyrase stalling DNA replication58, therefore cells cannot 
divide; cefotaxime binds PBPs and halts PG biosynthesis59, which is 
essential for the integrity of the cell envelope; nisin binds lipid II, 
causing membrane holes that leak ions60, disrupting cell homeostasis. 
However, the direct effect of primary target inhibition by an 
antibiotic is often merely the initial stage of a complex multi-layered 
mechanism leading to cellular death, and these mechanisms are not 
as well understood56. An example which illustrates this complexity 
pertains to the mode of action of quinolones, where binding of the 
General Discussion and Conclusions 
291 
quinolone to gyrase stalls DNA replication, which is by itself a 
bacteriostatic rather than bactericidal effect, in the sense that it 
prevents cell division without affecting cell viability. However, cell 
death then arises due to subsequent events during which the bacterial 
chromosomes are quickly fragmented. These events leading to cell 
death can be dependent on a variety of factors including deregulated 
protein synthesis, expression of toxin-antitoxin modules and the 
generation of reactive oxygen species58.  
The mode of action of antibiotics increases in complexity 
when combination therapy is considered. If treatment with a 
combination of two (or more) drugs results in lowered MICs for each 
drug, when compared to the individual MIC, then these drugs are 
synergistic61. Synergy is often (but not exclusively) observed when 
two agents affect the same biochemical pathway in the cell56. Such is 
the case for the cyslabdan/imipenem combination described above. 
Cyslabdan potentiates imipenem activity against MRSA essentially 
because both agents impair the same chemical reaction: 
transpeptidation of glycan strands catalysed by PBPs. In this way, 
cyslabdan inhibits the synthesis of the substrate (lipid II-gly5) of 
transpepetidation while imipenem inhibits the catalyst (PBP). 
Similarly, treatment with MurJ inhibitor DMPI also potentiates 
imipenem activity62, because DMPI prevents the translocation of lipid 
II-gly5 across the membrane26.  
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A less straightforward example relates to the synergy between 
PC190723 (which inhibits FtsZ treadmilling)63 and β-lactam 
antibiotics. When investigating the mode of action of PC190723 in S. 
aureus cells we noticed that FtsZ localisation was altered from the 
normal mid-cell position, instead appearing as extra rings and arcs 
seemingly in random positions in the cell32. This implied that the 
assembly of the divisome was impaired when cells were treated with 
PC190723, indicating that FtsZ-treadmilling in required to stabilise 
the S. aureus divisome. Because divisome assembly is a hierarchical 
process that is dependent on the sequential recruitment of proteins to 
the mid-cell64, we reasoned that PC190723 would prevent the correct 
localisation of PG synthases to mid-cell. Accordingly, we observed 
that PBP2 becomes dispersed throughout the cell surface in cells 
treated with PC19072332, similarly to previous studies showing 
dependence of FtsZ for correct PBP2 localisation65. Therefore even 
though PC190723 is effective on its own against MRSA because it 
prevents correct Z ring placement, it also synergises with β-lactam 
antibiotics due to both agents affecting PG synthesis at the septum. 
This effect probably extends to other combinations of inhibitors of 
steps of divisome assembly with β-lactams. Importantly, the 
frequency of resistance (i.e. the likelihood of appearance of a 
spontaneous mutation conferring resistance) to PC190723 in MRSA is 
very close to the value which is acceptable for a single-agent 
antibiotic (~10-8 events), with PC190723R spontaneous mutations 
invariably mapping to FtsZ32. On the other hand, MRSA PC190723R 
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isolates become markedly susceptible to β-lactam activity32, 
suggesting that this combination can constitute an option for 
antibiotic therapy. 
When investigating the mode of action of DNAC-1, a novel 
small molecule isolated in a screening for compounds synergistic 
with β-lactams, we found that incubation of S. aureus cells with 
DNAC-1 led to extensive membrane damage66. Furthermore, this 
membrane effect seemed direct rather than a downstream 
consequence of other pathways failing, as DNAC-1 rapidly caused 
membrane depolarisation and cell lysis66. Surprisingly DNAC-1 
revealed specific synergy with cell wall active antibiotics but not with 
other antibiotic classes, suggesting that its mode of action also 
involves perturbation of PG synthesis, directly or indirectly, in 
addition to membrane damage. In agreement, incubation of MRSA 
with DNAC-1 caused delocalisation of FtsZ and PG synthases 
PBP2/PBP4 within 15 minutes of exposure. Additionally, DNAC-1 
caused mild activation of the cell wall stress response operon vraSR, 
which is triggered when PG synthesis is impaired66. Therefore the 
mode of action of DNAC-1 shares some similarities with another 
membrane active compound, nisin, which also targets PG synthesis. 
Nisin forms pores in the membrane through lipid II binding, which 
both leads to rapid cell permeabilisation and interrupts PG 
synthesis60,67. Scanning electron microscopy imaging of E. coli and B. 
subtilis cells treated with nisin showed extensive membrane blebbing, 
similarly to what we observed with DNAC-168. Furthermore, studies 
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by Lages et al.69 have shown that nisin delocalises the elongation 
specific PG synthases PbpH and PBP2A in B. subtilis but, 
surprisingly, septation-specific PBP2B was unaffected. As PBP2B 
recruitment to mid-cell is dependent on the assembly of the 
divisome70, it can also be inferred that FtsZ localisation is not affected 
by nisin, although this has never been shown. Therefore DNAC-1 and 
nisin have a similar mode of action in terms of membrane effects but 
nisin only interferes with PG synthesis, while DNAC-1 also inhibits 
the assembly of the divisome66. It would be interesting to elucidate 
the precise molecular target of DNAC-1 in the bacterial membrane. 
This could be a PG synthesis lipid intermediate, akin to the 
mechanisms of nisin binding67, or alternatively, a putative membrane 
microdomain which is required for the assembly of the divisome. 
Both hypotheses are consistent with the observed synergy between 
DNAC-1 and β-lactam antibiotics66, as binding to either molecular 
target would potentiate the effects of inhibition of PG synthesis. 
However, a more likely interpretation is that the primary mode of 
action through which DNAC-1 kills bacterial cells is through 
destabilisation of the bacterial membrane, and that delocalisation of 
FtsZ and PG synthesis proteins constitutes a secondary effect.  
Antibiotics that disrupt bacterial membranes have quick 
bactericidal effects and the frequency of resistance is generally low71. 
Furthermore, these agents can disperse bacterial biofilms and readily 
kill metabolically dormant (persister) cells, which constitute an 
important factor associated with treatment failure due to inherent 
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resistance to most classes of antibiotics that target biosynthetic 
pathways71. As such, membrane active molecules such as DNAC-1 
have the potential to become powerful tools to treat persistent 
bacterial infections. A concerted effort into both improving the 
specificity and understanding the mode of action of these molecules 





In this thesis I have used different approaches to tackle the 
issue of escalating antibiotic resistance in bacteria, specifically 
focussing on clinically relevant S. aureus. My major goal was to 
investigate fundamental biological processes in this pathogen, 
specifically how it coordinates peptidoglycan synthesis and 
remodelling with the progression of its cell cycle. I then used this 
knowledge to study the mode of action of newly-developed 
antimicrobials, as well as to find new targets for antibiotic 
development.  
Although I believe we have made significant advances to the 
study of cell biology in bacteria, many questions still remain. Having 
determined the mechanism and timing of the recruitment of PG 
synthesis to mid-cell in S. aureus, I am most interested in investigating 
how it coordinates with DNA segregation and membrane synthesis. 
The ultimate objective would be to arrive at a complete model to 
septum synthesis, integrating the order of assembly of proteins, the 
timings of each process, and the structural dynamics between each 
component of the septum. It is likely that with further advances in 
technology, particularly towards the development of microscopy 
techniques, we will come to a virtually complete understanding of 
how bacteria function, down to each single molecule. Such 
knowledge will definitely prove invaluable, not only towards the 
design of better and more efficient antibiotics, but also to further 
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exploit the potential of bacterial cells as biological machines that can 
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